CHEBI ONTOLOGY - ANNOTATIONS |
|
The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/. The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
|
|
G |
A2m |
alpha-2-macroglobulin |
increases expression multiple interactions |
ISO |
Selenium results in increased expression of A2M mRNA Selenium inhibits the reaction [T-2 Toxin results in decreased expression of A2M mRNA]; Selenium promotes the reaction [T-2 Toxin results in decreased expression of A2M protein] |
CTD |
PMID:18997278 PMID:21144892 |
|
NCBI chr 4:154,897,770...154,947,787
Ensembl chr 4:154,897,877...154,947,786
|
|
G |
Aamp |
angio-associated, migratory cell protein |
increases expression |
ISO |
Selenium results in increased expression of AAMP mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 9:75,863,382...75,869,188
Ensembl chr 9:75,863,389...75,868,547
|
|
G |
Aass |
aminoadipate-semialdehyde synthase |
decreases expression multiple interactions |
ISO |
Selenium results in decreased expression of AASS mRNA [Selenium co-treated with Vitamin E] results in decreased expression of AASS mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 4:51,606,461...51,663,136
Ensembl chr 4:51,606,462...51,663,136
|
|
G |
Aatf |
apoptosis antagonizing transcription factor |
increases expression |
ISO |
Selenium results in increased expression of AATF mRNA |
CTD |
PMID:19244175 |
|
NCBI chr10:69,299,029...69,392,207
Ensembl chr10:69,299,037...69,392,201
|
|
G |
Abca7 |
ATP binding cassette subfamily A member 7 |
increases expression |
ISO |
Selenium results in increased expression of ABCA7 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 7:9,691,452...9,711,466
Ensembl chr 7:9,691,449...9,711,425
|
|
G |
Abcc2 |
ATP binding cassette subfamily C member 2 |
multiple interactions |
EXP ISO |
[Selenium deficiency co-treated with Vitamin E deficiency] results in decreased expression of ABCC2 mRNA [Sodium Selenite results in increased abundance of Selenium] inhibits the reaction [[Vancomycin co-treated with Neomycin co-treated with Ampicillin co-treated with Metronidazole co-treated with Amphotericin B] results in increased expression of ABCC2 mRNA] |
CTD |
PMID:11444866 PMID:36464106 |
|
NCBI chr 1:242,664,657...242,723,239
Ensembl chr 1:242,664,657...242,723,238
|
|
G |
Abcf3 |
ATP binding cassette subfamily F member 3 |
increases expression |
ISO |
Selenium results in increased expression of ABCF3 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr11:80,340,476...80,352,211
Ensembl chr11:80,339,977...80,352,211
|
|
G |
Abcg2 |
ATP binding cassette subfamily G member 2 |
multiple interactions |
ISO |
[Sodium Selenite results in increased abundance of Selenium] inhibits the reaction [[Vancomycin co-treated with Neomycin co-treated with Ampicillin co-treated with Metronidazole co-treated with Amphotericin B] results in increased expression of ABCG2 mRNA] |
CTD |
PMID:36464106 |
|
NCBI chr 4:87,676,241...87,802,757
Ensembl chr 4:87,745,319...87,802,409
|
|
G |
Abcg5 |
ATP binding cassette subfamily G member 5 |
multiple interactions |
ISO |
[Sodium Selenite results in increased abundance of Selenium] inhibits the reaction [[Vancomycin co-treated with Neomycin co-treated with Ampicillin co-treated with Metronidazole co-treated with Amphotericin B] results in decreased expression of ABCG5 mRNA] |
CTD |
PMID:36464106 |
|
NCBI chr 6:9,965,118...9,990,563
Ensembl chr 6:9,965,118...9,990,563
|
|
G |
Abhd17a |
abhydrolase domain containing 17A, depalmitoylase |
increases expression |
ISO |
Selenium results in increased expression of ABHD17A mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 7:9,124,332...9,132,762
Ensembl chr 7:9,124,332...9,130,762
|
|
G |
Abhd2 |
abhydrolase domain containing 2, acylglycerol lipase |
increases expression |
ISO |
Selenium results in increased expression of ABHD2 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 1:133,217,403...133,298,564
Ensembl chr 1:133,217,375...133,299,061
|
|
G |
Abr |
ABR activator of RhoGEF and GTPase |
increases expression |
ISO |
Selenium results in increased expression of ABR mRNA |
CTD |
PMID:19244175 |
|
NCBI chr10:61,262,516...61,461,331
Ensembl chr10:61,262,516...61,461,505
|
|
G |
Acaa2 |
acetyl-CoA acyltransferase 2 |
increases expression |
ISO |
Selenium results in increased expression of ACAA2 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr18:68,345,136...68,373,246
Ensembl chr18:68,345,012...68,373,249
|
|
G |
Acads |
acyl-CoA dehydrogenase short chain |
multiple interactions increases expression |
ISO |
[Selenium co-treated with Vitamin E] results in decreased expression of ACADS mRNA Selenium results in increased expression of ACADS mRNA |
CTD |
PMID:19244175 |
|
NCBI chr12:41,493,650...41,502,897
Ensembl chr12:41,493,626...41,502,898
|
|
G |
Ache |
acetylcholinesterase |
multiple interactions |
EXP |
[Aluminum co-treated with Lead co-treated with Mercury co-treated with Manganese co-treated with Selenium co-treated with Zinc] results in increased activity of ACHE protein; [Aluminum co-treated with Lead co-treated with Mercury co-treated with Manganese co-treated with Selenium] results in increased activity of ACHE protein; [Zinc co-treated with Selenium co-treated with Acetylcysteine] inhibits the reaction [dimethyl mercury results in decreased activity of ACHE protein] |
CTD |
PMID:20688495 PMID:37415728 |
|
NCBI chr12:19,406,133...19,413,713
Ensembl chr12:19,407,360...19,413,651
|
|
G |
Acin1 |
apoptotic chromatin condensation inducer 1 |
increases expression |
ISO |
Selenium results in increased expression of ACIN1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr15:28,102,112...28,147,001
Ensembl chr15:28,102,112...28,147,001
|
|
G |
Aco2 |
aconitase 2 |
increases expression |
ISO |
Selenium results in increased expression of ACO2 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 7:113,385,677...113,428,794
Ensembl chr 7:113,385,646...113,428,261
|
|
G |
Acot2 |
acyl-CoA thioesterase 2 |
multiple interactions increases expression |
ISO |
[Selenium co-treated with Vitamin E] results in increased expression of ACOT2 mRNA Selenium results in increased expression of ACOT2 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 6:103,611,738...103,619,404
Ensembl chr 6:103,611,544...103,619,245
|
|
G |
Acp1 |
acid phosphatase 1 |
decreases expression |
ISO |
Selenium results in decreased expression of ACP1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 6:47,506,380...47,522,021
Ensembl chr 6:47,506,380...47,522,021
|
|
G |
Acsl4 |
acyl-CoA synthetase long-chain family member 4 |
multiple interactions |
EXP |
[2-hydroxy-4-methylselenobutanoic acid results in increased abundance of Selenium] inhibits the reaction [Aflatoxin B1 results in increased expression of ACSL4 protein]; [2-hydroxy-4-methylselenobutanoic acid results in increased abundance of Selenium] which results in decreased expression of ACSL4 protein |
CTD |
PMID:34116104 |
|
NCBI chr X:105,942,794...106,006,573
Ensembl chr X:105,942,799...106,006,427
|
|
G |
Actb |
actin, beta |
increases expression |
ISO |
Selenium results in increased expression of ACTB mRNA |
CTD |
PMID:19244175 |
|
NCBI chr12:11,663,112...11,666,697
Ensembl chr12:11,663,109...11,672,877
|
|
G |
Actg1 |
actin, gamma 1 |
increases expression |
ISO |
Selenium results in increased expression of ACTG1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr10:105,619,738...105,622,587
Ensembl chr10:105,619,737...105,624,232 Ensembl chr 3:105,619,737...105,624,232
|
|
G |
Actn1 |
actinin, alpha 1 |
increases expression |
ISO |
Selenium results in increased expression of ACTN1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 6:98,998,553...99,093,334
Ensembl chr 6:98,998,556...99,093,251
|
|
G |
Actn4 |
actinin alpha 4 |
increases expression |
ISO |
Selenium results in increased expression of ACTN4 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 1:84,182,783...84,251,867
Ensembl chr 1:84,182,788...84,251,847
|
|
G |
Actr1a |
actin related protein 1A |
increases expression |
ISO |
Selenium results in increased expression of ACTR1A mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 1:245,237,821...245,256,618
Ensembl chr 1:245,237,826...245,256,495
|
|
G |
Actr1b |
actin related protein 1B |
increases expression |
ISO |
Selenium results in increased expression of ACTR1B mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 9:38,928,819...38,938,483
Ensembl chr 9:38,929,912...38,938,507
|
|
G |
Acy1 |
aminoacylase 1 |
increases expression |
ISO |
Selenium results in increased expression of ACY1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 8:107,072,354...107,077,756
Ensembl chr 8:107,072,358...107,077,682
|
|
G |
Adam17 |
ADAM metallopeptidase domain 17 |
multiple interactions increases expression |
ISO |
[Selenium deficiency co-treated with bisphenol A] results in increased expression of ADAM17 protein; bisphenol A promotes the reaction [Selenium deficiency results in increased expression of ADAM17 mRNA] |
CTD |
PMID:37422542 |
|
NCBI chr 6:40,872,936...40,920,700
Ensembl chr 6:40,872,856...40,920,639
|
|
G |
Adamts5 |
ADAM metallopeptidase with thrombospondin type 1 motif, 5 |
decreases expression |
ISO |
Selenium results in decreased expression of ADAMTS5 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr11:25,000,627...25,047,205
Ensembl chr11:25,000,637...25,047,205
|
|
G |
Adap1 |
ArfGAP with dual PH domains 1 |
increases expression |
ISO |
Selenium results in increased expression of ADAP1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr12:15,323,913...15,376,110
Ensembl chr12:15,324,209...15,380,831
|
|
G |
Adcy2 |
adenylate cyclase 2 |
multiple interactions decreases expression |
ISO |
[Selenium co-treated with Vitamin E] results in increased expression of ADCY2 mRNA Selenium results in decreased expression of ADCY2 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 1:34,375,639...34,822,252
Ensembl chr 1:34,375,895...34,822,236
|
|
G |
Adcy6 |
adenylate cyclase 6 |
increases expression |
ISO |
Selenium results in increased expression of ADCY6 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 7:129,742,827...129,763,922
Ensembl chr 7:129,742,838...129,763,754
|
|
G |
Add1 |
adducin 1 |
increases expression |
ISO |
Selenium results in increased expression of ADD1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr14:76,108,643...76,167,267
Ensembl chr14:76,108,654...76,167,182
|
|
G |
Add3 |
adducin 3 |
decreases expression |
ISO |
Selenium results in decreased expression of ADD3 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 1:252,147,341...252,255,126
Ensembl chr 1:252,147,386...252,255,124
|
|
G |
Adgrb1 |
adhesion G protein-coupled receptor B1 |
increases expression |
ISO |
Selenium results in increased expression of ADGRB1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 7:106,404,827...106,476,902
Ensembl chr 7:106,404,958...106,476,902
|
|
G |
Adissp |
adipose secreted signaling protein |
multiple interactions |
ISO |
[Selenium co-treated with Vitamin E] results in decreased expression of ADISSP mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 3:118,364,730...118,378,881
Ensembl chr 3:118,362,363...118,378,838
|
|
G |
Adora2a |
adenosine A2a receptor |
multiple interactions |
ISO |
[Cadmium analog co-treated with Selenium analog co-treated with zinc sulfide analog] results in increased expression of ADORA2A mRNA |
CTD |
PMID:21481475 |
|
NCBI chr20:13,315,848...13,333,386
Ensembl chr20:13,315,853...13,333,386
|
|
G |
Adra2c |
adrenoceptor alpha 2C |
increases expression |
ISO |
Selenium results in increased expression of ADRA2C mRNA |
CTD |
PMID:19244175 |
|
NCBI chr14:75,470,884...75,472,846
Ensembl chr14:75,471,143...75,472,846
|
|
G |
Adrm1 |
ADRM1 26S proteasome ubiquitin receptor |
increases expression |
ISO |
Selenium results in increased expression of ADRM1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 3:167,265,435...167,270,197
Ensembl chr 3:167,265,296...167,270,195
|
|
G |
Aebp2 |
AE binding protein 2 |
decreases methylation |
ISO |
Selenium results in decreased methylation of AEBP2 gene |
CTD |
PMID:21606628 |
|
NCBI chr 4:173,527,881...173,566,033
Ensembl chr 4:173,528,344...173,593,100
|
|
G |
Agpat2 |
1-acylglycerol-3-phosphate O-acyltransferase 2 |
multiple interactions increases expression |
ISO |
[Selenium co-treated with Vitamin E] results in decreased expression of AGPAT2 mRNA Selenium results in increased expression of AGPAT2 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 3:9,416,837...9,428,567
Ensembl chr 3:9,416,843...9,428,371
|
|
G |
Agrn |
agrin |
increases expression |
ISO |
Selenium results in increased expression of AGRN mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 5:166,749,306...166,782,212
Ensembl chr 5:166,749,310...166,786,003
|
|
G |
Aimp1 |
aminoacyl tRNA synthetase complex-interacting multifunctional protein 1 |
multiple interactions decreases expression |
ISO |
[Selenium co-treated with Vitamin E] results in decreased expression of AIMP1 mRNA Selenium results in decreased expression of AIMP1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 2:221,151,907...221,175,458
Ensembl chr 2:221,151,904...221,175,728
|
|
G |
Aip |
aryl-hydrocarbon receptor-interacting protein |
increases expression |
ISO |
Selenium results in increased expression of AIP mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 1:201,408,002...201,419,220
Ensembl chr 1:201,407,288...201,419,122
|
|
G |
Ak1 |
adenylate kinase 1 |
increases expression |
ISO |
Selenium results in increased expression of AK1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 3:15,912,431...15,923,045
Ensembl chr 3:15,912,485...15,923,041
|
|
G |
Ak2 |
adenylate kinase 2 |
increases expression |
ISO |
Selenium results in increased expression of AK2 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 5:141,308,650...141,364,633
Ensembl chr 5:141,346,063...141,364,632
|
|
G |
Ak3 |
adenylate kinase 3 |
multiple interactions |
ISO |
[Selenium co-treated with Vitamin E] results in increased expression of AK3 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 1:226,737,472...226,764,647
Ensembl chr 1:226,739,318...226,764,625
|
|
G |
Akap13 |
A-kinase anchoring protein 13 |
multiple interactions |
ISO |
[Selenium co-treated with Vitamin E] results in increased expression of AKAP13 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 1:129,313,183...129,619,647
Ensembl chr 1:129,314,402...129,619,646
|
|
G |
Akt1 |
AKT serine/threonine kinase 1 |
multiple interactions decreases phosphorylation increases expression increases phosphorylation |
ISO EXP |
[Selenium results in decreased phosphorylation of AKT1 protein] which results in increased susceptibility to Doxorubicin; AKT1 protein modified form inhibits the reaction [[Doxorubicin co-treated with Selenium] results in increased degradation of PARP1 protein]; Selenium inhibits the reaction [Doxorubicin results in increased phosphorylation of AKT1 protein] Selenium results in increased expression of AKT1 mRNA Selenium inhibits the reaction [Hydrogen Peroxide results in decreased phosphorylation of and results in decreased activity of AKT1 protein] Selenium results in increased phosphorylation of AKT1 protein Selenium inhibits the reaction [arsenite results in decreased expression of and results in decreased phosphorylation of AKT1 protein]; Selenium inhibits the reaction [Potassium Iodide results in increased phosphorylation of AKT1 protein] |
CTD |
PMID:17339365 PMID:17997286 PMID:19244175 PMID:29324385 PMID:38013145 |
|
NCBI chr 6:131,713,716...131,735,319
Ensembl chr 6:131,713,720...131,733,921
|
|
G |
Alad |
aminolevulinate dehydratase |
multiple interactions |
EXP |
Selenium inhibits the reaction [Arsenic results in decreased activity of ALAD protein] |
CTD |
PMID:20587388 |
|
NCBI chr 5:75,961,993...75,972,334
Ensembl chr 5:75,961,993...75,972,474
|
|
G |
Alas1 |
5'-aminolevulinate synthase 1 |
increases expression |
ISO |
Selenium results in increased expression of ALAS1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 8:106,876,514...106,889,917
Ensembl chr 8:106,876,514...106,889,917
|
|
G |
Alb |
albumin |
multiple interactions |
EXP |
[Selenium co-treated with Zinc] inhibits the reaction [[Lead co-treated with Cadmium co-treated with Mercury co-treated with Arsenic] results in decreased expression of ALB protein]; Acetylcysteine promotes the reaction [Selenium inhibits the reaction [Mercuric Chloride results in decreased expression of ALB protein]]; Selenium inhibits the reaction [[Lead co-treated with Cadmium co-treated with Mercury co-treated with Arsenic] results in decreased expression of ALB protein]; Selenium inhibits the reaction [Mercuric Chloride results in decreased expression of ALB protein]; Selenium promotes the reaction [Acetylcysteine inhibits the reaction [Mercuric Chloride results in decreased expression of ALB protein]] |
CTD |
PMID:24485406 PMID:37676925 |
|
NCBI chr14:17,607,397...17,622,814
Ensembl chr14:17,607,381...17,622,836
|
|
G |
Alcam |
activated leukocyte cell adhesion molecule |
decreases expression |
ISO |
Selenium results in decreased expression of ALCAM mRNA |
CTD |
PMID:19244175 |
|
NCBI chr11:48,336,123...48,536,296
Ensembl chr11:48,336,169...48,537,954
|
|
G |
Aldh1b1 |
aldehyde dehydrogenase 1 family, member B1 |
increases expression |
ISO |
Selenium deficiency results in increased expression of ALDH1B1 mRNA |
CTD |
PMID:16170372 |
|
NCBI chr 5:60,063,370...60,068,378
Ensembl chr 5:60,063,225...60,068,378
|
|
G |
Aldh1l1 |
aldehyde dehydrogenase 1 family, member L1 |
affects expression |
EXP |
Selenium affects the expression of ALDH1L1 protein |
CTD |
PMID:19351701 |
|
NCBI chr 4:123,059,989...123,106,471
Ensembl chr 4:123,060,008...123,106,465
|
|
G |
Aldh4a1 |
aldehyde dehydrogenase 4 family, member A1 |
increases expression |
ISO |
Selenium results in increased expression of ALDH4A1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 5:151,880,002...151,905,491
Ensembl chr 5:151,830,701...151,925,345
|
|
G |
Aldoa |
aldolase, fructose-bisphosphate A |
increases expression |
ISO |
Selenium results in increased expression of ALDOA mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 1:181,402,275...181,407,476
Ensembl chr 1:181,402,275...181,406,182
|
|
G |
Alg3 |
ALG3, alpha-1,3- mannosyltransferase |
increases expression |
ISO |
Selenium results in increased expression of ALG3 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr11:80,300,487...80,306,014
Ensembl chr11:80,300,498...80,307,912
|
|
G |
Alg9 |
ALG9, alpha-1,2-mannosyltransferase |
multiple interactions |
ISO |
[Selenium co-treated with Vitamin E] results in increased expression of ALG9 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 8:51,117,057...51,188,790
Ensembl chr 8:51,119,365...51,182,261
|
|
G |
Alox15 |
arachidonate 15-lipoxygenase |
increases expression multiple interactions |
EXP ISO |
Selenium deficiency results in increased expression of ALOX15 mRNA Selenomethionine inhibits the reaction [Selenium deficiency results in increased expression of ALOX15 protein]; Sodium Selenite inhibits the reaction [Selenium deficiency results in increased expression of ALOX15 protein] |
CTD |
PMID:11444866 PMID:34970773 |
|
NCBI chr10:55,060,169...55,068,885
Ensembl chr10:55,060,412...55,068,874
|
|
G |
Alox5 |
arachidonate 5-lipoxygenase |
multiple interactions |
EXP |
[Vitamin E co-treated with Selenium] results in decreased expression of ALOX5 mRNA; [Vitamin E co-treated with Selenium] results in decreased expression of ALOX5 protein |
CTD |
PMID:22223226 |
|
NCBI chr 4:149,531,329...149,578,696
Ensembl chr 4:149,531,515...149,578,743
|
|
G |
Als2cl |
ALS2 C-terminal like |
increases expression |
ISO |
Selenium results in increased expression of ALS2CL mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 8:110,863,753...110,884,434
Ensembl chr 8:110,864,975...110,884,419
|
|
G |
Ampd3 |
adenosine monophosphate deaminase 3 |
decreases expression |
ISO |
Selenium results in decreased expression of AMPD3 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 1:164,884,823...164,929,899
Ensembl chr 1:164,885,320...164,929,887
|
|
G |
Anapc15 |
anaphase promoting complex subunit 15 |
increases expression |
ISO |
Selenium results in increased expression of ANAPC15 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 1:156,238,640...156,266,005
Ensembl chr 1:156,262,841...156,268,145
|
|
G |
Anapc2 |
anaphase promoting complex subunit 2 |
increases expression |
ISO |
Selenium results in increased expression of ANAPC2 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 3:8,086,434...8,098,182
Ensembl chr 3:8,086,462...8,098,178
|
|
G |
Angpt1 |
angiopoietin 1 |
decreases expression |
ISO |
Selenium results in decreased expression of ANGPT1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 7:73,528,345...73,783,953
Ensembl chr 7:73,531,486...73,784,067
|
|
G |
Ank3 |
ankyrin 3 |
multiple interactions |
ISO |
[Selenium co-treated with Vitamin E] results in decreased expression of ANK3 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr20:18,602,267...19,225,831
Ensembl chr20:18,602,786...19,086,300
|
|
G |
Ankra2 |
ankyrin repeat family A member 2 |
decreases expression |
ISO |
Selenium results in decreased expression of ANKRA2 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 2:29,612,867...29,623,748
Ensembl chr 2:29,612,925...29,623,730
|
|
G |
Anp32b |
acidic nuclear phosphoprotein 32 family member B |
multiple interactions |
ISO |
[Selenium co-treated with Vitamin E] results in decreased expression of ANP32B mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 5:60,743,077...60,765,726
Ensembl chr 5:60,743,443...60,765,717
|
|
G |
Anpep |
alanyl aminopeptidase, membrane |
increases expression |
ISO |
Selenium results in increased expression of ANPEP mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 1:133,767,332...133,810,137
Ensembl chr 1:133,767,332...133,785,789
|
|
G |
Aox1 |
aldehyde oxidase 1 |
multiple interactions decreases expression |
EXP |
Selenium deficiency results in decreased expression of and results in decreased activity of AOX1 protein Selenium deficiency results in decreased expression of AOX1 mRNA |
CTD |
PMID:19182374 |
|
NCBI chr 9:59,579,621...59,658,772
Ensembl chr 9:59,579,649...59,658,770
|
|
G |
Ap1b1 |
adaptor related protein complex 1 subunit beta 1 |
increases expression |
ISO |
Selenium results in increased expression of AP1B1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr14:79,879,482...79,930,778
Ensembl chr14:79,879,533...79,930,778
|
|
G |
Ap1m2 |
adaptor related protein complex 1 subunit mu 2 |
increases expression |
ISO |
Selenium results in increased expression of AP1M2 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 8:19,838,579...19,856,560
Ensembl chr 8:19,838,580...19,856,482
|
|
G |
Ap2a2 |
adaptor related protein complex 2 subunit alpha 2 |
increases expression |
ISO |
Selenium results in increased expression of AP2A2 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 1:196,652,315...196,725,609
Ensembl chr 1:196,652,337...196,725,603
|
|
G |
Ap2m1 |
adaptor related protein complex 2 subunit mu 1 |
increases expression |
ISO |
Selenium results in increased expression of AP2M1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr11:80,355,307...80,364,218
Ensembl chr11:80,328,041...80,364,140
|
|
G |
Ap2s1 |
adaptor related protein complex 2 subunit sigma 1 |
increases expression |
ISO |
Selenium results in increased expression of AP2S1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 1:77,417,496...77,428,903
Ensembl chr 1:77,417,477...77,428,905
|
|
G |
Apc |
APC regulator of WNT signaling pathway |
decreases expression |
ISO |
Selenium results in decreased expression of APC mRNA |
CTD |
PMID:19244175 |
|
NCBI chr18:25,828,558...25,925,511
Ensembl chr18:25,864,222...25,922,696
|
|
G |
Apeh |
acylaminoacyl-peptide hydrolase |
increases expression |
ISO |
Selenium results in increased expression of APEH mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 8:108,773,791...108,782,903
Ensembl chr 8:108,773,794...108,782,933
|
|
G |
Aplp2 |
amyloid beta precursor like protein 2 |
increases expression |
ISO |
Selenium results in increased expression of APLP2 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 8:29,599,230...29,662,311
Ensembl chr 8:29,599,230...29,661,855
|
|
G |
Apob |
apolipoprotein B |
multiple interactions decreases expression |
EXP |
Selenium inhibits the reaction [Cholesterol results in increased expression of APOB protein] Selenium results in decreased expression of APOB protein |
CTD |
PMID:16271152 PMID:16581047 |
|
NCBI chr 6:30,844,386...30,883,983
Ensembl chr 6:30,844,368...30,892,497
|
|
G |
Apoe |
apolipoprotein E |
increases expression affects expression |
ISO |
Selenium results in increased expression of APOE mRNA Selenium affects the expression of APOE protein |
CTD |
PMID:17996733 PMID:19244175 |
|
NCBI chr 1:79,353,924...79,357,852
Ensembl chr 1:79,353,916...79,357,932
|
|
G |
App |
amyloid beta precursor protein |
decreases expression |
ISO |
Selenium results in decreased expression of APP mRNA |
CTD |
PMID:19244175 |
|
NCBI chr11:24,019,774...24,236,584
Ensembl chr11:24,019,778...24,236,561
|
|
G |
Appbp2 |
amyloid beta precursor protein binding protein 2 |
multiple interactions |
ISO |
[Selenium co-treated with Vitamin E] results in decreased expression of APPBP2 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr10:70,057,774...70,099,877
Ensembl chr10:70,057,774...70,099,835
|
|
G |
Aqp3 |
aquaporin 3 (Gill blood group) |
increases expression multiple interactions |
ISO |
Selenium results in increased expression of AQP3 mRNA [Selenium co-treated with Vitamin E] results in decreased expression of AQP3 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 5:56,239,200...56,244,718
Ensembl chr 5:56,239,201...56,244,720
|
|
G |
Ar |
androgen receptor |
multiple interactions decreases expression decreases localization |
ISO |
Selenium results in decreased expression of and results in decreased activity of AR protein Selenium results in decreased expression of AR mRNA Selenium results in decreased localization of AR protein |
CTD |
PMID:14729601 PMID:16648561 |
|
NCBI chr X:63,104,771...63,273,934
Ensembl chr X:63,104,771...63,273,925
|
|
G |
Araf |
A-Raf proto-oncogene, serine/threonine kinase |
increases expression multiple interactions |
ISO |
Selenium results in increased expression of ARAF mRNA [Selenium co-treated with Vitamin E] results in increased expression of ARAF mRNA |
CTD |
PMID:19244175 |
|
NCBI chr X:1,227,392...1,292,356
Ensembl chr X:1,227,392...1,239,073
|
|
G |
Arf5 |
ARF GTPase 5 |
increases expression |
ISO |
Selenium results in increased expression of ARF5 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 4:57,038,521...57,041,447
Ensembl chr 4:57,038,521...57,041,441
|
|
G |
Arfgap2 |
ARF GTPase activating protein 2 |
increases expression |
ISO |
Selenium results in increased expression of ARFGAP2 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 3:77,236,305...77,248,445
Ensembl chr 3:77,236,322...77,248,455
|
|
G |
Arfip2 |
ARF interacting protein 2 |
increases expression |
ISO |
Selenium results in increased expression of ARFIP2 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 1:159,974,255...159,980,398
Ensembl chr 1:159,974,201...159,980,336
|
|
G |
Arfrp1 |
ARF related protein 1 |
increases expression |
ISO |
Selenium results in increased expression of ARFRP1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 3:168,466,351...168,473,960
Ensembl chr 3:168,466,496...168,473,914
|
|
G |
Arg1 |
arginase 1 |
multiple interactions |
ISO |
2-chloro-5-nitrobenzanilide inhibits the reaction [[Selenium co-treated with IL4 protein] results in increased activity of ARG1 protein]; 4-benzhydryloxy-1-(3-(1H-tetrazol-5-yl-)-propyl)piperidine inhibits the reaction [[Selenium co-treated with IL4 protein] results in increased activity of ARG1 protein]; [Selenium co-treated with IL4 protein] results in increased activity of ARG1 protein; [Selenium co-treated with IL4 protein] results in increased expression of ARG1 mRNA; leflunomide inhibits the reaction [[Selenium co-treated with IL4 protein] results in increased activity of ARG1 protein]; rosiglitazone promotes the reaction [[Selenium co-treated with IL4 protein] results in increased activity of ARG1 protein] |
CTD |
PMID:21775527 |
|
NCBI chr 1:20,475,878...20,488,422
Ensembl chr 1:20,475,968...20,488,422
|
|
G |
Arg2 |
arginase 2 |
decreases expression |
ISO |
Selenium results in decreased expression of ARG2 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 6:97,936,002...97,961,379
Ensembl chr 6:97,936,002...97,961,378
|
|
G |
Arhgdia |
Rho GDP dissociation inhibitor alpha |
increases expression |
ISO |
Selenium results in increased expression of ARHGDIA mRNA |
CTD |
PMID:19244175 |
|
NCBI chr10:105,854,526...105,858,020
Ensembl chr10:105,854,533...105,858,023
|
|
G |
Arih1 |
ariadne RBR E3 ubiquitin protein ligase 1 |
decreases expression |
ISO |
Selenium results in decreased expression of ARIH1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 8:59,777,378...59,879,762
Ensembl chr 8:59,777,379...59,880,245
|
|
G |
Arl5a |
ARF like GTPase 5A |
decreases expression |
ISO |
Selenium results in decreased expression of ARL5A mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 3:36,878,461...36,903,362
Ensembl chr 3:36,880,712...36,903,211
|
|
G |
Arl6ip4 |
ARF like GTPase 6 interacting protein 4 |
increases expression |
ISO |
Selenium results in increased expression of ARL6IP4 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr12:32,479,623...32,481,768
Ensembl chr12:32,479,625...32,481,799
|
|
G |
Arpc1a |
actin related protein 2/3 complex, subunit 1A |
increases expression |
ISO |
Selenium results in increased expression of ARPC1A mRNA |
CTD |
PMID:19244175 |
|
NCBI chr12:9,502,496...9,525,304
Ensembl chr12:9,502,501...9,525,330
|
|
G |
Arpc1b |
actin related protein 2/3 complex, subunit 1B |
increases expression |
ISO |
Selenium results in increased expression of ARPC1B mRNA |
CTD |
PMID:19244175 |
|
NCBI chr12:9,482,176...9,495,772
Ensembl chr12:9,480,831...9,495,747
|
|
G |
Arpc4 |
actin related protein 2/3 complex, subunit 4 |
increases expression |
ISO |
Selenium results in increased expression of ARPC4 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 4:146,522,255...146,532,784
Ensembl chr 4:146,522,176...146,532,785
|
|
G |
As3mt |
arsenite methyltransferase |
multiple interactions |
ISO |
Selenium inhibits the reaction [AS3MT protein results in increased methylation of Arsenic] |
CTD |
PMID:19167370 |
|
NCBI chr 1:245,595,939...245,628,921
Ensembl chr 1:245,596,108...245,627,872
|
|
G |
Asap3 |
ArfGAP with SH3 domain, ankyrin repeat and PH domain 3 |
increases expression |
ISO |
Selenium results in increased expression of ASAP3 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 5:148,433,382...148,476,027
Ensembl chr 5:148,433,494...148,474,073
|
|
G |
Asb1 |
ankyrin repeat and SOCS box-containing 1 |
multiple interactions increases expression |
ISO |
[Selenium co-treated with Vitamin E] results in increased expression of ASB1 mRNA Selenium results in increased expression of ASB1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 9:92,120,332...92,140,790
Ensembl chr 9:92,120,306...92,136,376
|
|
G |
Ascc2 |
activating signal cointegrator 1 complex subunit 2 |
increases expression |
ISO |
Selenium results in increased expression of ASCC2 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr14:79,503,449...79,547,801
Ensembl chr14:79,503,517...79,545,494
|
|
G |
Asl |
argininosuccinate lyase |
increases expression |
ISO |
Selenium results in increased expression of ASL mRNA |
CTD |
PMID:19244175 |
|
NCBI chr12:26,659,664...26,677,136
Ensembl chr12:26,659,565...26,679,662
|
|
G |
Asmtl |
acetylserotonin O-methyltransferase-like |
increases expression |
ISO |
Selenium results in increased expression of ASMTL mRNA |
CTD |
PMID:19244175 |
|
NCBI chr12:16,315,335...16,318,083
Ensembl chr12:16,315,414...16,318,080
|
|
G |
Ass1 |
argininosuccinate synthase 1 |
increases expression |
ISO |
Selenium results in increased expression of ASS1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 3:14,747,355...14,796,909
Ensembl chr 3:14,747,368...14,796,903
|
|
G |
Asxl1 |
ASXL transcriptional regulator 1 |
decreases expression |
ISO |
Selenium results in decreased expression of ASXL1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 3:141,814,012...141,881,526
Ensembl chr 3:141,813,433...141,881,538
|
|
G |
Asxl2 |
ASXL transcriptional regulator 2 |
decreases expression |
ISO |
Selenium results in decreased expression of ASXL2 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 6:26,425,017...26,514,899
Ensembl chr 6:26,425,954...26,507,477
|
|
G |
Atf4 |
activating transcription factor 4 |
increases expression |
ISO |
Selenium results in increased expression of ATF4 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 7:111,804,135...111,806,457
Ensembl chr 7:111,804,183...111,806,446
|
|
G |
Atf5 |
activating transcription factor 5 |
multiple interactions increases expression |
ISO |
[Selenium co-treated with Vitamin E] results in increased expression of ATF5 mRNA Selenium results in increased expression of ATF5 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 1:95,295,602...95,299,755
Ensembl chr 1:95,295,610...95,299,707
|
|
G |
Atg12 |
autophagy related 12 |
decreases expression |
ISO |
Selenium results in decreased expression of ATG12 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr18:39,452,247...39,462,424
Ensembl chr18:39,452,191...39,462,418
|
|
G |
Atg13 |
autophagy related 13 |
increases expression |
ISO |
Selenium results in increased expression of ATG13 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 3:77,647,069...77,681,028
Ensembl chr 3:77,645,790...77,681,043
|
|
G |
Atg14 |
autophagy related 14 |
decreases expression |
ISO |
Selenium results in decreased expression of ATG14 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr15:20,795,750...20,827,113
Ensembl chr15:20,795,750...20,827,113
|
|
G |
Atg9a |
autophagy related 9A |
increases expression |
ISO |
Selenium results in increased expression of ATG9A mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 9:76,677,403...76,688,050
Ensembl chr 9:76,677,404...76,687,986
|
|
G |
Atmin |
ATM interactor |
multiple interactions decreases expression |
ISO |
[Selenium co-treated with Vitamin E] results in increased expression of ATMIN mRNA Selenium results in decreased expression of ATMIN mRNA |
CTD |
PMID:19244175 |
|
NCBI chr19:44,996,506...45,013,606
Ensembl chr19:44,996,356...45,013,605
|
|
G |
Atp10d |
ATPase phospholipid transporting 10D (putative) |
decreases expression |
ISO |
Selenium results in decreased expression of ATP10D mRNA |
CTD |
PMID:19244175 |
|
NCBI chr14:35,911,728...36,012,549
Ensembl chr14:35,912,141...36,012,564
|
|
G |
Atp2b4 |
ATPase plasma membrane Ca2+ transporting 4 |
increases expression |
ISO |
Selenium results in increased expression of ATP2B4 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr13:45,156,137...45,255,292
Ensembl chr13:45,156,146...45,255,246
|
|
G |
Atp2c1 |
ATPase secretory pathway Ca2+ transporting 1 |
decreases expression |
ISO |
Selenium results in decreased expression of ATP2C1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 8:106,034,777...106,155,854
Ensembl chr 8:106,034,636...106,156,006
|
|
G |
Atp5me |
ATP synthase membrane subunit e |
decreases expression |
ISO |
Selenium results in decreased expression of ATP5ME mRNA |
CTD |
PMID:19244175 |
|
NCBI chr14:1,319,868...1,320,996
Ensembl chr14:1,319,868...1,321,013
|
|
G |
Atp5pd |
ATP synthase peripheral stalk subunit d |
decreases expression |
ISO |
Selenium results in decreased expression of ATP5PD mRNA |
CTD |
PMID:19244175 |
|
NCBI chr10:100,657,700...100,662,960
Ensembl chr10:100,657,708...100,663,479
|
|
G |
Atp5pf |
ATP synthase peripheral stalk subunit F6 |
decreases expression |
ISO |
Selenium results in decreased expression of ATP5PF mRNA |
CTD |
PMID:19244175 |
|
NCBI chr11:23,881,594...23,889,581
Ensembl chr11:23,881,592...23,889,119
|
|
G |
Atp6ap1 |
ATPase H+ transporting accessory protein 1 |
increases expression |
ISO |
Selenium results in increased expression of ATP6AP1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr X:152,079,954...152,087,034
Ensembl chr X:152,079,865...152,087,034
|
|
G |
Atp6v0d1 |
ATPase H+ transporting V0 subunit D1 |
increases expression |
ISO |
Selenium results in increased expression of ATP6V0D1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr19:33,403,352...33,447,357
Ensembl chr19:33,403,355...33,447,450
|
|
G |
Atp6v0e1 |
ATPase H+ transporting V0 subunit e1 |
decreases expression |
ISO |
Selenium results in decreased expression of ATP6V0E mRNA |
CTD |
PMID:19244175 |
|
NCBI chr10:16,479,656...16,502,732
Ensembl chr10:16,479,567...16,524,434
|
|
G |
Atp6v1c1 |
ATPase H+ transporting V1 subunit C1 |
decreases expression |
ISO |
Selenium results in decreased expression of ATP6V1C1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 7:69,834,464...69,872,278
Ensembl chr 7:69,834,463...69,872,278
|
|
G |
Atrx |
ATRX, chromatin remodeler |
multiple interactions decreases expression |
ISO |
[Selenium co-treated with Vitamin E] results in decreased expression of ATRX mRNA Selenium results in decreased expression of ATRX mRNA |
CTD |
PMID:19244175 |
|
NCBI chr X:70,850,981...70,997,330
Ensembl chr X:70,850,981...70,997,330
|
|
G |
Atxn1 |
ataxin 1 |
decreases expression |
ISO |
Selenium results in decreased expression of ATXN1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr17:18,737,491...19,142,360
Ensembl chr17:18,737,533...19,142,360
|
|
G |
Atxn7 |
ataxin 7 |
multiple interactions decreases expression |
ISO |
[Selenium co-treated with Vitamin E] results in decreased expression of ATXN7 mRNA Selenium results in decreased expression of ATXN7 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr15:11,117,360...11,262,818
Ensembl chr15:11,118,886...11,263,106
|
|
G |
Avl9 |
AVL9 cell migration associated |
decreases expression |
ISO |
Selenium results in decreased expression of AVL9 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 4:85,961,493...86,008,347
Ensembl chr 4:85,961,635...86,008,791
|
|
G |
Axl |
Axl receptor tyrosine kinase |
decreases expression |
ISO |
Selenium results in decreased expression of AXL mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 1:81,265,088...81,296,278
Ensembl chr 1:81,265,088...81,296,265
|
|
G |
B3gat3 |
beta-1,3-glucuronyltransferase 3 |
increases expression |
ISO |
Selenium results in increased expression of B3GAT3 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 1:205,817,374...205,823,928
Ensembl chr 1:205,817,378...205,837,807
|
|
G |
Bag1 |
BAG cochaperone 1 |
increases expression |
ISO |
Selenium results in increased expression of BAG1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 5:56,068,494...56,081,075
Ensembl chr 5:56,068,494...56,081,075
|
|
G |
Bag6 |
BAG cochaperone 6 |
increases expression |
ISO |
Selenium results in increased expression of BAG6 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr20:3,675,938...3,690,414
Ensembl chr20:3,675,938...3,688,657
|
|
G |
Bap1 |
BRCA1 associated deubiquitinase 1 |
increases expression |
ISO |
Selenium results in increased expression of BAP1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr16:6,446,709...6,455,535
Ensembl chr16:6,446,709...6,455,535
|
|
G |
Bard1 |
BRCA1 associated RING domain 1 |
decreases expression |
ISO |
Selenium results in decreased expression of BARD1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 9:72,616,070...72,694,553
Ensembl chr 9:72,623,155...72,694,265
|
|
G |
Batf |
basic leucine zipper ATF-like transcription factor |
increases expression |
ISO |
Selenium results in increased expression of BATF mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 6:105,353,715...105,376,051
Ensembl chr 6:105,353,715...105,376,051
|
|
G |
Bax |
BCL2 associated X, apoptosis regulator |
decreases expression multiple interactions |
ISO EXP |
Selenium results in decreased expression of BAX protein [Selenium analog co-treated with Magnesium Oxide analog] inhibits the reaction [Diazinon results in increased expression of BAX mRNA]; Selenium analog inhibits the reaction [Diazinon results in increased expression of BAX mRNA]; Selenium inhibits the reaction [T-2 Toxin results in increased expression of BAX mRNA] Selenium inhibits the reaction [arsenite results in increased expression of BAX protein] |
CTD |
PMID:16307838 PMID:17997286 PMID:27920530 PMID:29324385 |
|
NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
|
|
G |
Baz1b |
bromodomain adjacent to zinc finger domain, 1B |
increases expression |
ISO |
Selenium results in increased expression of BAZ1B mRNA |
CTD |
PMID:19244175 |
|
NCBI chr12:21,431,985...21,489,956
Ensembl chr12:21,431,985...21,490,426
|
|
G |
Bbx |
BBX high mobility group box domain containing |
multiple interactions decreases expression |
ISO |
[Selenium co-treated with Vitamin E] results in decreased expression of BBX mRNA Selenium results in decreased expression of BBX mRNA |
CTD |
PMID:19244175 |
|
NCBI chr11:50,381,249...50,628,934
Ensembl chr11:50,381,247...50,623,251
|
|
G |
Bcl11a |
BCL11 transcription factor A |
decreases expression |
ISO |
Selenium results in decreased expression of BCL11A mRNA |
CTD |
PMID:19244175 |
|
NCBI chr14:98,029,018...98,124,181
Ensembl chr14:98,030,461...98,124,180
|
|
G |
Bcl2 |
BCL2, apoptosis regulator |
decreases expression multiple interactions |
ISO EXP |
Selenium results in decreased expression of BCL2 protein 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Selenium inhibits the reaction [nickel sulfate results in decreased expression of BCL2 protein]]; [Selenium analog co-treated with Magnesium Oxide analog] inhibits the reaction [Diazinon results in decreased expression of BCL2 mRNA]; Selenium analog inhibits the reaction [Diazinon results in decreased expression of BCL2 mRNA]; Selenium inhibits the reaction [nickel sulfate results in decreased expression of BCL2 protein] |
CTD |
PMID:17523932 PMID:27920530 PMID:34612572 |
|
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
|
|
G |
Bcl2l1 |
Bcl2-like 1 |
increases expression multiple interactions |
ISO EXP |
Selenium results in increased expression of BCL2L1 mRNA [Selenium deficiency co-treated with Vitamin E deficiency] results in decreased expression of BCL2L1 mRNA |
CTD |
PMID:11444866 PMID:19244175 |
|
NCBI chr 3:141,253,508...141,304,582
Ensembl chr 3:141,253,523...141,303,479 Ensembl chr 1:141,253,523...141,303,479
|
|
G |
Bcl2l11 |
Bcl2-like 11 |
multiple interactions increases expression |
ISO |
BCL2L11 protein affects the susceptibility to [Doxorubicin co-treated with Selenium]; BCL2L11 protein promotes the reaction [[Doxorubicin co-treated with Selenium] results in increased cleavage of and results in increased activity of CASP9 protein]; BCL2L11 protein promotes the reaction [[Doxorubicin co-treated with Selenium] results in increased degradation of PARP1 protein] Selenium results in increased expression of BCL2L11 protein |
CTD |
PMID:17339365 |
|
NCBI chr 3:115,366,783...115,404,068
Ensembl chr 3:115,366,646...115,404,068
|
|
G |
Bcl3 |
BCL3, transcription coactivator |
increases expression |
ISO |
Selenium results in increased expression of BCL3 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 1:79,471,368...79,485,908
Ensembl chr 1:79,471,369...79,485,607
|
|
G |
Bcl7b |
BAF chromatin remodeling complex subunit BCL7B |
increases expression |
ISO |
Selenium results in increased expression of BCL7B mRNA |
CTD |
PMID:19244175 |
|
NCBI chr12:21,496,860...21,510,079
Ensembl chr12:21,496,856...21,510,202
|
|
G |
Bclaf1 |
BCL2-associated transcription factor 1 |
decreases expression multiple interactions |
ISO |
Selenium results in decreased expression of BCLAF1 mRNA [Selenium co-treated with Vitamin E] results in increased expression of BCLAF1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 1:15,088,436...15,117,666
Ensembl chr 1:15,070,894...15,148,832
|
|
G |
Bdh2 |
3-hydroxybutyrate dehydrogenase 2 |
decreases expression |
ISO |
Selenium results in decreased expression of BDH2 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 2:223,702,410...223,723,076
Ensembl chr 2:223,702,412...223,723,072
|
|
G |
Bdnf |
brain-derived neurotrophic factor |
increases expression multiple interactions |
EXP |
Selenium results in increased expression of BDNF protein Selenium inhibits the reaction [[Dietary Fats co-treated with Cholesterol] results in decreased expression of BDNF protein] |
CTD |
PMID:30695686 |
|
NCBI chr 3:96,165,042...96,215,621
Ensembl chr 3:96,165,042...96,215,615
|
|
G |
Becn1 |
beclin 1 |
multiple interactions |
EXP |
Selenium deficiency inhibits the reaction [T-2 Toxin results in increased expression of BECN1 mRNA]; Selenium inhibits the reaction [Acrylamide results in increased expression of BECN1 protein] |
CTD |
PMID:30629952 PMID:37987225 |
|
NCBI chr10:86,231,387...86,246,742
Ensembl chr10:86,231,388...86,246,742
|
|
G |
Bicd1 |
BICD cargo adaptor 1 |
multiple interactions decreases expression |
ISO |
[Selenium co-treated with Vitamin E] results in decreased expression of BICD1 mRNA Selenium results in decreased expression of BICD1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 4:182,479,071...182,631,504
Ensembl chr 4:182,479,071...182,627,434
|
|
G |
Bicdl1 |
BICD family like cargo adaptor 1 |
increases expression |
ISO |
Selenium results in increased expression of BICDL1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr12:40,878,190...41,001,152
Ensembl chr12:40,876,884...40,966,130
|
|
G |
Bicra |
BRD4 interacting chromatin remodeling complex associated protein |
increases expression |
ISO |
Selenium results in increased expression of BICRA mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 1:76,661,897...76,736,146
Ensembl chr 1:76,661,897...76,737,157
|
|
G |
Bid |
BH3 interacting domain death agonist |
increases cleavage |
ISO |
Selenium results in increased cleavage of BID protein |
CTD |
PMID:12432279 |
|
NCBI chr 4:154,113,198...154,136,353
Ensembl chr 4:154,113,198...154,134,720
|
|
G |
Bin1 |
bridging integrator 1 |
increases expression |
ISO |
Selenium results in increased expression of BIN1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr18:24,009,731...24,067,267
Ensembl chr18:24,009,653...24,067,263
|
|
G |
Birc2 |
baculoviral IAP repeat-containing 2 |
multiple interactions |
EXP |
[Selenium deficiency co-treated with Vitamin E deficiency] results in decreased expression of BIRC2 mRNA |
CTD |
PMID:11444866 |
|
NCBI chr 8:4,968,856...4,989,325
Ensembl chr 8:4,968,842...4,988,732
|
|
G |
Birc5 |
baculoviral IAP repeat-containing 5 |
affects response to substance multiple interactions |
ISO |
BIRC5 protein affects the susceptibility to Selenium [Selenium analog co-treated with Magnesium Oxide analog] inhibits the reaction [Diazinon results in decreased expression of BIRC5 mRNA]; Selenium analog inhibits the reaction [Diazinon results in decreased expression of BIRC5 mRNA] |
CTD |
PMID:17876054 PMID:27920530 |
|
NCBI chr10:103,072,530...103,081,382
Ensembl chr10:103,073,408...103,081,380
|
|
G |
Bles03 |
basophilic leukemia expressed protein BLES03 |
increases expression |
ISO |
Selenium results in increased expression of C11ORF68 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 1:202,734,555...202,736,809
Ensembl chr 1:202,734,555...202,736,804
|
|
G |
Bltp2 |
bridge-like lipid transfer protein family member 2 |
increases expression |
ISO |
Selenium results in increased expression of BLTP2 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr10:63,155,999...63,185,213
Ensembl chr10:63,156,044...63,191,141
|
|
G |
Bltp3b |
bridge-like lipid transfer protein family member 3B |
multiple interactions decreases expression |
ISO |
[Selenium co-treated with Vitamin E] results in decreased expression of BLTP3B mRNA Selenium results in decreased expression of BLTP3B mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 7:24,181,635...24,261,720
Ensembl chr 7:24,181,644...24,261,720
|
|
G |
Blvrb |
biliverdin reductase B |
increases expression |
ISO |
Selenium results in increased expression of BLVRB mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 1:82,738,646...82,756,312
Ensembl chr 1:82,738,695...82,770,375
|
|
G |
Bptf |
bromodomain PHD finger transcription factor |
multiple interactions decreases expression |
ISO |
[Selenium co-treated with Vitamin E] results in decreased expression of BPTF mRNA Selenium results in decreased expression of BPTF mRNA |
CTD |
PMID:19244175 |
|
NCBI chr10:91,980,279...92,082,731
Ensembl chr10:91,982,758...92,082,769
|
|
G |
Brd2 |
bromodomain containing 2 |
multiple interactions increases expression |
ISO |
[Selenium co-treated with Vitamin E] results in decreased expression of BRD2 mRNA Selenium results in increased expression of BRD2 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr20:4,727,078...4,735,389
Ensembl chr20:4,728,151...4,735,388
|
|
G |
Brf2 |
BRF2 general transcription factor 3B subunit |
increases expression |
ISO |
Selenium results in increased expression of BRF2 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr16:64,928,334...64,933,057
Ensembl chr16:64,928,300...64,933,059
|
|
G |
Brms1 |
BRMS1, transcriptional repressor and anoikis regulator |
increases expression |
ISO |
Selenium results in increased expression of BRMS1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 1:202,345,766...202,355,028
Ensembl chr 1:202,345,704...202,355,028
|
|
G |
Bscl2 |
BSCL2 lipid droplet biogenesis associated, seipin |
multiple interactions increases expression |
ISO |
[Selenium co-treated with Vitamin E] results in increased expression of BSCL2 mRNA Selenium results in increased expression of BSCL2 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 1:205,731,828...205,743,430
Ensembl chr 1:205,733,872...205,743,421
|
|
G |
Bst2 |
bone marrow stromal cell antigen 2 |
increases expression |
ISO |
Selenium results in increased expression of BST2 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr16:18,216,605...18,220,979
Ensembl chr16:18,217,407...18,220,979
|
|
G |
Bysl |
bystin-like |
increases expression |
ISO |
Selenium results in increased expression of BYSL mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 9:13,382,806...13,392,557
Ensembl chr 9:13,382,557...13,394,339
|
|
G |
C17h7orf25 |
similar to human chromosome 7 open reading frame 25 |
decreases expression |
ISO |
Selenium results in decreased expression of C7ORF25 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr17:50,543,231...50,549,880
Ensembl chr17:50,542,858...50,549,976
|
|
G |
C1qb |
complement C1q B chain |
increases expression |
ISO |
Selenium results in increased expression of C1QB mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 5:149,118,843...149,124,394
Ensembl chr 5:149,118,846...149,124,407
|
|
G |
C2cd5 |
C2 calcium-dependent domain containing 5 |
decreases expression |
ISO |
Selenium results in decreased expression of C2CD5 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 4:175,969,544...176,055,597
Ensembl chr 4:175,969,545...176,055,558
|
|
G |
C2h1orf54 |
similar to human chromosome 1 open reading frame 54 |
decreases expression |
ISO |
Selenium results in decreased expression of C1ORF54 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 2:183,424,989...183,434,713
Ensembl chr 2:183,424,984...183,435,089
|
|
G |
C4h2orf42 |
similar to human chromosome 2 open reading frame 42 |
multiple interactions decreases expression |
ISO |
[Selenium co-treated with Vitamin E] results in increased expression of C2ORF42 mRNA Selenium results in decreased expression of C2ORF42 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 4:118,887,688...118,916,808
Ensembl chr 4:118,888,112...118,916,936
|
|
G |
C5h1orf50 |
similar to human chromosome 1 open reading frame 50 |
multiple interactions decreases expression |
ISO |
[Selenium co-treated with Vitamin E] results in decreased expression of C1ORF50 mRNA Selenium results in decreased expression of C1ORF50 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 5:132,837,135...132,841,744
Ensembl chr 5:132,836,506...132,841,762
|
|
G |
C6h14orf132 |
similar to human chromosome 14 open reading frame 132 |
decreases expression |
ISO |
Selenium results in decreased expression of C14ORF132 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 6:124,365,466...124,398,449
|
|
G |
Cabin1 |
calcineurin binding protein 1 |
increases expression |
ISO |
Selenium results in increased expression of CABIN1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr20:12,893,314...13,015,357
Ensembl chr20:12,893,358...13,015,357
|
|
G |
Calcoco1 |
calcium binding and coiled coil domain 1 |
increases expression |
ISO |
Selenium results in increased expression of CALCOCO1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 7:133,834,705...133,849,515
Ensembl chr 7:133,834,707...133,849,422
|
|
G |
Cald1 |
caldesmon 1 |
decreases expression |
ISO |
Selenium results in decreased expression of CALD1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 4:63,265,781...63,446,938
Ensembl chr 4:63,265,942...63,446,932
|
|
G |
Calhm2 |
calcium homeostasis modulator family member 2 |
increases expression |
ISO |
Selenium results in increased expression of CALHM2 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 1:246,022,324...246,028,050
Ensembl chr 1:246,022,324...246,028,218
|
|
G |
Calm3 |
calmodulin 3 |
increases expression |
ISO |
Selenium results in increased expression of CALM3 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 1:77,590,668...77,597,776
Ensembl chr 1:77,589,230...77,592,207
|
|
G |
Calr |
calreticulin |
multiple interactions decreases expression |
ISO |
[Selenium co-treated with Vitamin E] results in decreased expression of CALR mRNA Selenium results in decreased expression of CALR mRNA |
CTD |
PMID:19244175 |
|
NCBI chr19:23,308,525...23,313,420
Ensembl chr19:23,308,351...23,313,414
|
|
G |
Calu |
calumenin |
multiple interactions increases expression |
ISO |
[Selenium co-treated with Vitamin E] results in decreased expression of CALU mRNA Selenium results in increased expression of CALU mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 4:57,949,086...57,976,589
Ensembl chr 4:57,948,997...57,976,593
|
|
G |
Camk2b |
calcium/calmodulin-dependent protein kinase II beta |
increases expression |
ISO |
Selenium results in increased expression of CAMK2B mRNA |
CTD |
PMID:19244175 |
|
NCBI chr14:80,845,206...80,934,172
Ensembl chr14:80,845,238...80,933,994
|
|
G |
Cap2 |
cyclase associated actin cytoskeleton regulatory protein 2 |
decreases expression |
ISO |
Selenium results in decreased expression of CAP2 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr17:18,054,234...18,203,453
Ensembl chr17:18,054,431...18,203,373
|
|
G |
Capg |
capping actin protein, gelsolin like |
increases expression |
ISO |
Selenium results in increased expression of CAPG mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 4:104,594,743...104,611,856
Ensembl chr 4:104,594,753...104,611,856
|
|
G |
Capn1 |
calpain 1 |
increases expression |
ISO |
Selenium results in increased expression of CAPN1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 1:203,275,912...203,300,848
Ensembl chr 1:203,277,344...203,300,177
|
|
G |
Capn7 |
calpain 7 |
decreases expression |
ISO |
Selenium results in decreased expression of CAPN7 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr16:6,545,630...6,581,908
Ensembl chr16:6,545,731...6,581,905
|
|
G |
Capns1 |
calpain, small subunit 1 |
increases expression |
ISO |
Selenium results in increased expression of CAPNS1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 1:85,444,613...85,454,861
Ensembl chr 1:85,444,608...85,454,795
|
|
G |
Capzb |
capping actin protein of muscle Z-line subunit beta |
increases expression |
ISO |
Selenium results in increased expression of CAPZB mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 5:151,435,600...151,535,409
Ensembl chr 5:151,434,871...151,535,409
|
|
G |
Car3 |
carbonic anhydrase 3 |
multiple interactions |
EXP |
[Selenium deficiency co-treated with Vitamin E deficiency] results in decreased expression of CA3 mRNA |
CTD |
PMID:11444866 |
|
NCBI chr 2:86,770,418...86,780,011
Ensembl chr 2:86,770,420...86,784,280
|
|
G |
Casc3 |
CASC3 exon junction complex subunit |
multiple interactions |
ISO |
[Selenium co-treated with Vitamin E] results in increased expression of MLN51 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr10:83,769,014...83,788,966
Ensembl chr10:83,769,001...83,788,966
|
|
G |
Casp12 |
caspase 12 |
multiple interactions |
EXP |
Selenium inhibits the reaction [nickel sulfate results in increased expression of CASP12 protein] |
CTD |
PMID:34612572 |
|
NCBI chr 8:2,642,296...2,669,549
Ensembl chr 8:2,642,434...2,674,037
|
|
G |
Casp3 |
caspase 3 |
decreases activity increases activity multiple interactions |
ISO EXP |
Selenium results in decreased activity of CASP3 protein Selenium results in increased activity of CASP3 protein [Selenium co-treated with Zinc] inhibits the reaction [[Lead co-treated with Cadmium co-treated with Mercury co-treated with Arsenic] results in increased expression of CASP3 protein]; [Vitamin E co-treated with Selenium] inhibits the reaction [Malathion results in increased expression of CASP3 mRNA]; Selenium deficiency promotes the reaction [T-2 Toxin results in increased expression of CASP3 protein modified form]; Selenium inhibits the reaction [[Lead co-treated with Cadmium co-treated with Mercury co-treated with Arsenic] results in increased expression of CASP3 protein]; Selenium inhibits the reaction [arsenite results in increased expression of CASP3 protein]; Selenium inhibits the reaction [nickel sulfate results in increased expression of CASP3 protein modified form]; Selenium inhibits the reaction [nickel sulfate results in increased expression of CASP3 protein] 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Selenium inhibits the reaction [nickel sulfate results in decreased expression of CASP3 protein]]; 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Selenium inhibits the reaction [nickel sulfate results in increased expression of CASP3 protein modified form]]; [Selenium analog co-treated with Magnesium Oxide analog] inhibits the reaction [Diazinon results in increased expression of CASP3 mRNA]; Selenium inhibits the reaction [nickel sulfate results in decreased expression of CASP3 protein]; Selenium inhibits the reaction [nickel sulfate results in increased expression of CASP3 protein modified form] |
CTD |
PMID:15318939 PMID:17997286 PMID:21628957 PMID:27920530 PMID:29324385 PMID:30629952 PMID:34612572 PMID:37676925 More...
|
|
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
|
|
G |
Casp8 |
caspase 8 |
multiple interactions increases activity decreases expression |
ISO |
[Doxorubicin co-treated with Selenium] promotes the reaction [FADD protein binds to CASP8 protein]; [Doxorubicin co-treated with Selenium] promotes the reaction [FAS protein binds to CASP8 protein]; Acetylcysteine inhibits the reaction [bisphenol A promotes the reaction [Selenium deficiency results in decreased expression of CASP8 mRNA]]; Acetylcysteine inhibits the reaction [bisphenol A promotes the reaction [Selenium deficiency results in decreased expression of CASP8 protein]]; bisphenol A promotes the reaction [Selenium deficiency results in decreased expression of CASP8 mRNA]; bisphenol A promotes the reaction [Selenium deficiency results in decreased expression of CASP8 protein]; necrostatin-1 inhibits the reaction [bisphenol A promotes the reaction [Selenium deficiency results in decreased expression of CASP8 mRNA]]; necrostatin-1 inhibits the reaction [bisphenol A promotes the reaction [Selenium deficiency results in decreased expression of CASP8 protein]]; Selenium analog inhibits the reaction [Diazinon results in increased expression of CASP8 mRNA] Selenium results in increased activity of CASP8 protein Selenium deficiency results in decreased expression of CASP8 mRNA; Selenium deficiency results in decreased expression of CASP8 protein; Selenium results in decreased expression of CASP8 mRNA |
CTD |
PMID:12432279 PMID:17970047 PMID:19244175 PMID:27920530 PMID:37422542 |
|
NCBI chr 9:60,263,863...60,312,542
Ensembl chr 9:60,264,075...60,312,542
|
|
G |
Casp9 |
caspase 9 |
multiple interactions decreases activity |
ISO EXP |
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Selenium inhibits the reaction [nickel sulfate results in increased expression of CASP9 protein]]; [Doxorubicin co-treated with Selenium] results in increased cleavage of and results in increased activity of CASP9 protein; BCL2L11 protein promotes the reaction [[Doxorubicin co-treated with Selenium] results in increased cleavage of and results in increased activity of CASP9 protein]; Selenium analog inhibits the reaction [Magnesium Oxide analog inhibits the reaction [Diazinon results in increased expression of CASP9 mRNA]]; Selenium inhibits the reaction [nickel sulfate results in increased expression of CASP9 protein] [Vitamin E co-treated with Selenium] inhibits the reaction [Malathion results in increased expression of CASP9 mRNA]; Selenium inhibits the reaction [arsenite results in increased expression of CASP9 mRNA]; Selenium inhibits the reaction [nickel sulfate results in increased expression of CASP9 protein] Selenium results in decreased activity of CASP9 protein |
CTD |
PMID:17339365 PMID:17997286 PMID:21628957 PMID:27920530 PMID:29324385 PMID:34612572 More...
|
|
NCBI chr 5:154,108,872...154,126,628
Ensembl chr 5:154,109,046...154,126,626
|
|
G |
Cat |
catalase |
multiple interactions increases expression increases activity decreases expression |
ISO EXP |
Arsenic promotes the reaction [Selenium results in increased expression of CAT protein]; Fluorides promotes the reaction [Selenium results in increased activity of CAT protein]; Selenium inhibits the reaction [Fluorides results in decreased activity of CAT protein] [[Sodium Selenite results in increased abundance of Selenium] which co-treated with Ascorbic Acid] inhibits the reaction [barium chloride results in decreased activity of CAT protein]; [Aluminum co-treated with Lead co-treated with Mercury co-treated with Manganese co-treated with Selenium] results in decreased activity of CAT protein; [Selenium co-treated with Vitamin E] inhibits the reaction [Malathion results in decreased activity of CAT protein]; [Selenium co-treated with Zinc] inhibits the reaction [[Lead co-treated with Cadmium co-treated with Mercury co-treated with Arsenic] results in decreased expression of CAT protein]; [Sodium Selenite results in increased abundance of Selenium] inhibits the reaction [barium chloride results in decreased activity of CAT protein]; [Sodium Selenite results in increased abundance of Selenium] inhibits the reaction [bisphenol A results in decreased activity of CAT protein]; [Zinc co-treated with Selenium] inhibits the reaction [Streptozocin results in decreased expression of CAT protein]; Selenium affects the reaction [Clofibrate results in increased activity of CAT protein]; Selenium affects the reaction [Mercury results in decreased activity of CAT protein]; Selenium inhibits the reaction [[Lead co-treated with Cadmium co-treated with Mercury co-treated with Arsenic] results in decreased expression of CAT protein]; Selenium inhibits the reaction [Acrylamide results in decreased activity of CAT protein]; Selenium inhibits the reaction [chromium hexavalent ion results in decreased activity of CAT protein]; Selenium inhibits the reaction [chromium hexavalent ion results in increased activity of CAT protein]; Selenium inhibits the reaction [Chromium results in increased activity of CAT protein]; Selenium inhibits the reaction [cyfluthrin results in decreased activity of CAT protein]; Selenium inhibits the reaction [Enrofloxacin results in decreased activity of CAT protein]; Selenium inhibits the reaction [Mercuric Chloride results in decreased activity of CAT protein]; Selenium inhibits the reaction [nickel sulfate results in increased activity of CAT protein]; Selenium inhibits the reaction [Potassium Dichromate results in decreased activity of CAT protein]; Selenium inhibits the reaction [Potassium Dichromate results in increased activity of CAT protein]; Selenium promotes the reaction [Acetylcysteine inhibits the reaction [Mercuric Chloride results in decreased activity of CAT protein]] Selenium deficiency results in decreased expression of CAT mRNA |
CTD |
PMID:3456598 PMID:8250967 PMID:11260395 PMID:17512462 PMID:19652462 PMID:19913299 PMID:20143455 PMID:20478284 PMID:20494564 PMID:20580087 PMID:21628957 PMID:23595963 PMID:24485406 PMID:27083143 PMID:27941167 PMID:30526071 PMID:32233808 PMID:34612572 PMID:37415728 PMID:37676925 PMID:37987225 More...
|
|
NCBI chr 3:89,842,393...89,874,577
Ensembl chr 3:89,842,399...89,874,478
|
|
G |
Cavin1 |
caveolae associated protein 1 |
increases expression |
ISO |
Selenium results in increased expression of CAVIN1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr10:85,884,100...85,896,136
Ensembl chr10:85,889,036...85,896,120
|
|
G |
Cblb |
Cbl proto-oncogene B |
decreases expression |
ISO |
Selenium results in decreased expression of CBLB mRNA |
CTD |
PMID:19244175 |
|
NCBI chr11:48,589,878...48,756,940
Ensembl chr11:48,592,703...48,756,839
|
|
G |
Cbx5 |
chromobox 5 |
multiple interactions decreases expression |
ISO |
[Selenium co-treated with Vitamin E] results in decreased expression of CBX5 mRNA Selenium results in decreased expression of CBX5 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 7:134,333,165...134,376,102
Ensembl chr 7:134,331,335...134,375,022
|
|
G |
Cbx7 |
chromobox 7 |
increases expression |
ISO |
Selenium results in increased expression of CBX7 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 7:111,460,656...111,479,231
Ensembl chr 7:111,460,656...111,477,973
|
|
G |
Ccdc85b |
coiled-coil domain containing 85B |
multiple interactions increases expression |
ISO |
[Selenium co-treated with Vitamin E] results in decreased expression of DIPA mRNA Selenium results in increased expression of DIPA mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 1:202,763,645...202,764,660
Ensembl chr 1:202,763,631...202,764,703
|
|
G |
Cchcr1 |
coiled-coil alpha-helical rod protein 1 |
increases expression |
ISO |
Selenium results in increased expression of CCHCR1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr20:3,205,675...3,218,437
Ensembl chr20:3,205,676...3,218,308
|
|
G |
Ccl2 |
C-C motif chemokine ligand 2 |
multiple interactions |
ISO |
[Cadmium analog co-treated with Selenium analog co-treated with zinc sulfide analog] results in increased expression of CCL2 mRNA; Selenium inhibits the reaction [Glucose results in increased expression of CCL2 mRNA]; Selenium inhibits the reaction [Hydrogen Peroxide results in increased expression of CCL2 mRNA] |
CTD |
PMID:16143069 PMID:21481475 |
|
NCBI chr10:67,005,424...67,007,222
Ensembl chr10:67,005,424...67,007,226
|
|
G |
Ccnb1 |
cyclin B1 |
decreases expression |
ISO |
Selenium deficiency results in decreased expression of CCNB1 mRNA |
CTD |
PMID:11925459 |
|
NCBI chr 2:31,912,190...31,921,163
Ensembl chr 2:31,912,193...31,921,172
|
|
G |
Ccnc |
cyclin C |
decreases expression |
ISO |
Selenium deficiency results in decreased expression of CCNC mRNA |
CTD |
PMID:11925459 |
|
NCBI chr 5:35,266,828...35,284,943
Ensembl chr 5:35,266,823...35,296,584
|
|
G |
Ccnd1 |
cyclin D1 |
increases expression multiple interactions |
ISO EXP |
Selenium results in increased expression of CCND1 mRNA [Selenium deficiency co-treated with Vitamin E deficiency] results in decreased expression of CCND1 mRNA |
CTD |
PMID:11444866 PMID:19244175 |
|
NCBI chr 1:200,089,002...200,098,524
Ensembl chr 1:200,089,002...200,098,602
|
|
G |
Ccnd2 |
cyclin D2 |
decreases expression |
ISO |
Selenium deficiency results in decreased expression of CCND2 mRNA |
CTD |
PMID:11925459 |
|
NCBI chr 4:159,966,883...159,989,261
Ensembl chr 4:159,962,363...159,989,495
|
|
G |
Ccpg1 |
cell cycle progression 1 |
decreases expression |
ISO |
Selenium results in decreased expression of CPR8 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 8:73,719,960...73,752,437
Ensembl chr 8:73,719,955...73,752,430
|
|
G |
Ccr3 |
C-C motif chemokine receptor 3 |
multiple interactions |
ISO |
[Cadmium analog co-treated with Selenium analog co-treated with zinc sulfide analog] results in decreased expression of CCR3 mRNA |
CTD |
PMID:21481475 |
|
NCBI chr 8:123,586,100...123,634,178
Ensembl chr 8:123,616,236...123,634,990
|
|
G |
Ccser2 |
coiled-coil serine-rich protein 2 |
decreases expression |
ISO |
Selenium results in decreased expression of CCSER2 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr16:12,613,103...12,725,764
Ensembl chr16:12,613,103...12,725,738
|
|
G |
Cd14 |
CD14 molecule |
multiple interactions |
ISO |
[Cadmium analog co-treated with Selenium analog co-treated with zinc sulfide analog] results in decreased expression of CD14 mRNA |
CTD |
PMID:21481475 |
|
NCBI chr18:28,335,522...28,337,383
Ensembl chr18:28,335,340...28,337,261
|
|
G |
Cd2bp2 |
Cd2 (cytoplasmic tail) binding protein 2 |
increases expression |
ISO |
Selenium results in increased expression of CD2BP2 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 1:181,809,399...181,815,269
Ensembl chr 1:181,809,406...181,813,448
|
|
G |
Cd44 |
CD44 molecule |
multiple interactions increases expression |
ISO |
Selenium inhibits the reaction [T-2 Toxin results in decreased expression of CD44 protein] Selenium results in increased expression of CD44 mRNA; Selenium results in increased expression of CD44 protein |
CTD |
PMID:18196609 |
|
NCBI chr 3:89,155,850...89,244,615
Ensembl chr 3:89,157,058...89,244,620
|
|
G |
Cd74 |
CD74 molecule |
increases expression |
ISO |
Selenium results in increased expression of CD74 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr18:54,256,757...54,266,003
Ensembl chr18:54,256,778...54,266,003
|
|
G |
Cd99 |
CD99 molecule (Xg blood group) |
increases expression |
ISO |
Selenium results in increased expression of CD99 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr20:54,418,239...54,422,882
|
|
G |
Cdc14b |
cell division cycle 14B |
decreases expression |
ISO |
Selenium results in decreased expression of CDC14B mRNA |
CTD |
PMID:19244175 |
|
NCBI chr17:844,686...934,787
Ensembl chr17:844,685...933,235
|
|
G |
Cdc16 |
cell division cycle 16 |
decreases expression |
ISO |
Selenium results in decreased expression of CDC16 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr16:75,773,026...75,796,586
Ensembl chr16:75,773,028...75,796,550
|
|
G |
Cdc23 |
cell division cycle 23 |
decreases expression |
ISO |
Selenium results in decreased expression of CDC23 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr18:26,236,891...26,260,611
Ensembl chr18:26,236,890...26,291,163
|
|
G |
Cdc42bpa |
CDC42 binding protein kinase alpha |
multiple interactions decreases expression |
ISO |
[Selenium co-treated with Vitamin E] results in decreased expression of CDC42BPA mRNA Selenium results in decreased expression of CDC42BPA mRNA |
CTD |
PMID:19244175 |
|
NCBI chr13:91,683,775...91,903,732
Ensembl chr13:91,684,007...91,903,732
|
|
G |
Cdc42ep4 |
CDC42 effector protein 4 |
increases expression |
ISO |
Selenium results in increased expression of CDC42EP4 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr10:98,772,613...98,797,924
Ensembl chr10:98,772,495...98,797,695
|
|
G |
Cdc73 |
cell division cycle 73 |
decreases expression |
ISO |
Selenium results in decreased expression of CDC73 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr13:55,357,226...55,449,690
Ensembl chr13:55,357,226...55,449,656
|
|
G |
Cdh11 |
cadherin 11 |
decreases expression |
ISO |
Selenium results in decreased expression of CDH11 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr19:2,148,447...2,305,754
Ensembl chr19:2,148,458...2,304,272
|
|
G |
Cdh3 |
cadherin 3 |
increases expression |
ISO |
Selenium results in increased expression of CDH3 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr19:34,393,596...34,444,084
Ensembl chr19:34,393,727...34,444,084
|
|
G |
Cdk1 |
cyclin-dependent kinase 1 |
decreases expression |
ISO |
Selenium deficiency results in decreased expression of CDK1 mRNA |
CTD |
PMID:11925459 |
|
NCBI chr20:19,266,226...19,281,417
Ensembl chr20:19,266,248...19,281,408
|
|
G |
Cdk10 |
cyclin-dependent kinase 10 |
increases expression multiple interactions |
ISO |
Selenium results in increased expression of CDK10 mRNA [Selenium co-treated with Vitamin E] results in decreased expression of CDK10 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr19:51,260,012...51,273,009
Ensembl chr19:51,261,356...51,269,078
|
|
G |
Cdk2 |
cyclin dependent kinase 2 |
decreases expression |
ISO |
Selenium deficiency results in decreased expression of CDK2 mRNA |
CTD |
PMID:11925459 |
|
NCBI chr 7:1,129,878...1,137,431
Ensembl chr 7:1,129,811...1,137,403
|
|
G |
Cdk2ap2 |
cyclin-dependent kinase 2 associated protein 2 |
increases expression |
ISO |
Selenium results in increased expression of CDK2AP2 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 1:201,391,056...201,393,137
Ensembl chr 1:201,391,466...201,393,137
|
|
G |
Cdk4 |
cyclin-dependent kinase 4 |
decreases expression increases expression |
ISO |
Selenium deficiency results in decreased expression of CDK4 mRNA Selenium results in increased expression of CDK4 mRNA |
CTD |
PMID:11925459 PMID:19244175 |
|
NCBI chr 7:62,886,124...62,889,562
Ensembl chr 7:62,883,105...62,942,403
|
|
G |
Cdkn1c |
cyclin-dependent kinase inhibitor 1C |
decreases expression |
ISO |
Selenium results in decreased expression of CDKN1C mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 1:198,655,394...198,658,097
Ensembl chr 1:198,655,407...198,658,048
|
|
G |
Cds1 |
CDP-diacylglycerol synthase 1 |
decreases expression |
ISO |
Selenium results in decreased expression of CDS1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr14:7,820,328...7,882,943
Ensembl chr14:7,820,351...7,882,681
|
|
G |
Cebpa |
CCAAT/enhancer binding protein alpha |
increases expression |
ISO |
Selenium results in increased expression of CEBPA mRNA |
CTD |
PMID:28810182 |
|
NCBI chr 1:87,759,631...87,762,303
Ensembl chr 1:87,759,433...87,762,412
|
|
G |
Cel |
carboxyl ester lipase |
increases expression |
ISO |
Selenium results in increased expression of CEL mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 3:11,883,532...11,891,035
Ensembl chr 3:11,883,532...11,891,035
|
|
G |
Celf2 |
CUGBP, Elav-like family member 2 |
decreases expression |
ISO |
Selenium results in decreased expression of CELF2 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr17:70,904,462...71,729,072
Ensembl chr17:71,210,853...71,728,333
|
|
G |
Cep170 |
centrosomal protein 170 |
decreases expression |
ISO |
Selenium results in decreased expression of CEP170 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr13:88,669,672...88,754,011
Ensembl chr13:88,670,358...88,732,226
|
|
G |
Cep290 |
centrosomal protein 290 |
decreases expression |
ISO |
Selenium results in decreased expression of CEP290 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 7:35,310,071...35,399,388
Ensembl chr 7:35,310,199...35,399,392
|
|
G |
Cep350 |
centrosomal protein 350 |
multiple interactions decreases expression |
ISO |
[Selenium co-treated with Vitamin E] results in increased expression of CEP350 mRNA Selenium results in decreased expression of CEP350 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr13:68,023,327...68,164,478
Ensembl chr13:68,026,891...68,165,214
|
|
G |
Cep57 |
centrosomal protein 57 |
multiple interactions decreases expression |
ISO |
[Selenium co-treated with Vitamin E] results in decreased expression of CEP57 mRNA Selenium results in decreased expression of CEP57 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 8:10,669,588...10,689,257
Ensembl chr 8:10,669,590...10,689,249
|
|
G |
Cert1 |
ceramide transporter 1 |
multiple interactions decreases expression |
ISO |
[Selenium co-treated with Vitamin E] results in increased expression of CERT1 mRNA Selenium results in decreased expression of CERT1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 2:27,882,546...27,987,090
Ensembl chr 2:27,882,555...27,987,074
|
|
G |
Ces1d |
carboxylesterase 1D |
increases expression |
ISO |
Selenium results in increased expression of CES1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr19:13,873,490...13,912,035
Ensembl chr19:13,796,623...13,912,035
|
|
G |
Cfh |
complement factor H |
decreases expression |
ISO |
Selenium results in decreased expression of CFH mRNA |
CTD |
PMID:19244175 |
|
NCBI chr13:51,512,376...51,613,829
Ensembl chr13:51,511,828...51,613,838
|
|
G |
Cflar |
CASP8 and FADD-like apoptosis regulator |
multiple interactions |
ISO |
[Selenium analog co-treated with Magnesium Oxide analog] inhibits the reaction [Diazinon results in increased expression of CFLAR mRNA]; Selenium analog promotes the reaction [Diazinon results in increased expression of CFLAR mRNA] |
CTD |
PMID:27920530 |
|
NCBI chr 9:60,185,338...60,236,173
Ensembl chr 9:60,185,452...60,237,034
|
|
G |
Chd1 |
chromodomain helicase DNA binding protein 1 |
decreases expression multiple interactions |
ISO |
Selenium results in decreased expression of CHD1 mRNA [Selenium co-treated with Vitamin E] results in decreased expression of CHD1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 1:56,661,743...56,729,119
Ensembl chr 1:56,664,054...56,728,125
|
|
G |
Chd3 |
chromodomain helicase DNA binding protein 3 |
increases expression |
ISO |
Selenium results in increased expression of CHD3 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr10:54,063,629...54,090,030
Ensembl chr10:54,063,629...54,090,047
|
|
G |
Chd4 |
chromodomain helicase DNA binding protein 4 |
increases expression |
ISO |
Selenium results in increased expression of CHD4 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 4:157,898,503...157,931,632
Ensembl chr 4:157,899,391...157,931,541
|
|
G |
Chd9 |
chromodomain helicase DNA binding protein 9 |
decreases expression |
ISO |
Selenium results in decreased expression of CHD9 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr19:15,941,535...16,146,220
Ensembl chr19:15,942,687...16,164,556
|
|
G |
Chka |
choline kinase alpha |
increases expression |
ISO |
Selenium results in increased expression of CHKA mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 1:201,076,804...201,125,517
Ensembl chr 1:201,076,860...201,125,516
|
|
G |
Chmp1a |
charged multivesicular body protein 1A |
increases expression |
ISO |
Selenium results in increased expression of CHMP1A mRNA |
CTD |
PMID:19244175 |
|
NCBI chr19:51,238,153...51,246,433
Ensembl chr19:51,238,160...51,246,436
|
|
G |
Chmp2a |
charged multivesicular body protein 2A |
increases expression |
ISO |
Selenium results in increased expression of CHMP2A mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 1:73,660,045...73,662,894
Ensembl chr 1:73,660,046...73,662,452
|
|
G |
Chn2 |
chimerin 2 |
increases expression |
ISO |
Selenium results in increased expression of CHN2 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 4:83,148,616...83,407,711
Ensembl chr 4:83,147,983...83,407,709
|
|
G |
Chordc1 |
cysteine and histidine rich domain containing 1 |
decreases expression |
ISO |
Selenium results in decreased expression of CHORDC1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 8:15,374,356...15,398,436
Ensembl chr 8:15,374,471...15,399,162
|
|
G |
Chpf |
chondroitin polymerizing factor |
multiple interactions increases expression |
ISO |
[Selenium co-treated with Vitamin E] results in decreased expression of CHPF mRNA Selenium results in increased expression of CHPF mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 9:76,963,178...76,967,878
Ensembl chr 9:76,963,184...76,967,878
|
|
G |
Chrna4 |
cholinergic receptor nicotinic alpha 4 subunit |
increases expression |
ISO |
Selenium results in increased expression of CHRNA4 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 3:168,136,246...168,157,839
Ensembl chr 3:168,136,266...168,156,957
|
|
G |
Chrne |
cholinergic receptor nicotinic epsilon subunit |
increases expression |
ISO |
Selenium results in increased expression of CHRNE mRNA |
CTD |
PMID:19244175 |
|
NCBI chr10:55,331,211...55,339,923
Ensembl chr10:55,331,212...55,335,530
|
|
G |
Chst3 |
carbohydrate sulfotransferase 3 |
increases expression |
ISO |
Selenium results in increased expression of CHST3 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr20:28,114,386...28,152,046
Ensembl chr20:28,114,404...28,121,807
|
|
G |
Chst5 |
carbohydrate sulfotransferase 5 |
increases expression |
ISO |
Selenium results in increased expression of CHST6 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr19:39,860,729...39,881,019
Ensembl chr19:39,860,501...39,881,064
|
|
G |
Ciz1 |
CDKN1A interacting zinc finger protein 1 |
increases expression |
ISO |
Selenium results in increased expression of CIZ1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 3:15,658,479...15,673,762
Ensembl chr 3:15,658,539...15,673,762
|
|
G |
Ckap2 |
cytoskeleton associated protein 2 |
decreases expression |
ISO |
Selenium results in decreased expression of CKAP2 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr16:69,839,668...69,864,852
Ensembl chr16:69,839,630...69,864,913
|
|
G |
Ckb |
creatine kinase B |
increases expression |
ISO |
Selenium results in increased expression of CKB mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 6:130,729,420...130,732,301
Ensembl chr 6:130,729,423...130,732,315
|
|
G |
Cks2 |
CDC28 protein kinase regulatory subunit 2 |
decreases expression |
ISO |
Selenium results in decreased expression of CKS2 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr17:13,570,611...13,575,770
|
|
G |
Clcc1 |
chloride channel CLIC-like 1 |
decreases expression |
ISO |
Selenium results in decreased expression of CLCC1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 2:196,296,350...196,326,914
Ensembl chr 2:196,296,393...196,326,913
|
|
G |
Clcn3 |
chloride voltage-gated channel 3 |
multiple interactions decreases expression |
ISO |
[Selenium co-treated with Vitamin E] results in increased expression of CLCN3 mRNA Selenium results in decreased expression of CLCN3 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr16:29,127,152...29,200,133
Ensembl chr16:29,127,419...29,200,119
|
|
G |
Cldn4 |
claudin 4 |
increases expression |
ISO |
Selenium results in increased expression of CLDN4 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr12:21,751,638...21,753,436
Ensembl chr12:21,751,331...21,753,436
|
|
G |
Cldn5 |
claudin 5 |
multiple interactions |
ISO |
[gamma-Linolenic Acid co-treated with Iodine co-treated with Selenium] results in increased expression of and results in increased localization of CLDN5 protein; [Selenium co-treated with gamma-Linolenic Acid] results in increased expression of and results in increased localization of CLDN5 protein; [Selenium co-treated with Iodine] results in increased expression of and results in increased localization of CLDN5 protein; Selenium results in increased expression of and results in increased localization of CLDN5 protein |
CTD |
PMID:16514648 |
|
NCBI chr11:82,212,822...82,214,248
Ensembl chr11:82,211,475...82,214,992
|
|
G |
Clec3b |
C-type lectin domain family 3, member B |
multiple interactions increases expression |
ISO |
[Selenium co-treated with Vitamin E] results in increased expression of TNA mRNA Selenium results in increased expression of TNA mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 8:122,810,120...122,815,837
Ensembl chr 8:122,810,149...122,815,835
|
|
G |
Cln3 |
CLN3 lysosomal/endosomal transmembrane protein, battenin |
multiple interactions increases expression |
ISO |
[Selenium co-treated with Vitamin E] results in increased expression of CLN3 mRNA Selenium results in increased expression of CLN3 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 1:181,156,071...181,169,458
Ensembl chr 1:181,156,073...181,167,434
|
|
G |
Clptm1 |
CLPTM1 regulator of GABA type A receptor forward trafficking |
increases expression |
ISO |
Selenium results in increased expression of CLPTM1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 1:79,289,478...79,321,079
Ensembl chr 1:79,289,477...79,321,092
|
|
G |
Cltb |
clathrin, light chain B |
increases expression |
ISO |
Selenium results in increased expression of CLTB mRNA |
CTD |
PMID:19244175 |
|
NCBI chr17:10,001,512...10,019,201
Ensembl chr17:10,001,513...10,019,169
|
|
G |
Clu |
clusterin |
increases expression |
ISO |
Selenium results in increased expression of CLU mRNA |
CTD |
PMID:19244175 |
|
NCBI chr15:40,161,068...40,200,315
Ensembl chr15:40,174,617...40,200,315
|
|
G |
Cmc2 |
C-x(9)-C motif containing 2 |
decreases expression |
ISO |
Selenium results in decreased expression of CMC2 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr19:44,943,283...44,971,930
Ensembl chr19:44,943,285...44,971,983
|
|
G |
Cnih1 |
cornichon family member 1 |
decreases expression |
ISO |
Selenium results in decreased expression of CNIH1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr15:20,037,885...20,049,857
Ensembl chr15:20,037,885...20,049,761
|
|
G |
Cnih4 |
cornichon family member 4 |
decreases expression |
ISO |
Selenium results in decreased expression of CNIH4 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr13:92,910,315...92,926,428
Ensembl chr13:92,910,315...92,927,853
|
|
G |
Cnn2 |
calponin 2 |
increases expression |
ISO |
Selenium results in increased expression of CNN2 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 7:9,712,505...9,719,678
Ensembl chr 7:9,712,516...9,719,656
|
|
G |
Cnn3 |
calponin 3 |
increases expression |
ISO |
Selenium results in increased expression of CNN3 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 2:209,518,948...209,550,107
Ensembl chr 2:209,518,948...209,550,104
|
|
G |
Cnot8 |
CCR4-NOT transcription complex, subunit 8 |
decreases expression |
ISO |
Selenium results in decreased expression of CNOT8 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr10:42,281,614...42,294,740
Ensembl chr10:42,281,722...42,294,730
|
|
G |
Cnpy2 |
canopy FGF signaling regulator 2 |
decreases expression |
ISO |
Selenium results in decreased expression of CNPY2 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 7:748,877...754,352
Ensembl chr 7:749,008...755,519
|
|
G |
Cnpy3 |
canopy FGF signaling regulator 3 |
increases expression |
ISO |
Selenium results in increased expression of CNPY3 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 9:14,233,478...14,247,847
Ensembl chr 9:14,233,428...14,247,831
|
|
G |
Cog4 |
component of oligomeric golgi complex 4 |
multiple interactions |
ISO |
[Selenium co-treated with Vitamin E] results in increased expression of COG4 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr19:38,820,478...38,854,803
Ensembl chr19:38,820,501...38,854,796
|
|
G |
Cog7 |
component of oligomeric golgi complex 7 |
increases expression |
ISO |
Selenium results in increased expression of COG7 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 1:176,489,795...176,549,455
Ensembl chr 1:176,489,791...176,549,455
|
|
G |
Cog8 |
component of oligomeric golgi complex 8 |
increases expression |
ISO |
Selenium results in increased expression of COG8 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr19:34,951,625...34,962,377
Ensembl chr19:34,951,627...34,962,397
|
|
G |
Col14a1 |
collagen type XIV alpha 1 chain |
decreases expression |
ISO |
Selenium results in decreased expression of COL14A1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 7:86,722,093...86,937,215
Ensembl chr 7:86,722,094...86,937,214
|
|
G |
Col18a1 |
collagen type XVIII alpha 1 chain |
increases expression |
ISO |
Selenium results in increased expression of COL18A1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr20:11,474,104...11,582,593
Ensembl chr20:11,474,104...11,582,593
|
|
G |
Col1a1 |
collagen type I alpha 1 chain |
multiple interactions |
ISO |
[fulvic acid co-treated with Selenium deficiency] affects the metabolism of COL1A1 protein |
CTD |
PMID:8435081 |
|
NCBI chr10:79,883,622...79,900,625
Ensembl chr10:79,883,622...79,900,624
|
|
G |
Col2a1 |
collagen type II alpha 1 chain |
multiple interactions |
ISO |
[fulvic acid co-treated with Selenium deficiency] affects the metabolism of COL2A1 protein |
CTD |
PMID:8435081 |
|
NCBI chr 7:129,098,489...129,127,560
Ensembl chr 7:129,098,786...129,127,546
|
|
G |
Col4a3 |
collagen type IV alpha 3 chain |
decreases expression |
ISO |
Selenium results in decreased expression of COL4A3 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 9:83,875,849...84,004,955
Ensembl chr 9:83,875,561...84,001,895
|
|
G |
Col6a2 |
collagen type VI alpha 2 chain |
increases expression |
ISO |
Selenium results in increased expression of COL6A2 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr20:12,021,676...12,049,425
Ensembl chr20:12,021,767...12,057,564
|
|
G |
Colec12 |
collectin sub-family member 12 |
multiple interactions |
ISO |
[Cadmium analog co-treated with Selenium analog co-treated with zinc sulfide analog] results in decreased expression of COLEC12 mRNA |
CTD |
PMID:21481475 |
|
NCBI chr18:732,950...920,620
Ensembl chr18:732,950...920,618
|
|
G |
Commd3 |
COMM domain containing 3 |
decreases expression |
ISO |
Selenium results in decreased expression of COMMD3 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr17:81,327,444...81,331,191
Ensembl chr17:81,327,405...81,331,177
|
|
G |
Commd4 |
COMM domain containing 4 |
increases expression |
ISO |
Selenium results in increased expression of COMMD4 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 8:57,566,236...57,569,701
Ensembl chr 8:57,566,236...57,569,760
|
|
G |
Cope |
COPI coat complex subunit epsilon |
increases expression |
ISO |
Selenium results in increased expression of COPE mRNA |
CTD |
PMID:19244175 |
|
NCBI chr16:19,114,871...19,125,076
Ensembl chr16:19,114,871...19,128,907
|
|
G |
Copg1 |
COPI coat complex subunit gamma 1 |
increases expression |
ISO |
Selenium results in increased expression of COPG1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 4:120,366,540...120,392,502
Ensembl chr 4:120,366,542...120,415,616
|
|
G |
Cops7a |
COP9 signalosome subunit 7A |
increases expression |
ISO |
Selenium results in increased expression of COPS7A mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 4:157,766,626...157,792,632
Ensembl chr 4:157,766,588...157,773,948
|
|
G |
Cops8 |
COP9 signalosome subunit 8 |
decreases expression |
ISO |
Selenium results in decreased expression of COPS8 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 9:91,207,427...91,217,258
Ensembl chr 9:91,207,395...91,217,258
|
|
G |
Cox6a1 |
cytochrome c oxidase subunit 6A1 |
decreases expression |
ISO |
Selenium results in decreased expression of COX6A1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr12:41,261,983...41,265,037
Ensembl chr12:41,261,967...41,265,041
|
|
G |
Cox7a1 |
cytochrome c oxidase subunit 7A1 |
decreases expression |
ISO |
Selenium results in decreased expression of COX7A1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 1:85,422,162...85,447,530
Ensembl chr 1:85,441,871...85,445,151
|
|
G |
Cox7a2 |
cytochrome c oxidase subunit 7A2 |
decreases expression |
ISO |
Selenium results in decreased expression of COX7A2 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 8:80,716,824...80,720,922
Ensembl chr14:51,301,168...51,301,633 Ensembl chr 8:51,301,168...51,301,633
|
|
G |
Cox7b |
cytochrome c oxidase subunit 7B |
decreases expression |
ISO |
Selenium results in decreased expression of COX7B mRNA |
CTD |
PMID:19244175 |
|
NCBI chr X:71,083,486...71,089,733
Ensembl chr X:71,083,456...71,089,732
|
|
G |
Cox7c |
cytochrome c oxidase subunit 7C |
decreases expression |
ISO |
Selenium results in decreased expression of COX7C mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 2:16,841,771...16,843,796
Ensembl chr 2:16,840,837...16,843,760
|
|
G |
Cpa3 |
carboxypeptidase A3 |
decreases expression |
ISO |
Selenium results in decreased expression of CPA3 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 2:102,712,483...102,744,219
Ensembl chr 2:102,712,589...102,744,203
|
|
G |
Cpd |
carboxypeptidase D |
decreases expression |
ISO |
Selenium results in decreased expression of CPD mRNA |
CTD |
PMID:19244175 |
|
NCBI chr10:61,623,528...61,687,491
Ensembl chr10:61,623,526...61,687,491
|
|
G |
Cpsf1 |
cleavage and polyadenylation specific factor 1 |
increases expression |
ISO |
Selenium results in increased expression of CPSF1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 7:108,319,429...108,330,018
Ensembl chr 7:108,319,434...108,329,934
|
|
G |
Crabp2 |
cellular retinoic acid binding protein 2 |
increases expression |
EXP |
Selenium deficiency results in increased expression of CRABP2 mRNA |
CTD |
PMID:11444866 |
|
NCBI chr 2:173,417,004...173,421,352
Ensembl chr 2:173,416,857...173,421,379
|
|
G |
Crat |
carnitine O-acetyltransferase |
increases expression |
ISO |
Selenium results in increased expression of CRAT mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 3:13,675,684...13,689,282
Ensembl chr 3:13,675,684...13,689,255
|
|
G |
Crbn |
cereblon |
decreases expression |
ISO |
Selenium results in decreased expression of CRBN mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 4:139,701,154...139,719,949
Ensembl chr 4:139,701,094...139,719,938
|
|
G |
Creb1 |
cAMP responsive element binding protein 1 |
multiple interactions decreases expression |
ISO EXP |
[Selenium co-treated with Vitamin E] results in decreased expression of CREB1 mRNA Selenium inhibits the reaction [[Dietary Fats co-treated with Cholesterol] results in decreased expression of CREB1 protein] Selenium results in decreased expression of CREB1 mRNA |
CTD |
PMID:19244175 PMID:30695686 |
|
NCBI chr 9:65,903,511...65,972,562
Ensembl chr 9:65,903,547...65,970,816
|
|
G |
Creb3 |
cAMP responsive element binding protein 3 |
increases expression |
ISO |
Selenium results in increased expression of CREB3 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 5:57,817,865...57,823,233
Ensembl chr 5:57,817,832...57,824,390
|
|
G |
Crebbp |
CREB binding protein |
decreases expression |
ISO |
Selenium results in decreased expression of CREBBP mRNA |
CTD |
PMID:19244175 |
|
NCBI chr10:11,335,551...11,461,888
Ensembl chr10:11,335,953...11,461,888
|
|
G |
Creld1 |
cysteine-rich with EGF-like domains 1 |
increases expression |
ISO |
Selenium results in increased expression of CRELD1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 4:146,631,883...146,641,493
Ensembl chr 4:146,631,883...146,641,499
|
|
G |
Crtc1 |
CREB regulated transcription coactivator 1 |
increases expression |
ISO |
Selenium results in increased expression of CRTC1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr16:18,988,197...19,046,914
Ensembl chr16:18,988,250...19,043,381
|
|
G |
Crybg2 |
crystallin beta-gamma domain containing 2 |
increases expression multiple interactions |
ISO |
Selenium results in increased expression of CRYBG2 mRNA [Selenium co-treated with Vitamin E] results in increased expression of CRYBG2 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 5:146,286,406...146,318,417
Ensembl chr 5:146,286,925...146,323,666
|
|
G |
Csf1 |
colony stimulating factor 1 |
increases expression |
ISO |
Selenium results in increased expression of CSF1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 2:195,377,215...195,396,608
Ensembl chr 2:195,377,215...195,411,704
|
|
G |
Csk |
C-terminal Src kinase |
increases expression |
ISO |
Selenium results in increased expression of CSK mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 8:58,029,748...58,048,742
Ensembl chr 8:58,029,749...58,048,292
|
|
G |
Csnk1a1 |
casein kinase 1, alpha 1 |
multiple interactions decreases expression |
ISO |
[Selenium co-treated with Vitamin E] results in decreased expression of CSNK1A1 mRNA Selenium results in decreased expression of CSNK1A1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr18:55,017,049...55,050,184
Ensembl chr18:55,017,055...55,049,271
|
|
G |
Csnk1e |
casein kinase 1, epsilon |
multiple interactions increases expression |
ISO |
[Selenium co-treated with Vitamin E] results in decreased expression of CSNK1E mRNA Selenium results in increased expression of CSNK1E mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 7:110,983,322...111,006,926
Ensembl chr 7:110,983,318...111,006,794
|
|
G |
Csnk2a1 |
casein kinase 2 alpha 1 |
decreases expression |
ISO |
Selenium results in decreased expression of CSNK2A1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 3:140,709,984...140,756,757
Ensembl chr 3:140,709,991...140,756,696
|
|
G |
Csnk2b |
casein kinase 2 beta |
increases expression |
ISO |
Selenium results in increased expression of CSNK2B mRNA |
CTD |
PMID:19244175 |
|
NCBI chr20:3,700,363...3,705,331
Ensembl chr20:3,698,733...3,707,133
|
|
G |
Cspg4 |
chondroitin sulfate proteoglycan 4 |
multiple interactions |
ISO |
[Selenium co-treated with Vitamin E] results in increased expression of CSPG4 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 8:57,264,962...57,300,010
Ensembl chr 8:57,264,962...57,300,010
|
|
G |
Cspp1 |
centrosome and spindle pole associated protein 1 |
decreases expression multiple interactions |
ISO |
Selenium results in decreased expression of CSPP1 mRNA [Selenium co-treated with Vitamin E] results in increased expression of CSPP1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 5:9,077,161...9,192,402
Ensembl chr 5:9,077,161...9,193,377
|
|
G |
Cst3 |
cystatin C |
increases expression |
ISO |
Selenium results in increased expression of CST3 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 3:136,336,923...136,340,796
Ensembl chr 3:136,336,920...136,340,822
|
|
G |
Csta |
cystatin A |
decreases expression |
ISO |
Selenium results in decreased expression of CSTA mRNA |
CTD |
PMID:19244175 |
|
NCBI chr11:64,620,483...64,631,488
Ensembl chr11:64,620,483...64,631,488
|
|
G |
Ctbp1 |
C-terminal binding protein 1 |
increases expression |
ISO |
Selenium results in increased expression of CTBP1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr14:77,455,580...77,482,821
Ensembl chr14:77,455,696...77,482,821
|
|
G |
Ctbp2 |
C-terminal binding protein 2 |
multiple interactions decreases expression |
ISO |
[Selenium co-treated with Vitamin E] results in decreased expression of CTBP2 mRNA Selenium results in decreased expression of CTBP2 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 1:187,782,064...187,918,115
Ensembl chr 1:187,782,682...187,920,222
|
|
G |
Ctbs |
chitobiase |
decreases expression |
ISO |
Selenium results in decreased expression of CTBS mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 2:235,340,520...235,355,091
Ensembl chr 2:235,340,547...235,355,091
|
|
G |
Ctdnep1 |
CTD nuclear envelope phosphatase 1 |
multiple interactions increases expression |
ISO |
[Selenium co-treated with Vitamin E] results in decreased expression of CTDNEP1 mRNA Selenium results in increased expression of CTDNEP1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr10:54,704,367...54,713,781
Ensembl chr10:54,704,148...54,713,781
|
|
G |
Ctnna1 |
catenin alpha 1 |
increases expression |
ISO |
Selenium results in increased expression of CTNNA1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr18:26,728,246...26,860,911
Ensembl chr18:26,728,485...26,860,910
|
|
G |
Ctnnbl1 |
catenin, beta like 1 |
increases expression |
ISO |
Selenium results in increased expression of CTNNBL1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 3:146,387,940...146,548,987
Ensembl chr 3:146,387,889...146,548,987
|
|
G |
Ctsa |
cathepsin A |
increases expression |
ISO |
Selenium results in increased expression of CTSA mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 3:153,569,106...153,574,983
Ensembl chr 3:153,568,381...153,576,215
|
|
G |
Ctsb |
cathepsin B |
increases expression |
ISO |
Selenium results in increased expression of CTSB mRNA |
CTD |
PMID:19244175 |
|
NCBI chr15:37,389,636...37,410,508
Ensembl chr15:37,389,629...37,410,500
|
|
G |
Ctso |
cathepsin O |
decreases expression |
ISO |
Selenium results in decreased expression of CTSO mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 2:167,230,407...167,254,761
Ensembl chr 2:167,230,330...167,253,702
|
|
G |
Cuedc2 |
CUE domain containing 2 |
increases expression |
ISO |
Selenium results in increased expression of CUEDC2 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 1:245,192,057...245,200,594
Ensembl chr 1:245,192,063...245,200,339
|
|
G |
Cul3 |
cullin 3 |
decreases expression |
ISO |
Selenium results in decreased expression of CUL3 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 9:81,592,641...81,670,428
Ensembl chr 9:81,592,641...81,670,462
|
|
G |
Cul4a |
cullin 4A |
multiple interactions |
ISO |
[Selenium co-treated with Vitamin E] results in decreased expression of CUL4A mRNA |
CTD |
PMID:19244175 |
|
NCBI chr16:76,385,298...76,422,316
Ensembl chr16:76,384,546...76,422,330
|
|
G |
Cul7 |
cullin 7 |
increases expression |
ISO |
Selenium results in increased expression of CUL7 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 9:14,319,102...14,333,035
Ensembl chr 9:14,319,108...14,332,741
|
|
G |
Cutc |
cutC copper transporter |
multiple interactions decreases expression |
ISO |
[Selenium co-treated with Vitamin E] results in increased expression of CUTC mRNA Selenium results in decreased expression of CUTC mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 1:242,622,281...242,637,048
Ensembl chr 1:242,622,276...242,637,047
|
|
G |
Cxcl1 |
C-X-C motif chemokine ligand 1 |
increases expression |
ISO |
Selenium results in increased expression of CXCL1 mRNA |
CTD |
PMID:17293063 |
|
NCBI chr14:17,193,364...17,195,143
Ensembl chr14:17,193,365...17,195,215
|
|
G |
Cxcl2 |
C-X-C motif chemokine ligand 2 |
increases expression |
ISO |
Selenium results in increased expression of CXCL2 mRNA |
CTD |
PMID:17293063 |
|
NCBI chr14:17,181,030...17,183,075
Ensembl chr14:17,181,062...17,183,075
|
|
G |
Cxcl3 |
C-X-C motif chemokine ligand 3 |
increases expression |
ISO |
Selenium results in increased expression of CXCL1 mRNA |
CTD |
PMID:17293063 |
|
NCBI chr14:17,287,727...17,289,451
Ensembl chr14:17,270,146...17,289,511
|
|
G |
Cxcl9 |
C-X-C motif chemokine ligand 9 |
decreases expression |
ISO |
Selenium results in decreased expression of CXCL9 mRNA |
CTD |
PMID:18997278 |
|
NCBI chr14:15,722,868...15,727,779
Ensembl chr14:15,722,908...15,728,435
|
|
G |
Cxcr4 |
C-X-C motif chemokine receptor 4 |
multiple interactions |
ISO |
[Cadmium analog co-treated with Selenium analog co-treated with zinc sulfide analog] results in increased expression of CXCR4 mRNA |
CTD |
PMID:21481475 |
|
NCBI chr13:40,077,976...40,081,883
Ensembl chr13:40,077,976...40,081,883
|
|
G |
Cxxc1 |
CXXC finger protein 1 |
increases expression |
ISO |
Selenium results in increased expression of CXXC1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr18:67,813,185...67,818,556
Ensembl chr18:67,813,206...67,818,551
|
|
G |
Cyb561d2 |
cytochrome b561 family, member D2 |
increases expression |
ISO |
Selenium results in increased expression of CYB561D2 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 8:108,213,201...108,215,778
Ensembl chr 8:108,213,205...108,215,759
|
|
G |
Cycs |
cytochrome c, somatic |
multiple interactions |
ISO EXP |
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Selenium inhibits the reaction [nickel sulfate results in increased expression of CYCS protein]]; [Selenium analog co-treated with Magnesium Oxide analog] inhibits the reaction [Diazinon results in increased expression of CYCS mRNA]; Selenium inhibits the reaction [nickel sulfate results in increased expression of CYCS protein] |
CTD |
PMID:27920530 PMID:34612572 |
|
NCBI chr 4:79,651,894...79,653,994
Ensembl chr 4:79,651,378...79,654,054 Ensembl chr18:79,651,378...79,654,054
|
|
G |
Cyp17a1 |
cytochrome P450, family 17, subfamily a, polypeptide 1 |
multiple interactions |
EXP |
Selenium inhibits the reaction [Acrylamide results in decreased expression of CYP17A1 mRNA] |
CTD |
PMID:37987225 |
|
NCBI chr 1:245,535,462...245,543,148
Ensembl chr 1:245,535,462...245,541,573
|
|
G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
multiple interactions |
EXP |
Selenium promotes the reaction [Plant Extracts results in increased activity of CYP1A1 protein] |
CTD |
PMID:19650632 |
|
NCBI chr 8:58,096,021...58,102,130
Ensembl chr 8:58,096,077...58,102,125
|
|
G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
multiple interactions |
EXP |
[Acetylcysteine co-treated with Zinc co-treated with Selenium] inhibits the reaction [dimethyl mercury results in decreased expression of CYP1A2 protein] |
CTD |
PMID:21424224 |
|
NCBI chr 8:58,075,367...58,082,255
Ensembl chr 8:58,075,367...58,082,312
|
|
G |
Cyp27a1 |
cytochrome P450, family 27, subfamily a, polypeptide 1 |
multiple interactions |
ISO |
[Sodium Selenite results in increased abundance of Selenium] inhibits the reaction [[Vancomycin co-treated with Neomycin co-treated with Ampicillin co-treated with Metronidazole co-treated with Amphotericin B] results in decreased expression of CYP27A1 mRNA] |
CTD |
PMID:36464106 |
|
NCBI chr 9:76,264,655...76,294,551
Ensembl chr 9:76,264,860...76,294,551
|
|
G |
Cyp2b3 |
cytochrome P450, family 2, subfamily b, polypeptide 3 |
increases expression |
ISO |
Selenium deficiency results in increased expression of CYP2B10 mRNA |
CTD |
PMID:16170372 |
|
NCBI chr 1:81,652,762...81,732,153
Ensembl chr 1:81,652,787...81,732,143
|
|
G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
multiple interactions |
EXP |
[Acetylcysteine co-treated with Zinc co-treated with Selenium] inhibits the reaction [dimethyl mercury results in decreased expression of CYP2E1 protein] |
CTD |
PMID:21424224 |
|
NCBI chr 1:195,840,330...195,850,728
Ensembl chr 1:195,840,058...195,864,023
|
|
G |
Cyp3a2 |
cytochrome P450, family 3, subfamily a, polypeptide 2 |
decreases expression |
ISO |
Selenium results in decreased expression of CYP3A4 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr12:9,207,978...9,230,064
Ensembl chr12:9,015,383...9,285,008
|
|
G |
Cyp3a9 |
cytochrome P450, family 3, subfamily a, polypeptide 9 |
decreases expression |
ISO |
Selenium results in decreased expression of CYP3A5 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr12:16,806,222...16,846,428
Ensembl chr12:16,806,207...16,846,422
|
|
G |
Cyp4b1 |
cytochrome P450, family 4, subfamily b, polypeptide 1 |
increases expression |
EXP |
Selenium deficiency results in increased expression of CYP4B1 mRNA |
CTD |
PMID:11444866 |
|
NCBI chr 5:129,139,019...129,176,860
Ensembl chr 5:129,139,038...129,156,348
|
|
G |
Cyp7a1 |
cytochrome P450 family 7 subfamily A member 1 |
multiple interactions |
EXP ISO |
[Magnesium co-treated with Selenium co-treated with Dietary Fats] results in increased expression of CYP7A1 mRNA [Sodium Selenite results in increased abundance of Selenium] inhibits the reaction [[Vancomycin co-treated with Neomycin co-treated with Ampicillin co-treated with Metronidazole co-treated with Amphotericin B] results in decreased expression of CYP7A1 mRNA] |
CTD |
PMID:30031400 PMID:36464106 |
|
NCBI chr 5:19,376,979...19,386,676
Ensembl chr 5:19,376,974...19,386,688
|
|
G |
Cyp7b1 |
cytochrome P450 family 7 subfamily B member 1 |
increases expression |
ISO |
Selenium deficiency results in increased expression of CYP7B1 mRNA; Selenium results in increased expression of CYP7B1 mRNA |
CTD |
PMID:16170372 |
|
NCBI chr 2:100,502,791...100,669,713
Ensembl chr 2:100,502,791...100,669,698
|
|
G |
Cyp8b1 |
cytochrome P450 family 8 subfamily B member 1 |
increases expression multiple interactions |
ISO |
Selenium deficiency results in increased expression of CYP8B1 mRNA; Selenium results in increased expression of CYP8B1 mRNA [Sodium Selenite results in increased abundance of Selenium] inhibits the reaction [[Vancomycin co-treated with Neomycin co-treated with Ampicillin co-treated with Metronidazole co-treated with Amphotericin B] results in decreased expression of CYP8B1 mRNA] |
CTD |
PMID:16170372 PMID:36464106 |
|
NCBI chr 8:121,578,123...121,580,093
Ensembl chr 8:121,557,062...121,580,166
|
|
G |
Daam1 |
dishevelled associated activator of morphogenesis 1 |
decreases expression |
ISO |
Selenium results in decreased expression of DAAM1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 6:90,389,544...90,550,114
Ensembl chr 6:90,389,688...90,550,114
|
|
G |
Dact1 |
dishevelled-binding antagonist of beta-catenin 1 |
decreases expression |
ISO |
Selenium results in decreased expression of DACT1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 6:89,790,676...89,818,254
Ensembl chr 6:89,790,644...89,817,906
|
|
G |
Dad1 |
defender against cell death 1 |
multiple interactions |
EXP |
[Selenium deficiency co-treated with Vitamin E deficiency] results in decreased expression of DAD1 mRNA |
CTD |
PMID:11444866 |
|
NCBI chr15:27,677,286...27,697,120
Ensembl chr15:27,677,268...27,697,347
|
|
G |
Dapk3 |
death-associated protein kinase 3 |
multiple interactions increases expression |
ISO |
[Selenium co-treated with Vitamin E] results in decreased expression of DAPK3 mRNA Selenium results in increased expression of DAPK3 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 7:8,524,182...8,532,552
Ensembl chr 7:8,524,183...8,532,558
|
|
G |
Dctn1 |
dynactin subunit 1 |
increases expression |
ISO |
Selenium results in increased expression of DCTN1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 4:115,671,024...115,703,824
Ensembl chr 4:115,661,638...115,703,815
|
|
G |
Dcx |
doublecortin |
multiple interactions |
ISO |
[diethyl phosphate co-treated with Cotinine co-treated with bis(2,3,3,3-tetrachloropropyl) ether co-treated with Mercury co-treated with Selenium] results in increased expression of DCX mRNA |
CTD |
PMID:37914285 |
|
NCBI chr X:107,430,767...107,573,612
Ensembl chr X:107,430,767...107,507,476
|
|
G |
Dcxr |
dicarbonyl and L-xylulose reductase |
increases expression |
ISO |
Selenium results in increased expression of DCXR mRNA |
CTD |
PMID:19244175 |
|
NCBI chr10:106,006,404...106,008,293
|
|
G |
Ddah2 |
DDAH family member 2, ADMA-independent |
increases expression |
ISO |
Selenium results in increased expression of DDAH2 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr20:3,761,460...3,764,718
Ensembl chr20:3,761,465...3,764,511
|
|
G |
Ddost |
dolichyl-diphosphooligosaccharide--protein glycosyltransferase non-catalytic subunit |
increases expression |
ISO |
Selenium results in increased expression of DDOST mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 5:150,522,297...150,529,413
Ensembl chr 5:150,522,242...150,529,413
|
|
G |
Ddx17 |
DEAD-box helicase 17 |
multiple interactions decreases expression |
ISO |
[Selenium co-treated with Vitamin E] results in increased expression of DDX17 mRNA Selenium results in decreased expression of DDX17 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 7:111,091,127...111,109,353
Ensembl chr 7:111,089,445...111,109,193
|
|
G |
Ddx18 |
DEAD-box helicase 18 |
decreases expression multiple interactions |
ISO |
Selenium results in decreased expression of DDX18 mRNA [Selenium co-treated with Vitamin E] results in decreased expression of DDX18 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr13:32,729,697...32,743,161
Ensembl chr13:32,729,700...32,743,161
|
|
G |
Ddx24 |
DEAD-box helicase 24 |
multiple interactions decreases expression |
ISO |
[Selenium co-treated with Vitamin E] results in decreased expression of DDX24 mRNA Selenium results in decreased expression of DDX24 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 6:122,564,767...122,582,032
Ensembl chr 6:122,564,767...122,581,927
|
|
G |
Ddx39b |
DExD-box helicase 39B |
decreases expression increases expression |
ISO |
Selenium results in decreased expression of DDX39B mRNA Selenium results in increased expression of DDX39B mRNA |
CTD |
PMID:19244175 |
|
NCBI chr20:3,547,702...3,585,064
Ensembl chr20:3,572,056...3,584,996
|
|
G |
Ddx3y |
DEAD box helicase 3, Y-linked |
decreases expression |
ISO |
Selenium results in decreased expression of DDX3Y mRNA |
CTD |
PMID:19244175 |
|
NCBI chr Y:1,115,095...1,135,754
Ensembl chr Y:1,116,309...1,135,706
|
|
G |
Ddx41 |
DEAD-box helicase 41 |
multiple interactions increases expression |
ISO |
[Selenium co-treated with Vitamin E] results in decreased expression of DDX41 mRNA Selenium results in increased expression of DDX41 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr17:9,102,926...9,108,415
Ensembl chr17:9,103,010...9,108,415
|
|
G |
Ddx49 |
DEAD-box helicase 49 |
increases expression |
ISO |
Selenium results in increased expression of DDX49 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr16:19,125,388...19,133,042
Ensembl chr16:19,125,384...19,133,616
|
|
G |
Decr2 |
2,4-dienoyl-CoA reductase 2 |
increases expression |
ISO |
Selenium deficiency results in increased expression of DECR2 mRNA |
CTD |
PMID:16170372 |
|
NCBI chr10:15,104,907...15,113,281
Ensembl chr10:15,002,926...15,118,479
|
|
G |
Dedd |
death effector domain-containing |
increases expression |
ISO |
Selenium results in increased expression of DEDD mRNA |
CTD |
PMID:19244175 |
|
NCBI chr13:83,755,874...83,769,982
Ensembl chr13:83,756,108...83,769,332
|
|
G |
Degs1 |
delta(4)-desaturase, sphingolipid 1 |
decreases expression |
ISO |
Selenium results in decreased expression of DEGS1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr13:93,946,154...93,953,677
Ensembl chr13:93,946,157...93,953,664
|
|
G |
Dennd2b |
DENN domain containing 2B |
increases expression |
ISO |
Selenium results in increased expression of DENND2B mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 1:163,544,075...163,734,736
Ensembl chr 1:163,544,074...163,694,680
|
|
G |
Dera |
deoxyribose-phosphate aldolase |
decreases expression |
ISO |
Selenium results in decreased expression of DERA mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 4:170,663,689...170,742,469
Ensembl chr 4:170,663,665...170,758,865
|
|
G |
Des |
desmin |
increases expression |
ISO |
Selenium results in increased expression of DES mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 9:76,850,979...76,858,695
Ensembl chr 9:76,850,982...76,858,699
|
|
G |
Desi2 |
desumoylating isopeptidase 2 |
decreases expression |
ISO |
Selenium results in decreased expression of DESI2 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr13:89,961,767...90,011,255
Ensembl chr13:89,961,934...90,016,416
|
|
G |
Dgcr6 |
DiGeorge syndrome critical region gene 6 |
increases expression |
ISO |
Selenium results in increased expression of DGCR6 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr11:82,927,725...82,932,823
Ensembl chr11:82,927,725...82,932,823
|
|
G |
Dgcr8 |
DGCR8 microprocessor complex subunit |
multiple interactions increases expression |
ISO |
[Selenium co-treated with Vitamin E] results in increased expression of DGCR8 mRNA Selenium results in increased expression of DGCR8 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr11:82,704,673...82,737,251
Ensembl chr11:82,704,729...82,737,242
|
|
G |
Dhcr24 |
24-dehydrocholesterol reductase |
increases expression |
ISO |
Selenium results in increased expression of DHCR24 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 5:121,344,552...121,371,124
Ensembl chr 5:121,344,575...121,371,137
|
|
G |
Dhcr7 |
7-dehydrocholesterol reductase |
increases expression |
ISO |
Selenium results in increased expression of DHCR7 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 1:199,015,081...199,031,055
Ensembl chr 1:199,015,081...199,031,055
|
|
G |
Dhps |
deoxyhypusine synthase |
increases expression multiple interactions |
ISO |
Selenium results in increased expression of DHPS mRNA [Selenium co-treated with Vitamin E] results in increased expression of DHPS mRNA |
CTD |
PMID:19244175 |
|
NCBI chr19:23,082,454...23,086,544
Ensembl chr19:23,082,448...23,086,881
|
|
G |
Dhrs4 |
dehydrogenase/reductase 4 |
increases expression |
ISO |
Selenium results in increased expression of DHRS4 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr15:28,966,544...28,978,135
Ensembl chr15:28,966,553...28,978,127
|
|
G |
Dhrs7b |
dehydrogenase/reductase 7B |
increases expression |
ISO |
Selenium results in increased expression of DHRS7B mRNA |
CTD |
PMID:19244175 |
|
NCBI chr10:45,504,344...45,537,094
Ensembl chr10:45,504,426...45,537,076
|
|
G |
Dhx30 |
DExH-box helicase 30 |
increases expression |
ISO |
Selenium results in increased expression of DHX30 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 8:110,064,751...110,096,954
Ensembl chr 8:110,064,752...110,097,381
|
|
G |
Dicer1 |
dicer 1 ribonuclease III |
decreases expression |
ISO |
Selenium results in decreased expression of DICER1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 6:123,627,529...123,692,278
Ensembl chr 6:123,631,250...123,693,965
|
|
G |
Dio1 |
iodothyronine deiodinase 1 |
decreases expression increases expression affects expression increases activity multiple interactions |
ISO EXP |
Selenium deficiency results in decreased expression of DIO1 mRNA Selenium results in increased expression of DIO1 mRNA Selenium deficiency affects the expression of DIO1 mRNA Selenium results in increased activity of DIO1 protein Selenium inhibits the reaction [Iodine results in decreased activity of DIO1 protein]; Selenium inhibits the reaction [Iodine results in decreased expression of DIO1 mRNA]; Selenium inhibits the reaction [potassium iodate results in decreased activity of DIO1 protein] |
CTD |
PMID:16170372 PMID:16271152 PMID:16874406 PMID:16959840 PMID:17044649 PMID:18095564 More...
|
|
NCBI chr 5:122,074,285...122,090,983
Ensembl chr 5:122,074,279...122,090,970
|
|
G |
Dio2 |
iodothyronine deiodinase 2 |
multiple interactions increases activity |
ISO |
Selenium results in increased expression of and results in increased activity of DIO2 protein Selenium results in increased activity of DIO2 protein |
CTD |
PMID:11425850 PMID:15471965 |
|
NCBI chr 6:109,665,523...109,679,809
Ensembl chr 6:109,665,523...109,679,809
|
|
G |
Dip2c |
disco-interacting protein 2 homolog C |
decreases expression |
ISO |
Selenium results in decreased expression of DIP2C mRNA |
CTD |
PMID:19244175 |
|
NCBI chr17:60,647,346...61,032,467
Ensembl chr17:60,649,065...61,032,305
|
|
G |
Dlg1 |
discs large MAGUK scaffold protein 1 |
decreases expression |
ISO |
Selenium results in decreased expression of DLG1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr11:68,911,883...69,103,230
Ensembl chr11:68,911,883...69,102,689
|
|
G |
Dmgdh |
dimethylglycine dehydrogenase |
affects abundance |
ISO |
DMGDH gene SNP affects the abundance of Selenium |
CTD |
PMID:23720494 |
|
NCBI chr 2:24,912,600...24,987,533
Ensembl chr 2:24,912,578...24,987,528
|
|
G |
Dmtf1 |
cyclin D binding myb-like transcription factor 1 |
multiple interactions decreases expression |
ISO |
[Selenium co-treated with Vitamin E] results in increased expression of DMTF1 mRNA Selenium results in decreased expression of DMTF1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 4:24,909,937...24,950,786
Ensembl chr 4:24,910,534...24,950,967
|
|
G |
Dmwd |
DM1 locus, WD repeat containing |
increases expression |
ISO |
Selenium results in increased expression of DMWD mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 1:78,722,436...78,729,224
Ensembl chr 1:78,722,330...78,740,593
|
|
G |
Dmxl2 |
Dmx-like 2 |
decreases expression |
ISO |
Selenium results in decreased expression of DMXL2 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 8:54,741,164...54,884,948
Ensembl chr 8:54,741,160...54,885,161
|
|
G |
Dnaja3 |
DnaJ heat shock protein family (Hsp40) member A3 |
multiple interactions decreases expression |
ISO |
[Selenium co-treated with Vitamin E] results in decreased expression of DNAJA3 mRNA Selenium results in decreased expression of DNAJA3 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr10:10,854,732...10,880,171
Ensembl chr10:10,854,732...10,880,161
|
|
G |
Dnajb3 |
DnaJ heat shock protein family (Hsp40) member B3 |
multiple interactions decreases expression |
ISO |
[Selenium co-treated with Selenium] results in decreased expression of DNAJB3 mRNA Selenium deficiency results in decreased expression of DNAJB3 mRNA |
CTD |
PMID:19367646 |
|
NCBI chr 9:88,795,542...88,796,555
Ensembl chr 9:88,795,488...88,796,560
|
|
G |
Dnajb4 |
DnaJ heat shock protein family (Hsp40) member B4 |
decreases expression |
ISO |
Selenium results in decreased expression of DNAJB4 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 2:241,129,346...241,159,272
Ensembl chr 2:241,130,340...241,159,089
|
|
G |
Dnajc2 |
DnaJ heat shock protein family (Hsp40) member C2 |
multiple interactions |
ISO |
[Selenium co-treated with Vitamin E] results in decreased expression of DNAJC2 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 4:13,270,239...13,297,438
Ensembl chr 4:13,270,191...13,297,431
|
|
G |
Dnajc7 |
DnaJ heat shock protein family (Hsp40) member C7 |
multiple interactions |
ISO |
[Selenium co-treated with Vitamin E] results in decreased expression of DNAJC7 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr10:85,518,637...85,555,079
Ensembl chr10:85,518,621...85,555,575
|
|
G |
Dnajc9 |
DnaJ heat shock protein family (Hsp40) member C9 |
decreases expression |
ISO |
Selenium results in decreased expression of DNAJC9 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr15:3,923,842...3,928,118
Ensembl chr15:3,923,268...3,928,118
|
|
G |
Dnmt1 |
DNA methyltransferase 1 |
affects activity |
EXP |
Selenium affects the activity of DNMT1 protein |
CTD |
PMID:16632891 |
|
NCBI chr 8:19,440,611...19,486,659
Ensembl chr 8:19,440,611...19,486,659
|
|
G |
Dnpep |
aspartyl aminopeptidase |
increases expression |
ISO |
Selenium results in increased expression of DNPEP mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 9:76,799,931...76,808,841
Ensembl chr 9:76,783,966...76,808,716
|
|
G |
Dohh |
deoxyhypusine hydroxylase |
increases expression multiple interactions |
ISO |
Selenium results in increased expression of DOHH mRNA [Selenium co-treated with Vitamin E] results in increased expression of DOHH mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 7:8,321,466...8,326,305
Ensembl chr 7:8,321,466...8,326,289
|
|
G |
Dolpp1 |
dolichyldiphosphatase 1 |
increases expression |
ISO |
Selenium results in increased expression of DOLPP1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 3:13,666,000...13,674,312
Ensembl chr 3:13,665,823...13,674,311
|
|
G |
Dpyd |
dihydropyrimidine dehydrogenase |
decreases expression |
ISO |
Selenium results in decreased expression of DPYD mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 2:206,609,043...207,474,982
Ensembl chr 2:206,609,122...207,474,982
|
|
G |
Dr1 |
down-regulator of transcription 1 |
decreases expression |
ISO |
Selenium results in decreased expression of DR1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr14:1,458,223...1,469,578
Ensembl chr14:1,458,223...1,469,638
|
|
G |
Drg2 |
developmentally regulated GTP binding protein 2 |
increases expression |
ISO |
Selenium results in increased expression of DRG2 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr10:45,255,512...45,269,971
Ensembl chr10:45,255,507...45,269,969
|
|
G |
Dsc2 |
desmocollin 2 |
multiple interactions decreases expression |
ISO |
[Selenium co-treated with Vitamin E] results in decreased expression of DSC2 mRNA Selenium results in decreased expression of DSC2 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr18:11,450,392...11,482,476
Ensembl chr18:11,450,390...11,482,392
|
|
G |
Dse |
dermatan sulfate epimerase |
decreases expression |
ISO |
Selenium results in decreased expression of DSE mRNA |
CTD |
PMID:19244175 |
|
NCBI chr20:26,118,194...26,196,889
Ensembl chr20:26,118,196...26,196,992
|
|
G |
Duox1 |
dual oxidase 1 |
increases expression |
ISO |
Selenium results in increased expression of DUOX1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 3:109,260,526...109,295,588
Ensembl chr 3:109,262,397...109,295,563
|
|
G |
Dusp8 |
dual specificity phosphatase 8 |
increases expression |
ISO |
Selenium results in increased expression of DUSP8 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 1:197,167,392...197,184,285
Ensembl chr 1:197,169,422...197,182,921
|
|
G |
Dxo |
decapping exoribonuclease |
increases expression |
ISO |
Selenium results in increased expression of DXO mRNA |
CTD |
PMID:19244175 |
|
NCBI chr20:3,993,322...3,995,484
Ensembl chr20:3,993,327...3,995,494
|
|
G |
Dym |
dymeclin |
decreases expression |
ISO |
Selenium results in decreased expression of DYM mRNA |
CTD |
PMID:19244175 |
|
NCBI chr18:68,605,131...68,900,905
Ensembl chr18:68,605,185...68,900,903
|
|
G |
Dync1h1 |
dynein cytoplasmic 1 heavy chain 1 |
increases expression |
ISO |
Selenium results in increased expression of DYNC1H1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 6:129,615,208...129,680,888
Ensembl chr 6:129,609,397...129,680,883
|
|
G |
Dynlrb1 |
dynein light chain roadblock-type 1 |
decreases expression |
ISO |
Selenium results in decreased expression of DYNLRB1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 3:143,742,427...143,764,227
Ensembl chr 3:143,742,586...143,764,227
|
|
G |
E2f1 |
E2F transcription factor 1 |
increases expression |
ISO |
Selenium results in increased expression of E2F1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 3:143,064,535...143,075,362
Ensembl chr 3:143,049,478...143,075,361
|
|
G |
E2f4 |
E2F transcription factor 4 |
increases expression |
ISO |
Selenium results in increased expression of E2F4 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr19:33,174,396...33,181,806
Ensembl chr19:33,174,410...33,181,806
|
|
G |
E2f6 |
E2F transcription factor 6 |
multiple interactions decreases expression |
ISO |
[Selenium co-treated with Vitamin E] results in increased expression of E2F6 mRNA Selenium results in decreased expression of E2F6 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 6:39,592,224...39,608,685
Ensembl chr 6:39,592,228...39,608,683
|
|
G |
E4f1 |
E4F transcription factor 1 |
increases expression |
ISO |
Selenium results in increased expression of E4F1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr10:13,471,478...13,495,018
Ensembl chr10:13,474,456...13,485,974
|
|
G |
Ecm2 |
extracellular matrix protein 2 |
decreases expression |
ISO |
Selenium results in decreased expression of ECM2 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr17:15,120,194...15,152,536
Ensembl chr17:15,120,196...15,152,516
|
|
G |
Ecsit |
ECSIT signaling integrator |
multiple interactions increases expression |
ISO |
[Selenium co-treated with Vitamin E] results in increased expression of ECSIT mRNA Selenium results in increased expression of ECSIT mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 8:20,605,583...20,618,453
Ensembl chr 8:20,605,583...20,618,390
|
|
G |
Edf1 |
endothelial differentiation-related factor 1 |
increases expression |
ISO |
Selenium results in increased expression of EDF1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 3:8,377,058...8,381,363
Ensembl chr 3:8,366,613...8,381,363
|
|
G |
Ednra |
endothelin receptor type A |
multiple interactions decreases expression |
ISO |
[Selenium co-treated with Vitamin E] results in increased expression of EDNRA mRNA Selenium results in decreased expression of EDNRA mRNA |
CTD |
PMID:19244175 |
|
NCBI chr19:30,233,540...30,303,727
Ensembl chr19:30,233,571...30,297,049
|
|
G |
Eef1a2 |
eukaryotic translation elongation factor 1 alpha 2 |
multiple interactions increases expression |
ISO |
[Selenium co-treated with Vitamin E] results in decreased expression of EEF1A2 mRNA Selenium results in increased expression of EEF1A2 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 3:168,265,893...168,275,071
Ensembl chr 3:168,195,357...168,275,071
|
|
G |
Eef1d |
eukaryotic translation elongation factor 1 delta |
increases expression |
ISO |
Selenium results in increased expression of EEF1D mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 7:107,581,930...107,596,735
Ensembl chr 7:107,581,930...107,608,799
|
|
G |
Efcab14 |
EF-hand calcium binding domain 14 |
increases expression |
ISO |
Selenium results in increased expression of EFCAB14 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 5:129,218,139...129,258,628
Ensembl chr 5:129,218,424...129,258,625
|
|
G |
Efemp2 |
EGF containing fibulin extracellular matrix protein 2 |
increases expression |
ISO |
Selenium results in increased expression of EFEMP2 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 1:202,781,692...202,789,784
Ensembl chr 1:202,781,665...202,789,414
|
|
G |
Efhc1 |
EF-hand domain containing 1 |
decreases expression |
ISO |
Selenium results in decreased expression of EFHC1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 9:23,375,815...23,414,283
Ensembl chr 9:23,375,840...23,414,283
|
|
G |
Efhd2 |
EF-hand domain family, member D2 |
increases expression |
ISO |
Selenium results in increased expression of EFHD2 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 5:154,160,945...154,176,980
Ensembl chr 5:154,160,946...154,176,980
|
|
G |
Egf |
epidermal growth factor |
multiple interactions |
EXP |
Selenium inhibits the reaction [EGF protein results in increased abundance of 8-hydroxyguanosine]; Selenium inhibits the reaction [EGF protein results in increased abundance of Peroxides] |
CTD |
PMID:11158190 |
|
NCBI chr 2:218,219,408...218,302,359
Ensembl chr 2:218,219,415...218,302,064
|
|
G |
Egfr |
epidermal growth factor receptor |
decreases expression |
ISO |
Selenium results in decreased expression of EGFR mRNA |
CTD |
PMID:17390030 |
|
NCBI chr14:91,176,979...91,349,722
Ensembl chr14:91,177,067...91,344,382
|
|
G |
Egr1 |
early growth response 1 |
multiple interactions |
EXP |
[Selenium deficiency co-treated with Vitamin E deficiency] results in increased expression of EGR1 mRNA |
CTD |
PMID:11444866 |
|
NCBI chr18:26,462,967...26,466,766
Ensembl chr18:26,462,981...26,466,766
|
|
G |
Ehbp1 |
EH domain binding protein 1 |
decreases expression |
ISO |
Selenium results in decreased expression of EHBP1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr14:96,093,327...96,380,502
Ensembl chr14:96,093,327...96,345,332
|
|
G |
Ehd2 |
EH-domain containing 2 |
increases expression |
ISO |
Selenium results in increased expression of EHD2 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 1:76,639,568...76,658,747
Ensembl chr 1:76,637,482...76,658,783
|
|
G |
Eif1b |
eukaryotic translation initiation factor 1B |
decreases expression |
ISO |
Selenium results in decreased expression of EIF1B mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 8:120,203,561...120,206,176
Ensembl chr 8:120,203,451...120,206,176 Ensembl chr 5:120,203,451...120,206,176
|
|
G |
Eif2ak2 |
eukaryotic translation initiation factor 2-alpha kinase 2 |
decreases expression |
ISO |
Selenium results in decreased expression of EIF2AK2 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 6:16,189,000...16,224,972
Ensembl chr 6:16,188,979...16,224,971
|
|
G |
Eif3a |
eukaryotic translation initiation factor 3, subunit A |
multiple interactions |
ISO |
[Selenium co-treated with Vitamin E] results in increased expression of EIF3A mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 1:259,902,767...259,932,976
Ensembl chr 1:259,902,680...259,932,976
|
|
G |
Eif3b |
eukaryotic translation initiation factor 3, subunit B |
increases expression |
ISO |
Selenium results in increased expression of EIF3B mRNA |
CTD |
PMID:19244175 |
|
NCBI chr12:14,196,403...14,220,865
Ensembl chr12:14,196,403...14,220,886
|
|
G |
Eif3c |
eukaryotic translation initiation factor 3, subunit C |
increases expression |
ISO |
Selenium results in increased expression of EIF3C mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 1:181,134,604...181,152,489
Ensembl chr 1:181,134,604...181,152,493
|
|
G |
Eif4g1 |
eukaryotic translation initiation factor 4 gamma 1 |
multiple interactions increases expression |
ISO |
[Selenium co-treated with Vitamin E] results in decreased expression of EIF4G1 mRNA Selenium results in increased expression of EIF4G1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr11:80,221,919...80,241,958
Ensembl chr11:80,221,919...80,241,941
|
|
G |
Eif5a |
eukaryotic translation initiation factor 5A |
multiple interactions |
ISO |
[Selenium co-treated with Vitamin E] results in decreased expression of EIF5A mRNA |
CTD |
PMID:19244175 |
|
NCBI chr10:54,640,104...54,644,845
Ensembl chr10:54,640,024...54,644,656
|
|
G |
Eif5b |
eukaryotic translation initiation factor 5B |
multiple interactions decreases expression |
ISO |
[Selenium co-treated with Vitamin E] results in increased expression of IF2 mRNA Selenium results in decreased expression of IF2 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 9:40,222,769...40,277,482
Ensembl chr 9:40,222,898...40,277,482
|
|
G |
Eif6 |
eukaryotic translation initiation factor 6 |
multiple interactions increases expression |
ISO |
[Selenium co-treated with Vitamin E] results in increased expression of EIF6 mRNA Selenium results in increased expression of EIF6 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 3:144,325,038...144,331,396
Ensembl chr 3:144,325,036...144,331,401
|
|
G |
Eloa |
elongin A |
multiple interactions |
ISO |
[Selenium co-treated with Vitamin E] results in decreased expression of ELOA mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 5:148,231,600...148,246,760
Ensembl chr 5:148,231,596...148,246,765
|
|
G |
Elp1 |
elongator acetyltransferase complex subunit 1 |
decreases expression |
ISO |
Selenium results in decreased expression of ELP1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 5:71,453,338...71,505,833
Ensembl chr 5:71,456,310...71,505,762
|
|
G |
Emc9 |
ER membrane protein complex subunit 9 |
multiple interactions |
ISO |
[Selenium co-treated with Vitamin E] results in decreased expression of EMC9 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr15:29,071,881...29,076,098
Ensembl chr15:29,071,883...29,076,098
|
|
G |
Emilin1 |
elastin microfibril interfacer 1 |
increases expression |
ISO |
Selenium results in increased expression of EMILIN1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 6:25,455,974...25,463,713
Ensembl chr 6:25,445,298...25,463,698
|
|
G |
Eml2 |
EMAP like 2 |
multiple interactions increases expression |
ISO |
[Selenium co-treated with Vitamin E] results in decreased expression of EML2 mRNA Selenium results in increased expression of EML2 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 1:78,827,595...78,859,342
Ensembl chr 1:78,828,080...78,859,341
|
|
G |
Emp2 |
epithelial membrane protein 2 |
increases expression |
ISO |
Selenium results in increased expression of EMP2 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr10:5,360,073...5,394,734
Ensembl chr10:5,360,073...5,394,733
|
|
G |
Emp3 |
epithelial membrane protein 3 |
increases expression |
ISO |
Selenium results in increased expression of EMP3 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 1:96,388,651...96,391,946
Ensembl chr 1:96,388,652...96,391,988
|
|
G |
Emsy |
EMSY transcriptional repressor, BRCA2 interacting |
decreases expression |
ISO |
Selenium results in decreased expression of EMSY mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 1:152,881,485...152,960,420
Ensembl chr 1:152,883,992...152,953,528
|
|
G |
Endog |
endonuclease G |
increases expression |
ISO |
Selenium results in increased expression of ENDOG mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 3:13,449,113...13,451,715
Ensembl chr 3:13,449,086...13,451,932
|
|
G |
Eng |
endoglin |
increases expression |
ISO |
Selenium results in increased expression of ENG mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 3:15,934,566...15,972,618
Ensembl chr 3:15,934,518...15,973,230
|
|
G |
Eno2 |
enolase 2 |
increases expression |
ISO |
Selenium results in increased expression of ENO2 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 4:157,572,085...157,580,971
Ensembl chr 4:157,572,088...157,580,980
|
|
G |
Enpp1 |
ectonucleotide pyrophosphatase/phosphodiesterase 1 |
decreases expression |
ISO |
Selenium results in decreased expression of ENPP1 mRNA |
CTD |
PMID:28810182 |
|
NCBI chr 1:20,698,746...20,763,741
Ensembl chr 1:20,698,764...20,763,715
|
|
G |
Epb41l4b |
erythrocyte membrane protein band 4.1 like 4B |
decreases expression |
ISO |
Selenium results in decreased expression of EPB41L4B mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 5:71,691,706...71,852,583
Ensembl chr 5:71,694,331...71,851,990
|
|
G |
Ephb6 |
Eph receptor B6 |
increases expression |
ISO |
Selenium results in increased expression of EPHB6 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 4:70,491,973...70,507,230
Ensembl chr 4:70,491,973...70,507,230
|
|
G |
Ephx2 |
epoxide hydrolase 2 |
increases expression |
ISO |
Selenium results in increased expression of EPHX2 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr15:40,289,901...40,327,632
Ensembl chr15:40,289,902...40,327,615
|
|
G |
Epn2 |
epsin 2 |
increases expression |
ISO |
Selenium results in increased expression of EPN2 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr10:46,197,785...46,259,673
Ensembl chr10:46,197,785...46,259,642
|
|
G |
Erbb2 |
erb-b2 receptor tyrosine kinase 2 |
increases expression multiple interactions |
ISO |
Selenium results in increased expression of ERBB2 mRNA [Selenium co-treated with Vitamin E] results in increased expression of ERBB2 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr10:83,411,197...83,435,078
Ensembl chr10:83,411,313...83,435,078
|
|
G |
Ercc1 |
ERCC excision repair 1, endonuclease non-catalytic subunit |
increases expression |
ISO |
Selenium results in increased expression of ERCC1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 1:78,971,310...79,007,963
Ensembl chr 1:78,996,390...79,007,963
|
|
G |
Ergic3 |
ERGIC and golgi 3 |
increases expression |
ISO |
Selenium results in increased expression of ERGIC3 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 3:144,525,059...144,534,813
Ensembl chr 3:144,525,092...144,534,813
|
|
G |
Esr1 |
estrogen receptor 1 |
multiple interactions |
EXP |
[Sodium Selenite results in increased abundance of Selenium] inhibits the reaction [bisphenol A results in increased expression of ESR1 mRNA] |
CTD |
PMID:30526071 |
|
NCBI chr 1:41,106,335...41,499,104
Ensembl chr 1:41,210,475...41,495,002
|
|
G |
Esrp2 |
epithelial splicing regulatory protein 2 |
multiple interactions |
ISO |
[Selenium co-treated with Vitamin E] results in increased expression of ESRP2 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr19:34,034,559...34,041,726
Ensembl chr19:34,034,559...34,041,726
|
|
G |
Ess2 |
ess-2 splicing factor homolog |
increases expression |
ISO |
Selenium results in increased expression of ESS2 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr11:83,075,893...83,085,849
Ensembl chr11:83,075,925...83,084,846
|
|
G |
Evc |
EvC ciliary complex subunit 1 |
increases expression |
ISO |
Selenium results in increased expression of EVC mRNA |
CTD |
PMID:19244175 |
|
NCBI chr14:73,456,181...73,498,955
Ensembl chr14:73,456,222...73,498,099
|
|
G |
Evi5 |
ecotropic viral integration site 5 |
decreases expression |
ISO |
Selenium results in decreased expression of EVI5 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr14:1,875,601...2,021,678
Ensembl chr14:1,875,647...2,021,678
|
|
G |
Ewsr1 |
EWS RNA-binding protein 1 |
multiple interactions increases expression |
ISO |
[Selenium co-treated with Vitamin E] results in increased expression of EWSR1 mRNA Selenium results in increased expression of EWSR1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr14:79,965,365...79,994,108
Ensembl chr14:79,965,368...79,994,544
|
|
G |
Exoc3 |
exocyst complex component 3 |
increases expression |
ISO |
Selenium results in increased expression of SEC6 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 1:29,091,298...29,122,056
Ensembl chr 1:29,091,294...29,122,045
|
|
G |
Exosc4 |
exosome component 4 |
increases expression |
ISO |
Selenium results in increased expression of EXOSC4 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 7:108,047,831...108,050,573
Ensembl chr 7:108,047,831...108,050,573
|
|
G |
Exosc8 |
exosome component 8 |
decreases expression |
ISO |
Selenium results in decreased expression of EXOSC8 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 2:138,930,405...138,937,009
Ensembl chr 2:138,930,405...138,936,928
|
|
G |
Ext1 |
exostosin glycosyltransferase 1 |
multiple interactions |
ISO |
[Selenium co-treated with Vitamin E] results in increased expression of EXT1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 7:84,375,769...84,654,625
Ensembl chr 7:84,375,784...84,655,357
|
|
G |
Ext2 |
exostosin glycosyltransferase 2 |
decreases expression |
ISO |
Selenium results in decreased expression of EXT2 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 3:79,665,414...79,798,077
Ensembl chr 3:79,665,415...79,798,059
|
|
G |
Eya2 |
EYA transcriptional coactivator and phosphatase 2 |
increases expression |
ISO |
Selenium results in increased expression of EYA2 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 3:154,335,598...154,519,006
Ensembl chr 3:154,335,400...154,518,793
|
|
G |
Ezr |
ezrin |
decreases expression multiple interactions |
ISO |
Selenium results in decreased expression of EZR mRNA [Selenium co-treated with Vitamin E] results in decreased expression of EZR mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 1:46,967,961...47,011,505
Ensembl chr 1:46,967,658...47,011,505
|
|
G |
F11r |
F11 receptor |
increases expression |
ISO |
Selenium results in increased expression of F11R mRNA |
CTD |
PMID:19244175 |
|
NCBI chr13:83,873,797...83,897,388
Ensembl chr13:83,873,797...83,897,402
|
|
G |
F2r |
coagulation factor II (thrombin) receptor |
decreases expression multiple interactions |
ISO |
Selenium results in decreased expression of F2R mRNA [Selenium co-treated with Vitamin E] results in increased expression of F2R mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 2:26,869,343...26,885,856
Ensembl chr 2:26,868,404...26,885,870
|
|
G |
Faah |
fatty acid amide hydrolase |
increases expression |
ISO |
Selenium results in increased expression of FAAH mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 5:129,479,774...129,499,018
Ensembl chr 5:129,479,824...129,498,677
|
|
G |
Fadd |
Fas associated via death domain |
multiple interactions increases expression |
ISO |
[Doxorubicin co-treated with Selenium] promotes the reaction [FADD protein binds to CASP8 protein]; [Selenium analog co-treated with Magnesium Oxide analog] promotes the reaction [Diazinon results in decreased expression of FADD mRNA]; Selenium analog inhibits the reaction [Diazinon results in decreased expression of FADD mRNA] Selenium results in increased expression of FADD protein |
CTD |
PMID:17970047 PMID:27920530 |
|
NCBI chr 1:199,743,200...199,745,746
Ensembl chr 1:199,739,994...199,745,653
|
|
G |
Fads3 |
fatty acid desaturase 3 |
increases expression |
ISO |
Selenium results in increased expression of FADS3 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 1:206,685,667...206,702,538
Ensembl chr 1:206,685,894...206,704,769
|
|
G |
Fam107a |
family with sequence similarity 107, member A |
increases expression |
ISO |
Selenium results in increased expression of FAM107A mRNA |
CTD |
PMID:19244175 |
|
NCBI chr15:16,608,362...16,630,398
Ensembl chr15:16,607,205...16,630,396
|
|
G |
Fam111a |
FAM111 trypsin like peptidase A |
multiple interactions decreases expression |
ISO |
[Selenium co-treated with Vitamin E] results in decreased expression of FAM111A mRNA Selenium results in decreased expression of FAM111A mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 1:209,640,865...209,656,551
Ensembl chr 1:209,640,953...209,656,547
|
|
G |
Fam149a |
family with sequence similarity 149, member A |
multiple interactions decreases expression |
ISO |
[Selenium co-treated with Vitamin E] results in increased expression of FAM149A mRNA Selenium results in decreased expression of FAM149A mRNA |
CTD |
PMID:19244175 |
|
NCBI chr16:46,855,377...46,914,553
Ensembl chr16:46,854,635...46,912,066
|
|
G |
Fam32a |
family with sequence similarity 32, member A |
increases expression |
ISO |
Selenium results in increased expression of FAM32A mRNA |
CTD |
PMID:19244175 |
|
NCBI chr16:17,603,054...17,607,376
Ensembl chr16:17,603,946...17,607,398
|
|
G |
Fam3a |
FAM3 metabolism regulating signaling molecule A |
multiple interactions increases expression |
ISO |
[Selenium co-treated with Vitamin E] results in decreased expression of FAM3A mRNA Selenium results in increased expression of FAM3A mRNA |
CTD |
PMID:19244175 |
|
NCBI chr X:152,166,716...152,175,327
Ensembl chr X:152,165,535...152,175,362
|
|
G |
Fam50a |
family with sequence similarity 50, member A |
increases expression |
ISO |
Selenium results in increased expression of FAM50A mRNA |
CTD |
PMID:19244175 |
|
NCBI chr X:152,095,245...152,102,362
Ensembl chr X:152,095,245...152,102,362
|
|
G |
Fam53b |
family with sequence similarity 53, member B |
increases expression |
ISO |
Selenium results in increased expression of FAM53B mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 1:187,500,061...187,591,186
Ensembl chr 1:187,500,066...187,591,186
|
|
G |
Fan1 |
FANCD2 and FANCI associated nuclease 1 |
decreases expression |
ISO |
Selenium results in decreased expression of FAN1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 1:117,915,323...117,945,044
Ensembl chr 1:117,917,099...117,944,977
|
|
G |
Farp1 |
FERM, ARH/RhoGEF and pleckstrin domain protein 1 |
increases expression |
ISO |
Selenium results in increased expression of FARP1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr15:98,124,304...98,363,299
Ensembl chr15:98,182,329...98,363,299
|
|
G |
Farsa |
phenylalanyl-tRNA synthetase subunit alpha |
multiple interactions increases expression |
ISO |
[Selenium co-treated with Vitamin E] results in increased expression of FARSA mRNA Selenium results in increased expression of FARSA mRNA |
CTD |
PMID:19244175 |
|
NCBI chr19:23,291,409...23,300,985
Ensembl chr19:23,268,869...23,300,980
|
|
G |
Fas |
Fas cell surface death receptor |
multiple interactions |
ISO |
[Doxorubicin co-treated with Selenium] promotes the reaction [FAS protein binds to CASP8 protein]; [Selenium analog co-treated with Magnesium Oxide analog] inhibits the reaction [Diazinon results in increased expression of FAS mRNA]; Selenium analog inhibits the reaction [Diazinon results in increased expression of FAS mRNA] |
CTD |
PMID:17970047 PMID:27920530 |
|
NCBI chr 1:231,798,963...231,832,591
Ensembl chr 1:231,798,960...231,832,591
|
|
G |
Faslg |
Fas ligand |
multiple interactions |
ISO |
[Selenium analog co-treated with Magnesium Oxide analog] promotes the reaction [Diazinon results in decreased expression of FASLG mRNA] |
CTD |
PMID:27920530 |
|
NCBI chr13:74,151,519...74,172,760
Ensembl chr13:74,154,954...74,162,215
|
|
G |
Fasn |
fatty acid synthase |
increases expression multiple interactions |
EXP ISO |
Selenium results in increased expression of FASN mRNA [Sodium Selenite results in increased abundance of Selenium] inhibits the reaction [[Vancomycin co-treated with Neomycin co-treated with Ampicillin co-treated with Metronidazole co-treated with Amphotericin B] results in increased expression of FASN mRNA] |
CTD |
PMID:19022953 PMID:19244175 PMID:36464106 |
|
NCBI chr10:106,072,093...106,090,259
Ensembl chr10:106,072,091...106,090,261
|
|
G |
Fat4 |
FAT atypical cadherin 4 |
decreases expression |
ISO |
Selenium results in decreased expression of FAT4 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 2:121,927,266...122,056,700
Ensembl chr 2:121,927,942...122,056,707
|
|
G |
Faxdc2 |
fatty acid hydroxylase domain containing 2 |
decreases expression |
ISO |
Selenium results in decreased expression of FAXDC2 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr10:42,245,808...42,271,679
Ensembl chr10:42,246,868...42,271,871
|
|
G |
Fbln1 |
fibulin 1 |
increases expression |
ISO |
Selenium results in increased expression of FBLN1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 7:116,310,582...116,390,075
Ensembl chr 7:116,310,582...116,390,075
|
|
G |
Fbln5 |
fibulin 5 |
increases expression |
ISO |
Selenium results in increased expression of FBLN5 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 6:120,899,219...120,977,829
Ensembl chr 6:120,899,224...120,977,755
|
|
G |
Fbp1 |
fructose-bisphosphatase 1 |
increases expression |
ISO |
Selenium results in increased expression of FBP1 mRNA |
CTD |
PMID:28810182 |
|
NCBI chr17:2,207,271...2,230,076
Ensembl chr17:2,208,031...2,230,071
|
|
G |
Fbxl5 |
F-box and leucine-rich repeat protein 5 |
decreases expression |
ISO |
Selenium results in decreased expression of FBXL5 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr14:67,305,109...67,347,383
Ensembl chr14:67,267,801...67,347,383
|
|
G |
Fbxl8 |
F-box and leucine-rich repeat protein 8 |
increases expression |
ISO |
Selenium results in increased expression of FBXL8 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr19:33,142,705...33,147,266
Ensembl chr19:33,142,715...33,147,262
|
|
G |
Fbxo11 |
F-box protein 11 |
decreases expression |
ISO |
Selenium results in decreased expression of FBXO11 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 6:6,486,761...6,562,664
Ensembl chr 6:6,486,015...6,562,662
|
|
G |
Fbxo17 |
F-box protein 17 |
increases expression |
ISO |
Selenium results in increased expression of FBXO17 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 1:84,002,276...84,024,455
Ensembl chr 1:84,002,267...84,024,453
|
|
G |
Fbxo2 |
F-box protein 2 |
increases expression |
ISO |
Selenium results in increased expression of FBXO2 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 5:158,592,926...158,598,355
Ensembl chr 5:158,592,925...158,598,355
|
|
G |
Fbxo28 |
F-box protein 28 |
multiple interactions decreases expression |
ISO |
[Selenium co-treated with Vitamin E] results in increased expression of FBXO28 mRNA Selenium results in decreased expression of FBXO28 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr13:93,995,993...94,021,464
Ensembl chr13:93,995,996...94,021,464
|
|
G |
Fcgrt |
Fc gamma receptor and transporter |
increases expression |
ISO |
Selenium results in increased expression of FCGRT mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 1:95,574,436...95,584,171
Ensembl chr 1:95,567,175...95,584,084
|
|
G |
Fdft1 |
farnesyl diphosphate farnesyl transferase 1 |
increases expression |
ISO |
Selenium deficiency results in increased expression of FDFT1 mRNA |
CTD |
PMID:16170372 |
|
NCBI chr15:37,412,143...37,440,198
Ensembl chr15:37,412,146...37,440,287
|
|
G |
Fech |
ferrochelatase |
decreases expression |
ISO |
Selenium results in decreased expression of FECH mRNA |
CTD |
PMID:19244175 |
|
NCBI chr18:57,945,123...57,978,327
Ensembl chr18:57,945,122...57,979,348
|
|
G |
Fermt1 |
FERM domain containing kindlin 1 |
decreases expression |
ISO |
Selenium results in decreased expression of FERMT1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 3:120,171,301...120,213,555
Ensembl chr 3:120,171,561...120,213,555
|
|
G |
Ffar2 |
free fatty acid receptor 2 |
increases expression |
ISO |
Selenium results in increased expression of FFAR2 mRNA |
CTD |
PMID:17293063 |
|
NCBI chr 1:86,071,855...86,075,049
Ensembl chr 1:86,072,184...86,075,033
|
|
G |
Fgg |
fibrinogen gamma chain |
multiple interactions |
EXP |
[Selenium deficiency co-treated with Vitamin E deficiency] results in increased expression of FGG mRNA |
CTD |
PMID:11444866 |
|
NCBI chr 2:168,354,880...168,362,325
Ensembl chr 2:168,355,013...168,362,322
|
|
G |
Fhod3 |
formin homology 2 domain containing 3 |
decreases expression |
ISO |
Selenium results in decreased expression of FHOD3 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr18:15,993,079...16,425,796
Ensembl chr18:15,993,324...16,425,796
|
|
G |
Fig4 |
FIG4 phosphoinositide 5-phosphatase |
multiple interactions decreases expression |
ISO |
[Selenium co-treated with Vitamin E] results in decreased expression of FIG4 mRNA Selenium results in decreased expression of FIG4 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr20:44,600,603...44,724,047
Ensembl chr20:44,600,603...44,723,844
|
|
G |
Fis1 |
fission, mitochondrial 1 |
increases expression |
ISO |
Selenium results in increased expression of FIS1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr12:19,708,560...19,723,392
Ensembl chr12:19,708,558...19,723,377
|
|
G |
Fkbp1a |
FKBP prolyl isomerase 1A |
increases expression multiple interactions |
ISO |
Selenium results in increased expression of FKBP1A mRNA [Selenium co-treated with Vitamin E] results in decreased expression of FKBP1A mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 3:140,040,359...140,060,107
Ensembl chr 3:140,040,278...140,060,743
|
|
G |
Fkbp3 |
FKBP prolyl isomerase 3 |
decreases expression |
ISO |
Selenium results in decreased expression of FKBP3 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 6:83,113,885...83,125,500
Ensembl chr 6:83,113,786...83,127,011
|
|
G |
Flii |
FLII, actin remodeling protein |
increases expression |
ISO |
Selenium results in increased expression of FLII mRNA |
CTD |
PMID:19244175 |
|
NCBI chr10:45,394,032...45,408,051
Ensembl chr10:45,394,032...45,407,970
|
|
G |
Flna |
filamin A |
increases expression |
ISO |
Selenium results in increased expression of FLNA mRNA |
CTD |
PMID:19244175 |
|
NCBI chr X:152,007,758...152,034,266
Ensembl chr X:152,007,758...152,031,052
|
|
G |
Flot1 |
flotillin 1 |
increases expression |
ISO |
Selenium results in increased expression of FLOT1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr20:2,917,864...2,927,993
Ensembl chr20:2,917,137...2,927,978
|
|
G |
Flot2 |
flotillin 2 |
increases expression |
ISO |
Selenium results in increased expression of FLOT2 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr10:62,926,047...62,947,759
Ensembl chr10:62,920,665...62,947,756
|
|
G |
Flrt3 |
fibronectin leucine rich transmembrane protein 3 |
decreases expression |
ISO |
Selenium results in decreased expression of FLRT3 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 3:127,994,491...128,008,137
Ensembl chr 3:127,994,226...128,007,841
|
|
G |
Fmo5 |
flavin containing dimethylaniline monoxygenase 5 |
multiple interactions |
ISO |
[Selenium co-treated with Vitamin E] results in increased expression of FMO5 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 2:185,197,184...185,249,699
Ensembl chr 2:185,222,204...185,249,693
|
|
G |
Folh1 |
folate hydrolase 1 |
multiple interactions decreases expression |
ISO |
[Selenium co-treated with Vitamin E] results in decreased expression of FOLH1 mRNA Selenium results in decreased expression of FOLH1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 1:140,428,101...140,501,563
Ensembl chr 1:140,428,101...140,501,379
|
|
G |
Fos |
Fos proto-oncogene, AP-1 transcription factor subunit |
increases expression multiple interactions |
EXP |
Selenium results in increased expression of FOS mRNA; Selenium results in increased expression of FOS protein [Selenium co-treated with Iodine] results in increased expression of FOS mRNA; [Selenium co-treated with Iodine] results in increased expression of FOS protein |
CTD |
PMID:12475444 PMID:12666833 |
|
NCBI chr 6:105,121,170...105,124,036
Ensembl chr 6:105,121,170...105,124,036
|
|
G |
Foxf2 |
forkhead box F2 |
decreases expression |
ISO |
Selenium results in decreased expression of FOXF2 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr17:32,835,730...32,842,547
Ensembl chr17:32,836,777...32,842,176
|
|
G |
Foxo1 |
forkhead box O1 |
multiple interactions |
EXP |
Selenium inhibits the reaction [arsenite results in decreased phosphorylation of FOXO1 protein] |
CTD |
PMID:29324385 |
|
NCBI chr 2:136,312,168...136,390,603
Ensembl chr 2:136,312,168...136,387,790
|
|
G |
Foxo3 |
forkhead box O3 |
multiple interactions |
ISO |
Selenium results in decreased phosphorylation of and results in increased activity of FOXO3 protein |
CTD |
PMID:17339365 |
|
NCBI chr20:45,669,708...45,764,606
Ensembl chr20:45,672,995...45,764,561
|
|
G |
Frat1 |
FRAT regulator of WNT signaling pathway 1 |
increases expression |
ISO |
Selenium results in increased expression of FRAT1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 1:240,638,309...240,640,857
Ensembl chr 1:240,638,296...240,640,945
|
|
G |
Fshb |
follicle stimulating hormone subunit beta |
multiple interactions |
EXP |
Selenium inhibits the reaction [Acrylamide results in decreased expression of FSHB protein]; Selenium inhibits the reaction [Cadmium Chloride results in decreased expression of FSHB protein] |
CTD |
PMID:20957662 PMID:37987225 |
|
NCBI chr 3:93,548,560...93,552,370
Ensembl chr 3:93,548,560...93,552,370
|
|
G |
Ftl1 |
ferritin light chain 1 |
increases expression |
ISO |
Selenium results in increased expression of FTL mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 1:95,936,387...95,938,234
Ensembl chr 1:95,936,387...95,939,725 Ensembl chr10:95,936,387...95,939,725 Ensembl chr 2:95,936,387...95,939,725
|
|
G |
Fus |
Fus RNA binding protein |
increases expression |
ISO |
Selenium results in increased expression of FUS mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 1:182,576,479...182,590,417
Ensembl chr 1:182,576,545...182,590,414
|
|
G |
Fxr1 |
FMR1 autosomal homolog 1 |
decreases expression |
ISO |
Selenium results in decreased expression of FXR1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 2:116,884,167...116,937,590
Ensembl chr 2:116,884,248...116,937,590
|
|
G |
Fzd7 |
frizzled class receptor 7 |
decreases expression |
ISO |
Selenium results in decreased expression of FZD7 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 9:60,931,433...60,934,252
Ensembl chr 9:60,930,875...60,935,781
|
|
G |
Fzr1 |
fizzy and cell division cycle 20 related 1 |
multiple interactions increases expression |
ISO |
[Selenium co-treated with Vitamin E] results in increased expression of FZR1 mRNA Selenium results in increased expression of FZR1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 7:8,332,029...8,343,953
Ensembl chr 7:8,332,029...8,343,952
|
|
G |
G0s2 |
G0/G1switch 2 |
increases expression |
ISO |
Selenium results in increased expression of G0S2 mRNA |
CTD |
PMID:17293063 |
|
NCBI chr13:104,806,351...104,807,263
Ensembl chr13:104,806,156...104,807,451
|
|
G |
Gadd45a |
growth arrest and DNA-damage-inducible, alpha |
multiple interactions |
ISO |
[Selenium co-treated with Vitamin E] results in increased expression of GADD45A mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 4:96,154,789...96,157,091
Ensembl chr 4:96,154,789...96,157,115
|
|
G |
Galnt1 |
polypeptide N-acetylgalactosaminyltransferase 1 |
multiple interactions decreases expression |
ISO |
[Selenium co-treated with Vitamin E] results in decreased expression of GALNT1 mRNA Selenium results in decreased expression of GALNT1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr18:15,489,015...15,568,849
Ensembl chr18:15,489,020...15,568,245
|
|
G |
Ganab |
glucosidase II alpha subunit |
increases expression |
ISO |
Selenium results in increased expression of GANAB mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 1:205,793,910...205,813,704
Ensembl chr 1:205,793,895...205,813,695
|
|
G |
Gapdh |
glyceraldehyde-3-phosphate dehydrogenase |
increases expression |
ISO |
Selenium results in increased expression of GAPDH mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 4:157,962,312...157,967,158
Ensembl chr 4:157,962,343...157,966,235
|
|
G |
Gas8 |
growth arrest specific 8 |
multiple interactions increases expression |
ISO |
[Selenium co-treated with Vitamin E] results in decreased expression of GAS8 mRNA Selenium results in increased expression of GAS8 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr19:51,552,770...51,572,323
Ensembl chr19:51,552,816...51,572,305
|
|
G |
Gatad2a |
GATA zinc finger domain containing 2A |
increases expression |
ISO |
Selenium results in increased expression of GATAD2A mRNA |
CTD |
PMID:19244175 |
|
NCBI chr16:19,429,578...19,520,320
Ensembl chr16:19,429,578...19,519,587
|
|
G |
Gbp1 |
guanylate binding protein 1 |
decreases expression |
ISO |
Selenium results in decreased expression of GBP1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 2:231,398,136...231,432,773
Ensembl chr 2:231,398,163...231,432,131 Ensembl chr 2:231,398,163...231,432,131
|
|
G |
Gcat |
glycine C-acetyltransferase |
increases expression |
ISO |
Selenium results in increased expression of GCAT mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 7:110,595,126...110,601,474
Ensembl chr 7:110,595,091...110,601,473
|
|
G |
Gclc |
glutamate-cysteine ligase, catalytic subunit |
multiple interactions |
EXP |
[Selenium deficiency co-treated with Vitamin E deficiency] results in decreased expression of GCLC mRNA |
CTD |
PMID:11444866 |
|
NCBI chr 8:78,629,899...78,668,547
Ensembl chr 8:78,630,127...78,668,544
|
|
G |
Gfus |
GDP-L-fucose synthase |
increases expression |
ISO |
Selenium results in increased expression of GFUS mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 7:107,612,087...107,617,005
Ensembl chr 7:107,612,094...107,616,948
|
|
G |
Ggps1 |
geranylgeranyl diphosphate synthase 1 |
decreases expression |
ISO |
Selenium results in decreased expression of GGPS1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr17:51,263,262...51,282,471
Ensembl chr17:51,263,263...51,276,220
|
|
G |
Ggt1 |
gamma-glutamyltransferase 1 |
multiple interactions |
ISO EXP |
[Selenium co-treated with Vitamin E] results in increased expression of GGT1 mRNA Acetylcysteine promotes the reaction [Selenium inhibits the reaction [Mercuric Chloride results in increased expression of GGT1 protein]]; Selenium inhibits the reaction [Mercuric Chloride results in increased expression of GGT1 protein]; Selenium promotes the reaction [Acetylcysteine inhibits the reaction [Mercuric Chloride results in increased expression of GGT1 protein]] |
CTD |
PMID:19244175 PMID:24485406 |
|
NCBI chr20:13,074,695...13,104,095
Ensembl chr20:13,074,700...13,108,442
|
|
G |
Gipc1 |
GIPC PDZ domain containing family, member 1 |
multiple interactions increases expression |
ISO |
[Selenium co-treated with Vitamin E] results in increased expression of GIPC1 mRNA Selenium results in increased expression of GIPC1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr19:24,474,291...24,487,083
Ensembl chr19:24,453,123...24,486,997
|
|
G |
Gjb1 |
gap junction protein, beta 1 |
increases expression |
ISO |
Selenium results in increased expression of GJB1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr X:66,501,848...66,509,783
Ensembl chr X:66,501,820...66,509,925
|
|
G |
Glg1 |
golgi glycoprotein 1 |
decreases expression increases expression |
ISO |
Selenium results in decreased expression of GLG1 mRNA Selenium results in increased expression of GLG1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr19:39,124,892...39,224,178
Ensembl chr19:39,124,641...39,224,178
|
|
G |
Gli2 |
GLI family zinc finger 2 |
increases expression |
ISO |
Selenium results in increased expression of GLI2 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr13:29,946,882...30,163,589
Ensembl chr13:29,946,809...30,163,574
|
|
G |
Glmn |
glomulin, FKBP associated protein |
decreases expression |
ISO |
Selenium results in decreased expression of GLMN mRNA |
CTD |
PMID:19244175 |
|
NCBI chr14:2,187,144...2,231,295
Ensembl chr14:2,187,642...2,230,420
|
|
G |
Glrx |
glutaredoxin |
increases expression affects expression |
ISO EXP |
Selenium deficiency results in increased expression of GLRX mRNA; Selenium results in increased expression of GLRX mRNA Selenium affects the expression of GLRX mRNA |
CTD |
PMID:16170372 PMID:19351701 |
|
NCBI chr 2:5,341,873...5,351,686
Ensembl chr 2:5,341,885...5,351,680
|
|
G |
Glrx2 |
glutaredoxin 2 |
affects activity affects expression |
EXP |
Selenium affects the activity of GLRX2 protein Selenium affects the expression of GLRX2 protein |
CTD |
PMID:19351701 |
|
NCBI chr13:55,481,875...55,504,737
Ensembl chr13:55,482,694...55,492,831
|
|
G |
Glud1 |
glutamate dehydrogenase 1 |
affects expression |
EXP |
Selenium affects the expression of GLUD1 protein |
CTD |
PMID:19351701 |
|
NCBI chr16:9,640,312...9,673,961
Ensembl chr16:9,640,312...9,673,957
|
|
G |
Gmnn |
geminin, DNA replication inhibitor |
decreases expression |
ISO |
Selenium results in decreased expression of GMNN mRNA |
CTD |
PMID:19244175 |
|
NCBI chr17:40,301,771...40,310,054
Ensembl chr17:40,301,808...40,310,054
|
|
G |
Gmppa |
GDP-mannose pyrophosphorylase A |
increases expression |
ISO |
Selenium results in increased expression of GMPPA mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 9:76,926,724...76,934,274
Ensembl chr 9:76,926,739...76,934,269
|
|
G |
Gmpr2 |
guanosine monophosphate reductase 2 |
increases expression |
ISO |
Selenium results in increased expression of GMPR2 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr15:29,165,421...29,175,933
Ensembl chr15:29,165,783...29,174,935
|
|
G |
Gnai2 |
G protein subunit alpha i2 |
increases expression |
ISO |
Selenium results in increased expression of GNAI2 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 8:108,288,401...108,309,009
Ensembl chr 8:108,288,401...108,308,979
|
|
G |
Gnas |
GNAS complex locus |
multiple interactions decreases expression |
ISO |
[Selenium co-treated with Vitamin E] results in decreased expression of GNAS mRNA Selenium results in decreased expression of GNAS mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 3:163,071,003...163,136,350
Ensembl chr 3:163,071,417...163,127,262 Ensembl chr 3:163,071,417...163,127,262
|
|
G |
Gnb2 |
G protein subunit beta 2 |
increases expression |
ISO |
Selenium results in increased expression of GNB2 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr12:19,159,002...19,164,021
Ensembl chr12:19,158,973...19,164,019
|
|
G |
Gnl1 |
G protein nucleolar 1 |
increases expression |
ISO |
Selenium results in increased expression of GNL1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr20:2,783,130...2,792,115
Ensembl chr20:2,778,985...2,792,115
|
|
G |
Gnmt |
glycine N-methyltransferase |
affects activity |
EXP |
Selenium affects the activity of GNMT protein |
CTD |
PMID:16632891 |
|
NCBI chr 9:14,254,675...14,258,028
Ensembl chr 9:14,254,675...14,258,434
|
|
G |
Gns |
glucosamine (N-acetyl)-6-sulfatase |
decreases expression |
ISO |
Selenium results in decreased expression of GNS mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 7:56,889,148...56,923,173
Ensembl chr 7:56,889,232...56,923,151
|
|
G |
Golga3 |
golgin A3 |
increases expression multiple interactions |
ISO |
Selenium results in increased expression of GOLGA3 mRNA [Selenium co-treated with Vitamin E] results in decreased expression of GOLGA3 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr12:46,452,409...46,500,509
Ensembl chr12:46,454,870...46,500,509 Ensembl chr 4:46,454,870...46,500,509
|
|
G |
Gorasp1 |
golgi reassembly stacking protein 1 |
increases expression |
ISO |
Selenium results in increased expression of GORASP1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 8:119,655,267...119,667,022
Ensembl chr 8:119,655,268...119,666,972
|
|
G |
Gosr1 |
golgi SNAP receptor complex member 1 |
decreases expression |
ISO |
Selenium results in decreased expression of GOSR1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr10:61,570,499...61,607,287
Ensembl chr10:61,450,494...61,607,177 Ensembl chr10:61,450,494...61,607,177
|
|
G |
Gpi |
glucose-6-phosphate isomerase |
increases expression |
ISO |
Selenium results in increased expression of GPI mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 1:86,828,211...86,856,077
Ensembl chr 1:86,828,216...86,856,086
|
|
G |
Gpkow |
G patch domain and KOW motifs |
increases expression |
ISO |
Selenium results in increased expression of GPKOW mRNA |
CTD |
PMID:19244175 |
|
NCBI chr X:14,791,601...14,806,384
Ensembl chr X:14,791,610...14,806,384
|
|
G |
Gpr107 |
G protein-coupled receptor 107 |
increases expression |
ISO |
Selenium results in increased expression of GPR107 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 3:14,431,704...14,497,623
Ensembl chr 3:14,434,723...14,495,958
|
|
G |
Gpr137 |
G protein-coupled receptor 137 |
increases expression |
ISO |
Selenium results in increased expression of GPR137 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 1:204,129,636...204,132,622
Ensembl chr 1:204,129,636...204,133,082
|
|
G |
Gpr137b |
G protein-coupled receptor 137B |
decreases expression |
ISO |
Selenium results in decreased expression of GPR137B mRNA |
CTD |
PMID:19244175 |
|
NCBI chr17:86,003,635...86,041,841
Ensembl chr17:85,966,921...86,041,835
|
|
G |
Gprin2 |
G protein regulated inducer of neurite outgrowth 2 |
multiple interactions |
ISO |
[Selenium co-treated with Vitamin E] results in decreased expression of GPRIN2 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr16:9,496,452...9,512,672
Ensembl chr16:9,505,643...9,507,010
|
|
G |
Gpt |
glutamic--pyruvic transaminase |
multiple interactions |
EXP ISO |
[[gluconic acid results in increased abundance of Magnesium] co-treated with [Sodium Selenite results in increased abundance of Selenium]] inhibits the reaction [Dietary Fats results in increased expression of GPT protein]; [Selenium co-treated with Zinc] inhibits the reaction [[Lead co-treated with Cadmium co-treated with Mercury co-treated with Arsenic] results in increased expression of GPT protein]; [Zinc co-treated with Selenium co-treated with Acetylcysteine] inhibits the reaction [dimethyl mercury results in increased activity of GPT protein]; [Zinc co-treated with Selenium] inhibits the reaction [Streptozocin results in increased expression of GPT protein]; Selenium inhibits the reaction [[Lead co-treated with Cadmium co-treated with Mercury co-treated with Arsenic] results in increased expression of GPT protein]; Selenium inhibits the reaction [Mercuric Chloride results in increased activity of GPT protein]; Selenium promotes the reaction [Acetylcysteine inhibits the reaction [Mercuric Chloride results in increased activity of GPT protein]] [Sodium Selenite results in increased abundance of Selenium] inhibits the reaction [[Vancomycin co-treated with Neomycin co-treated with Ampicillin co-treated with Metronidazole co-treated with Amphotericin B] results in increased activity of GPT protein] |
CTD |
PMID:20688495 PMID:24485406 PMID:30031400 PMID:32233808 PMID:36464106 PMID:37676925 More...
|
|
NCBI chr 7:108,416,646...108,419,495
Ensembl chr 7:108,416,642...108,419,494
|
|
G |
Gpx1 |
glutathione peroxidase 1 |
affects response to substance decreases activity increases activity increases expression decreases expression multiple interactions affects expression affects activity |
ISO EXP |
GPX1 gene polymorphism affects the susceptibility to Selenium; GPX1 protein polymorphism affects the susceptibility to Selenium Selenium deficiency results in decreased activity of GPX1 protein Selenium results in increased activity of GPX1 protein Selenium results in increased expression of GPX1 mRNA; Selenium results in increased expression of GPX1 protein Selenium deficiency results in decreased expression of GPX1 mRNA; Selenium deficiency results in decreased expression of GPX1 protein [Selenium deficiency co-treated with Vitamin E deficiency] results in decreased expression of GPX1 mRNA; Selenium inhibits the reaction [2-iodohexadecanal results in decreased expression of GPX1 mRNA]; Selenium inhibits the reaction [arsenite results in decreased expression of GPX1 protein]; Selenium inhibits the reaction [Cisplatin results in decreased expression of GPX1 mRNA]; Selenium inhibits the reaction [Potassium Iodide results in decreased expression of GPX1 mRNA]; Selenium results in increased expression of and results in decreased degradation of GPX1 mRNA Selenium affects the expression of GPX1 mRNA Selenium affects the activity of GPX1 protein Selenium deficiency inhibits the reaction [IL4 protein results in increased expression of GPX1 protein]; Selenium deficiency inhibits the reaction [Lipopolysaccharides results in increased expression of GPX1 protein]; Selenium deficiency results in decreased expression of and results in decreased activity of GPX1 protein Selenium affects the expression of GPX1 mRNA; Selenium affects the expression of GPX1 protein |
CTD |
PMID:10874123 PMID:10949970 PMID:11294903 PMID:11444866 PMID:11463357 PMID:11776067 PMID:12031252 PMID:12667700 PMID:12810669 PMID:15203190 PMID:15203381 PMID:15670848 PMID:15792362 PMID:15795427 PMID:16170372 PMID:16837816 PMID:17052796 PMID:17109141 PMID:17150329 PMID:17512462 PMID:17513408 PMID:17709542 PMID:19022953 PMID:19076066 PMID:19106321 PMID:19125369 PMID:19234057 PMID:19415410 PMID:21775527 PMID:29324385 PMID:38013145 More...
|
|
NCBI chr 8:109,026,905...109,028,031
Ensembl chr 8:109,026,905...109,028,024
|
|
G |
Gpx2 |
glutathione peroxidase 2 |
decreases activity decreases expression |
ISO |
Selenium deficiency results in decreased activity of GPX2 protein Selenium deficiency results in decreased expression of GPX2 mRNA |
CTD |
PMID:15795427 |
|
NCBI chr 6:95,493,589...95,496,877
Ensembl chr 6:95,493,589...95,496,877
|
|
G |
Gpx3 |
glutathione peroxidase 3 |
increases expression affects activity increases activity affects expression |
ISO EXP |
Selenium results in increased expression of GPX3 mRNA Selenium affects the activity of GPX3 protein Selenium results in increased activity of GPX3 protein Selenium affects the expression of GPX3 mRNA |
CTD |
PMID:15894816 PMID:19022953 PMID:19106321 PMID:19244175 PMID:19351701 |
|
NCBI chr10:39,028,624...39,036,695
Ensembl chr10:39,028,570...39,037,035
|
|
G |
Gpx4 |
glutathione peroxidase 4 |
increases activity decreases expression multiple interactions increases expression decreases activity affects activity decreases abundance |
ISO EXP |
Selenium analog results in increased activity of GPX4 protein Selenium deficiency results in decreased expression of GPX4 protein Selenomethionine inhibits the reaction [Selenium deficiency results in decreased expression of GPX4 protein]; Sodium Selenite inhibits the reaction [Selenium deficiency results in decreased expression of GPX4 protein] [2-hydroxy-4-methylselenobutanoic acid results in increased abundance of Selenium] which results in increased expression of GPX4 protein; [Zinc co-treated with Selenium] inhibits the reaction [Streptozocin results in decreased expression of GPX4 protein] Selenium deficiency results in decreased expression of GPX4 mRNA Selenium results in increased expression of GPX4 mRNA Selenium deficiency results in decreased activity of GPX4 protein Selenium affects the activity of GPX4 protein Selenium results in increased activity of GPX4 protein GPX4 gene mutant form results in decreased abundance of Selenium Selenium results in increased expression of and results in increased activity of GPX4 protein Selenium results in increased expression of GPX4 mRNA; Selenium results in increased expression of GPX4 protein |
CTD |
PMID:11673642 PMID:12031252 PMID:15670848 PMID:15792362 PMID:16246897 PMID:17052796 PMID:17150329 PMID:19022953 PMID:19106321 PMID:19244175 PMID:32233808 PMID:34116104 PMID:34970773 More...
|
|
NCBI chr 7:9,650,186...9,652,982
Ensembl chr 7:9,650,185...9,652,982
|
|
G |
Gpx5 |
glutathione peroxidase 5 |
affects expression multiple interactions |
ISO EXP |
Selenium affects the expression of GPX5 [Zinc co-treated with Selenium] inhibits the reaction [Streptozocin results in decreased expression of GPX5 protein] |
CTD |
PMID:10542376 PMID:32233808 |
|
NCBI chr17:43,436,126...43,443,074
Ensembl chr17:43,416,340...43,443,074
|
|
G |
Gria2 |
glutamate ionotropic receptor AMPA type subunit 2 |
decreases expression |
ISO |
Selenium results in decreased expression of GRIA2 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 2:165,949,379...166,069,510
Ensembl chr 2:165,947,521...166,069,510
|
|
G |
Grina |
glutamate ionotropic receptor NMDA type subunit associated protein 1 |
multiple interactions increases expression |
ISO |
[Selenium co-treated with Vitamin E] results in decreased expression of GRINA mRNA Selenium results in increased expression of GRINA mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 7:107,962,194...107,965,372
Ensembl chr 7:107,962,207...107,965,366
|
|
G |
Grk6 |
G protein-coupled receptor kinase 6 |
increases expression |
ISO |
Selenium results in increased expression of GRK6 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr17:9,177,018...9,192,813
Ensembl chr17:9,177,019...9,192,644
|
|
G |
Grn |
granulin precursor |
multiple interactions increases expression |
ISO |
[Selenium co-treated with Vitamin E] results in increased expression of GRN mRNA Selenium results in increased expression of GRN mRNA |
CTD |
PMID:19244175 |
|
NCBI chr10:87,387,672...87,393,777
Ensembl chr10:87,387,638...87,393,775
|
|
G |
Gsdme |
gasdermin E |
decreases expression |
ISO |
Selenium results in decreased expression of GSDME mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 4:79,258,799...79,321,129
Ensembl chr 4:79,257,804...79,320,806
|
|
G |
Gsk3a |
glycogen synthase kinase 3 alpha |
increases expression |
ISO |
Selenium results in increased expression of GSK3A mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 1:80,815,843...80,825,732
Ensembl chr 1:80,815,850...80,825,802
|
|
G |
Gsk3b |
glycogen synthase kinase 3 beta |
multiple interactions decreases phosphorylation decreases expression |
ISO |
[Selenium co-treated with Vitamin E] results in increased expression of GSK3B mRNA; Selenium inhibits the reaction [Doxorubicin results in increased phosphorylation of GSK3B protein] Selenium results in decreased phosphorylation of GSK3B protein Selenium results in decreased expression of GSK3B mRNA |
CTD |
PMID:17339365 PMID:19244175 |
|
NCBI chr11:62,498,997...62,648,665
Ensembl chr11:62,504,316...62,648,646
|
|
G |
Gsn |
gelsolin |
increases expression |
ISO |
Selenium results in increased expression of GSN mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 3:18,585,166...18,638,404
Ensembl chr 3:18,585,172...18,638,402
|
|
G |
Gsr |
glutathione-disulfide reductase |
multiple interactions |
EXP |
Selenium inhibits the reaction [cyfluthrin results in decreased activity of GSR protein] |
CTD |
PMID:23595963 |
|
NCBI chr16:58,482,209...58,525,256
Ensembl chr16:58,482,505...58,525,661
|
|
G |
Gsta3 |
glutathione S-transferase alpha 3 |
affects expression |
EXP |
Selenium affects the expression of GSTA3 protein |
CTD |
PMID:4004801 |
|
NCBI chr 9:23,658,574...23,684,240
Ensembl chr 9:23,658,574...23,684,240
|
|
G |
Gsta5 |
glutathione S-transferase alpha 5 |
increases expression |
EXP |
Selenium deficiency results in increased expression of GSTA5 mRNA; Selenium deficiency results in increased expression of GSTA5 protein |
CTD |
PMID:9331086 |
|
NCBI chr 8:79,105,561...79,117,472
Ensembl chr 8:79,105,661...79,117,472
|
|
G |
Gstp1 |
glutathione S-transferase pi 1 |
multiple interactions affects expression increases expression |
ISO EXP |
[Selenium co-treated with Vitamin E] results in decreased expression of GSTP1 mRNA Selenium affects the expression of GSTP1 protein Selenium results in increased expression of GSTP1 mRNA |
CTD |
PMID:7532609 PMID:19244175 |
|
NCBI chr 1:201,337,762...201,340,230
Ensembl chr 1:201,321,672...201,340,226
|
|
G |
Gstt1 |
glutathione S-transferase theta 1 |
increases expression |
EXP |
Selenium deficiency results in increased expression of GSTT1 |
CTD |
PMID:9331086 |
|
NCBI chr20:12,856,613...12,873,586
Ensembl chr20:12,856,669...12,873,585
|
|
G |
Gtf2f1 |
general transcription factor IIF subunit 1 |
increases expression |
ISO |
Selenium results in increased expression of GTF2F1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 9:1,844,027...1,853,455
Ensembl chr 9:1,843,901...1,853,423
|
|
G |
Gtf3c1 |
general transcription factor IIIC subunit 1 |
increases expression |
ISO |
Selenium results in increased expression of GTF3C1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 1:180,203,995...180,270,201
Ensembl chr 1:180,203,995...180,270,201
|
|
G |
Gtpbp8 |
GTP binding protein 8 |
multiple interactions decreases expression |
ISO |
[Selenium co-treated with Vitamin E] results in decreased expression of GTPBP8 mRNA Selenium results in decreased expression of GTPBP8 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr11:55,945,778...55,955,743
Ensembl chr11:55,945,795...55,955,635
|
|
G |
Gulp1 |
GULP PTB domain containing engulfment adaptor 1 |
decreases expression |
ISO |
Selenium results in decreased expression of GULP1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 9:46,622,699...46,899,005
Ensembl chr 9:46,622,669...46,899,005
|
|
G |
H2ax |
H2A.X variant histone |
increases expression multiple interactions |
ISO EXP |
Selenium results in increased expression of H2AX mRNA Selenium inhibits the reaction [Acrylamide results in increased expression of H2AX protein] |
CTD |
PMID:19244175 PMID:37987225 |
|
NCBI chr 8:44,671,907...44,673,262
Ensembl chr 8:44,671,786...44,673,239 Ensembl chr 4:44,671,786...44,673,239
|
|
G |
H3f3a |
H3.3 histone A |
decreases expression |
ISO |
Selenium results in decreased expression of H3-3A mRNA |
CTD |
PMID:19244175 |
|
NCBI chr13:92,533,289...92,544,902
Ensembl chr13:92,533,298...92,544,908
|
|
G |
H4cl1 |
histone H4C like 1 |
decreases expression |
ISO |
Selenium results in decreased expression of H4C6 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr17:41,368,743...41,426,735
|
|
G |
H6pd |
hexose-6-phosphate dehydrogenase (glucose 1-dehydrogenase) |
multiple interactions increases expression |
ISO |
[Selenium co-treated with Vitamin E] results in decreased expression of H6PD mRNA Selenium results in increased expression of H6PD mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 5:160,434,499...160,470,203
Ensembl chr 5:160,438,697...160,470,171
|
|
G |
Hadha |
hydroxyacyl-CoA dehydrogenase trifunctional multienzyme complex subunit alpha |
decreases expression |
ISO |
Selenium results in decreased expression of HADHA mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 6:26,187,969...26,227,605
Ensembl chr 6:26,187,956...26,227,869
|
|
G |
Hagh |
hydroxyacyl glutathione hydrolase |
increases expression |
ISO |
Selenium results in increased expression of HAGH mRNA |
CTD |
PMID:19244175 |
|
NCBI chr10:13,874,883...13,889,527
Ensembl chr10:13,875,241...13,889,504
|
|
G |
Hars1 |
histidyl-tRNA synthetase 1 |
increases expression |
ISO |
Selenium results in increased expression of HARS1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr18:28,381,649...28,398,699
Ensembl chr18:28,381,655...28,398,740
|
|
G |
Haus3 |
HAUS augmin-like complex, subunit 3 |
decreases expression multiple interactions |
ISO |
Selenium results in decreased expression of HAUS3 mRNA [Selenium co-treated with Vitamin E] results in increased expression of HAUS3 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr14:76,580,549...76,599,542
Ensembl chr14:76,580,546...76,752,463
|
|
G |
Haus4 |
HAUS augmin-like complex, subunit 4 |
increases expression |
ISO |
Selenium results in increased expression of HAUS4 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr15:27,994,530...28,006,147
Ensembl chr15:27,994,532...28,005,938
|
|
G |
Hba-a3 |
hemoglobin alpha, adult chain 3 |
multiple interactions |
ISO |
[Selenium co-treated with Vitamin E] results in decreased expression of HBA2 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr10:15,311,637...15,312,481
Ensembl chr10:15,311,634...15,312,481
|
|
G |
Hdgf |
heparin binding growth factor |
increases expression |
ISO |
Selenium results in increased expression of HDGF mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 2:173,370,147...173,379,756
Ensembl chr 2:173,370,465...173,379,747
|
|
G |
Hdlbp |
high density lipoprotein binding protein |
increases expression |
ISO |
Selenium results in increased expression of HDLBP mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 9:93,948,099...94,018,040
Ensembl chr 9:93,949,913...94,018,048
|
|
G |
Heph |
hephaestin |
decreases expression |
ISO |
Selenium results in decreased expression of HEPH mRNA |
CTD |
PMID:19244175 |
|
NCBI chr X:61,151,131...61,402,980
Ensembl chr X:61,296,345...61,402,980
|
|
G |
Hes1 |
hes family bHLH transcription factor 1 |
decreases expression multiple interactions |
ISO |
Selenium results in decreased expression of HES1 mRNA [Selenium co-treated with Vitamin E] results in increased expression of HES1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr11:70,705,763...70,708,176
Ensembl chr11:70,705,764...70,708,192
|
|
G |
Hgs |
hepatocyte growth factor-regulated tyrosine kinase substrate |
increases expression |
ISO |
Selenium results in increased expression of HGS mRNA |
CTD |
PMID:19244175 |
|
NCBI chr10:105,739,617...105,757,838
Ensembl chr10:105,739,296...105,757,835
|
|
G |
Hhip |
Hedgehog-interacting protein |
increases expression |
ISO |
Selenium results in increased expression of HHIP mRNA |
CTD |
PMID:18997278 |
|
NCBI chr19:27,863,684...27,952,528
Ensembl chr19:27,863,213...27,952,528
|
|
G |
Hip1r |
huntingtin interacting protein 1 related |
increases expression |
ISO |
Selenium results in increased expression of HIP1R mRNA |
CTD |
PMID:19244175 |
|
NCBI chr12:32,590,164...32,618,841
Ensembl chr12:32,590,165...32,618,734
|
|
G |
Hipk2 |
homeodomain interacting protein kinase 2 |
multiple interactions decreases expression |
ISO |
[Selenium co-treated with Vitamin E] results in decreased expression of HIPK2 mRNA Selenium results in decreased expression of HIPK2 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 4:67,439,327...67,619,223
Ensembl chr 4:67,440,501...67,619,223
|
|
G |
Hirip3 |
HIRA interacting protein 3 |
increases expression |
ISO |
Selenium results in increased expression of HIRIP3 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 1:181,472,537...181,475,082
Ensembl chr 1:181,472,056...181,475,079
|
|
G |
Hlf |
HLF transcription factor, PAR bZIP family member |
decreases expression |
ISO |
Selenium results in decreased expression of HLF mRNA |
CTD |
PMID:19244175 |
|
NCBI chr10:75,154,244...75,211,884
Ensembl chr10:75,154,507...75,211,935
|
|
G |
Hmbs |
hydroxymethylbilane synthase |
increases expression |
ISO |
Selenium results in increased expression of HMBS mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 8:44,673,554...44,680,950
Ensembl chr 8:44,673,554...44,680,957
|
|
G |
Hmgb1 |
high mobility group box 1 |
multiple interactions |
ISO |
[Selenium co-treated with Vitamin E] results in decreased expression of HMGB1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr12:5,972,950...5,979,658
Ensembl chr12:5,901,586...5,978,565 Ensembl chr16:5,901,586...5,978,565
|
|
G |
Hmgcr |
3-hydroxy-3-methylglutaryl-CoA reductase |
multiple interactions |
EXP ISO |
[[gluconic acid results in increased abundance of Magnesium] co-treated with [Sodium Selenite results in increased abundance of Selenium]] inhibits the reaction [Dietary Fats results in increased expression of HMGCR mRNA]; Selenium promotes the reaction [Cholesterol results in decreased expression of HMGCR mRNA] [Sodium Selenite results in increased abundance of Selenium] inhibits the reaction [[Vancomycin co-treated with Neomycin co-treated with Ampicillin co-treated with Metronidazole co-treated with Amphotericin B] results in increased expression of HMGCR mRNA] |
CTD |
PMID:16581047 PMID:30031400 PMID:36464106 |
|
NCBI chr 2:27,997,523...28,018,983
Ensembl chr 2:27,997,525...28,019,703
|
|
G |
Hmgxb3 |
HMG-box containing 3 |
increases expression |
ISO |
Selenium results in increased expression of HMGXB3 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr18:54,590,558...54,638,050
Ensembl chr18:54,590,560...54,638,155
|
|
G |
Hmgxb4 |
HMG-box containing 4 |
multiple interactions decreases expression |
ISO |
[Selenium co-treated with Vitamin E] results in decreased expression of HMGXB4 mRNA Selenium results in decreased expression of HMGXB4 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr19:13,364,741...13,403,563
Ensembl chr19:13,364,807...13,403,563
|
|
G |
Hmox1 |
heme oxygenase 1 |
multiple interactions increases expression affects expression affects activity |
ISO EXP |
[Arsenic co-treated with Selenium] results in increased expression of HMOX1 mRNA; [Arsenic co-treated with Selenium] results in increased expression of HMOX1 protein; [Cadmium analog co-treated with Selenium analog co-treated with zinc sulfide analog] affects the expression of HMOX1 mRNA; [Cadmium analog co-treated with Selenium analog co-treated with zinc sulfide analog] results in increased expression of HMOX1 mRNA Selenium deficiency results in increased expression of HMOX1 mRNA Phenobarbital promotes the reaction [Selenium deficiency results in increased expression of and results in increased activity of HMOX1 protein]; Phenobarbital promotes the reaction [Selenium deficiency results in increased expression of HMOX1 mRNA]; Selenium deficiency results in increased expression of and results in increased activity of HMOX1 protein; Selenium inhibits the reaction [Cisplatin results in increased expression of HMOX1 protein] Selenium affects the expression of HMOX1 protein Selenium affects the activity of HMOX1 protein NFE2L2 protein affects the reaction [Selenium affects the activity of HMOX1 protein] Selenium results in increased expression of HMOX1 mRNA; Selenium results in increased expression of HMOX1 protein |
CTD |
PMID:12751798 PMID:16837816 PMID:18279678 PMID:20478284 PMID:21481475 |
|
NCBI chr19:13,466,287...13,474,082
Ensembl chr19:13,467,244...13,474,079
|
|
G |
Hmx1 |
H6 family homeobox 1 |
increases expression |
ISO |
Selenium results in increased expression of HMX1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr14:75,361,207...75,364,993
Ensembl chr14:75,361,225...75,364,993
|
|
G |
Hnf1b |
HNF1 homeobox B |
increases expression |
ISO |
Selenium results in increased expression of HNF1B mRNA |
CTD |
PMID:28810182 |
|
NCBI chr10:68,735,894...68,789,888
Ensembl chr10:68,735,894...68,789,888
|
|
G |
Hnmt |
histamine N-methyltransferase |
decreases expression multiple interactions |
ISO |
Selenium results in decreased expression of HNMT mRNA [Selenium co-treated with Vitamin E] results in decreased expression of HNMT mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 3:6,591,804...6,623,821
Ensembl chr 3:6,591,463...6,624,012
|
|
G |
Hnrnpd |
heterogeneous nuclear ribonucleoprotein D |
increases expression |
ISO |
Selenium results in increased expression of HNRNPD mRNA |
CTD |
PMID:19244175 |
|
NCBI chr14:9,615,375...9,638,975
Ensembl chr14:9,615,479...9,633,786
|
|
G |
Hnrnpm |
heterogeneous nuclear ribonucleoprotein M |
increases expression |
ISO |
Selenium results in increased expression of HNRNPM mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 7:14,438,703...14,476,781
Ensembl chr 7:14,438,688...14,476,762
|
|
G |
Homer1 |
homer scaffold protein 1 |
decreases expression multiple interactions |
ISO |
Selenium results in decreased expression of HOMER1 mRNA [Selenium co-treated with Vitamin E] results in decreased expression of HOMER1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 2:24,542,777...24,645,715
Ensembl chr 2:24,543,093...24,644,785
|
|
G |
Hook1 |
hook microtubule-tethering protein 1 |
multiple interactions decreases expression |
ISO |
[Selenium co-treated with Vitamin E] results in decreased expression of HOOK1 mRNA Selenium results in decreased expression of HOOK1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 5:110,824,501...110,887,791
Ensembl chr 5:110,824,501...110,887,787
|
|
G |
Hpcal1 |
hippocalcin-like 1 |
multiple interactions increases expression |
ISO |
[Selenium co-treated with Vitamin E] results in decreased expression of HPCAL1 mRNA Selenium results in increased expression of HPCAL1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 6:40,478,206...40,584,721
Ensembl chr 6:40,478,208...40,584,687
|
|
G |
Hpgds |
hematopoietic prostaglandin D synthase |
multiple interactions |
ISO |
[Selenium deficiency co-treated with 4-(benzo(b)thiophen-2-yl)-3-bromo-5-hydroxydihydrofuran-2(3H)-one co-treated with Lipopolysaccharides] results in increased expression of HPGDS mRNA; [Selenium deficiency co-treated with 4-(benzo(b)thiophen-2-yl)-3-bromo-5-hydroxydihydrofuran-2(3H)-one co-treated with Lipopolysaccharides] results in increased expression of HPGDS protein; [Selenium deficiency co-treated with parthenolide co-treated with Lipopolysaccharides] results in increased expression of HPGDS mRNA; [Selenium deficiency co-treated with parthenolide co-treated with Lipopolysaccharides] results in increased expression of HPGDS protein; [Selenium deficiency co-treated with rosiglitazone] results in increased expression of HPGDS protein |
CTD |
PMID:21669866 |
|
NCBI chr 4:94,368,426...94,397,931
Ensembl chr 4:94,373,342...94,397,883
|
|
G |
Hpn |
hepsin |
increases expression |
ISO |
Selenium results in increased expression of HPN mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 1:86,337,085...86,352,785
Ensembl chr 1:86,337,087...86,352,811
|
|
G |
Hras |
HRas proto-oncogene, GTPase |
multiple interactions increases expression |
ISO |
[Selenium co-treated with Vitamin E] results in increased expression of HRAS mRNA Selenium results in increased expression of HRAS mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 1:196,290,127...196,299,823
Ensembl chr 1:196,296,263...196,300,615
|
|
G |
Hs3st3a1 |
heparan sulfate-glucosamine 3-sulfotransferase 3A1 |
decreases expression |
ISO |
Selenium results in decreased expression of HS3ST3A1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr10:49,092,850...49,180,676
Ensembl chr10:49,094,026...49,180,676
|
|
G |
Hsd11b2 |
hydroxysteroid 11-beta dehydrogenase 2 |
multiple interactions |
EXP ISO |
[Selenium deficiency co-treated with Vitamin E deficiency] results in decreased expression of HSD11B2 mRNA; [Sodium Selenite results in increased abundance of Selenium] inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of HSD11B2 mRNA]; [Sodium Selenite results in increased abundance of Selenium] inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of HSD11B2 protein]; [Sodium Selenite results in increased abundance of Selenium] which results in increased expression of HSD11B2 protein |
CTD |
PMID:11444866 PMID:35384129 |
|
NCBI chr19:33,397,656...33,402,899
Ensembl chr19:33,397,656...33,402,899
|
|
G |
Hsd17b11 |
hydroxysteroid (17-beta) dehydrogenase 11 |
increases expression |
ISO |
Selenium deficiency results in increased expression of HSD17B11 mRNA; Selenium results in increased expression of HSD17B11 mRNA |
CTD |
PMID:16170372 |
|
NCBI chr14:5,693,304...5,743,157
Ensembl chr14:5,711,964...5,743,161
|
|
G |
Hsd17b3 |
hydroxysteroid (17-beta) dehydrogenase 3 |
multiple interactions |
EXP |
Selenium inhibits the reaction [Acrylamide results in decreased expression of HSD17B3 mRNA] |
CTD |
PMID:37987225 |
|
NCBI chr17:1,027,229...1,058,554
Ensembl chr17:1,027,229...1,058,554
|
|
G |
Hsd17b8 |
hydroxysteroid (17-beta) dehydrogenase 8 |
increases expression |
ISO |
Selenium results in increased expression of HSD17B8 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr20:4,826,725...4,828,742
Ensembl chr20:4,822,026...4,828,742
|
|
G |
Hsd3b1 |
hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 1 |
increases expression |
ISO |
Selenium deficiency results in increased expression of HSD3B2 mRNA; Selenium results in increased expression of HSD3B2 mRNA |
CTD |
PMID:16170372 |
|
NCBI chr 2:186,169,864...186,175,984
Ensembl chr 2:186,169,863...186,175,999
|
|
G |
Hsp90aa1 |
heat shock protein 90 alpha family class A member 1 |
multiple interactions increases expression decreases expression |
ISO |
[Selenium co-treated with Vitamin E] results in decreased expression of HSP90AA1 mRNA; Acetylcysteine inhibits the reaction [bisphenol A promotes the reaction [Selenium deficiency results in increased expression of HSP90AA1 mRNA]]; Acetylcysteine inhibits the reaction [bisphenol A promotes the reaction [Selenium deficiency results in increased expression of HSP90AA1 protein]]; bisphenol A promotes the reaction [Selenium deficiency results in increased expression of HSP90AA1 mRNA]; bisphenol A promotes the reaction [Selenium deficiency results in increased expression of HSP90AA1 protein]; necrostatin-1 inhibits the reaction [bisphenol A promotes the reaction [Selenium deficiency results in increased expression of HSP90AA1 mRNA]]; necrostatin-1 inhibits the reaction [bisphenol A promotes the reaction [Selenium deficiency results in increased expression of HSP90AA1 protein]] Selenium deficiency results in increased expression of HSP90AA1 mRNA; Selenium deficiency results in increased expression of HSP90AA1 protein Selenium results in decreased expression of HSP90AA1 mRNA |
CTD |
PMID:19244175 PMID:37422542 |
|
NCBI chr 6:129,702,376...129,707,907
Ensembl chr 6:129,702,383...129,707,268
|
|
G |
Hsp90ab1 |
heat shock protein 90 alpha family class B member 1 |
increases expression |
ISO |
Selenium results in increased expression of HSP90AB1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 9:15,432,986...15,438,358
Ensembl chr 9:15,433,691...15,438,488
|
|
G |
Hsp90b1 |
heat shock protein 90 beta family member 1 |
multiple interactions decreases expression |
ISO |
[Selenium co-treated with Vitamin E] results in decreased expression of HSP90B1 mRNA Selenium results in decreased expression of HSP90B1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 7:21,110,431...21,124,762
Ensembl chr 7:21,110,457...21,124,788
|
|
G |
Hspa1a |
heat shock protein family A (Hsp70) member 1A |
increases expression multiple interactions |
ISO |
Selenium results in increased expression of HSPA1A mRNA; Selenium results in increased expression of HSPA1A protein [Selenium co-treated with Fluorides] results in increased expression of HSPA1A mRNA; Fluorides promotes the reaction [Selenium results in increased expression of HSPA1A protein] |
CTD |
PMID:19244175 PMID:19652462 |
|
NCBI chr20:3,870,765...3,873,221
Ensembl chr20:3,856,006...3,873,227
|
|
G |
Hspa4 |
heat shock protein family A (Hsp70) member 4 |
multiple interactions |
ISO |
[Selenium co-treated with Vitamin E] results in increased expression of HSPA4 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr10:37,408,025...37,449,080
Ensembl chr10:37,408,025...37,449,001
|
|
G |
Hspa9 |
heat shock protein family A (Hsp70) member 9 |
decreases expression multiple interactions |
ISO |
Selenium results in decreased expression of HSPA9 mRNA [Selenium co-treated with Vitamin E] results in decreased expression of HSPA9 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr18:26,536,131...26,554,294
Ensembl chr18:26,535,798...26,554,292
|
|
G |
Hspb1 |
heat shock protein family B (small) member 1 |
increases expression |
ISO |
Selenium results in increased expression of HSPB1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr12:20,794,014...20,795,675
Ensembl chr12:20,794,028...20,795,743
|
|
G |
Hspb2 |
heat shock protein family B (small) member 2 |
decreases expression |
ISO |
Selenium results in decreased expression of HSPB2 mRNA |
CTD |
PMID:18997278 |
|
NCBI chr 8:51,093,267...51,094,528
Ensembl chr 8:51,081,342...51,094,533
|
|
G |
Hspbap1 |
HSPB1 associated protein 1 |
decreases expression |
ISO |
Selenium results in decreased expression of HSPBAP1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr11:64,940,089...64,994,753
Ensembl chr11:64,940,091...64,994,756
|
|
G |
Hspd1 |
heat shock protein family D (Hsp60) member 1 |
multiple interactions increases expression |
ISO |
Acetylcysteine inhibits the reaction [bisphenol A promotes the reaction [Selenium deficiency results in increased expression of HSPD1 mRNA]]; Acetylcysteine inhibits the reaction [bisphenol A promotes the reaction [Selenium deficiency results in increased expression of HSPD1 protein]]; bisphenol A promotes the reaction [Selenium deficiency results in increased expression of HSPD1 mRNA]; bisphenol A promotes the reaction [Selenium deficiency results in increased expression of HSPD1 protein]; necrostatin-1 inhibits the reaction [bisphenol A promotes the reaction [Selenium deficiency results in increased expression of HSPD1 mRNA]]; necrostatin-1 inhibits the reaction [bisphenol A promotes the reaction [Selenium deficiency results in increased expression of HSPD1 protein]] Selenium deficiency results in increased expression of HSPD1 mRNA; Selenium deficiency results in increased expression of HSPD1 protein |
CTD |
PMID:37422542 |
|
NCBI chr 9:56,579,195...56,590,011
Ensembl chr 9:56,579,201...56,589,662
|
|
G |
Htr4 |
5-hydroxytryptamine receptor 4 |
increases expression |
ISO |
Selenium results in increased expression of HTR4 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr18:55,765,981...55,949,921
Ensembl chr18:55,766,725...55,949,321
|
|
G |
Iars1 |
isoleucyl-tRNA synthetase 1 |
multiple interactions decreases expression |
ISO |
[Selenium co-treated with Vitamin E] results in increased expression of IARS1 mRNA Selenium results in decreased expression of IARS1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr17:14,940,919...14,987,277
Ensembl chr17:14,940,924...14,987,237
|
|
G |
Ica1 |
islet cell autoantigen 1 |
multiple interactions increases expression |
ISO |
[Selenium co-treated with Vitamin E] results in decreased expression of ICA1 mRNA Selenium results in increased expression of ICA1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 4:36,656,475...36,804,705
Ensembl chr 4:36,656,475...36,804,298
|
|
G |
Id1 |
inhibitor of DNA binding 1 |
increases expression |
ISO |
Selenium results in increased expression of ID1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 3:141,210,666...141,212,420
Ensembl chr 3:141,211,267...141,212,419
|
|
G |
Id2 |
inhibitor of DNA binding 2 |
decreases expression |
ISO |
Selenium results in decreased expression of ID2 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 6:41,740,556...41,742,393
Ensembl chr 6:41,728,946...41,744,400
|
|
G |
Idh3b |
isocitrate dehydrogenase (NAD(+)) 3 non-catalytic subunit beta |
increases expression |
ISO |
Selenium results in increased expression of IDH3B mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 3:117,481,845...117,486,909
Ensembl chr 3:117,481,845...117,486,982
|
|
G |
Idh3g |
isocitrate dehydrogenase (NAD(+)) 3 non-catalytic subunit gamma |
multiple interactions increases expression |
ISO |
[Selenium co-treated with Vitamin E] results in increased expression of IDH3G mRNA Selenium results in increased expression of IDH3G mRNA |
CTD |
PMID:19244175 |
|
NCBI chr X:151,515,244...151,524,175
Ensembl chr X:151,515,247...151,524,171
|
|
G |
Idua |
alpha-L-iduronidase |
multiple interactions increases expression |
ISO |
[Selenium co-treated with Vitamin E] results in increased expression of IDUA mRNA Selenium results in increased expression of IDUA mRNA |
CTD |
PMID:19244175 |
|
NCBI chr14:1,031,588...1,059,494
Ensembl chr14:1,032,171...1,046,522
|
|
G |
Ier3 |
immediate early response 3 |
increases expression |
ISO |
Selenium results in increased expression of IER3 mRNA |
CTD |
PMID:17293063 |
|
NCBI chr20:2,928,378...2,929,582
Ensembl chr20:2,928,378...2,929,583
|
|
G |
Ifi35 |
interferon-induced protein 35 |
increases expression |
ISO |
Selenium results in increased expression of IFI35 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr10:86,381,023...86,389,279
Ensembl chr10:86,381,010...86,389,952
|
|
G |
Ifitm1 |
interferon induced transmembrane protein 1 |
increases expression |
ISO |
Selenium results in increased expression of IFITM1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 1:196,067,163...196,069,169
Ensembl chr 1:196,067,963...196,069,169
|
|
G |
Ifitm2 |
interferon induced transmembrane protein 2 |
increases expression |
ISO |
Selenium results in increased expression of IFITM2 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 1:196,051,539...196,052,719
Ensembl chr 1:196,051,537...196,052,741
|
|
G |
Ifitm3 |
interferon induced transmembrane protein 3 |
increases expression |
ISO |
Selenium results in increased expression of IFITM3 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 1:196,111,026...196,112,135
Ensembl chr 1:196,111,043...196,112,203
|
|
G |
Ifna1 |
interferon, alpha 1 |
multiple interactions |
ISO |
[Cadmium analog co-treated with Selenium analog co-treated with zinc sulfide analog] affects the expression of IFNA1 mRNA |
CTD |
PMID:21481475 |
|
NCBI chr 5:103,097,356...103,097,925
Ensembl chr 5:103,097,356...103,097,925
|
|
G |
Ifng |
interferon gamma |
decreases expression |
ISO |
Selenium results in decreased expression of IFNG protein |
CTD |
PMID:14624943 |
|
NCBI chr 7:53,903,339...53,907,375
Ensembl chr 7:53,903,337...53,907,375
|
|
G |
Ifrd2 |
interferon-related developmental regulator 2 |
increases expression |
ISO |
Selenium results in increased expression of IFRD2 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 8:108,260,969...108,266,191
Ensembl chr 8:108,260,969...108,266,194
|
|
G |
Ift74 |
intraflagellar transport 74 |
decreases expression multiple interactions |
ISO |
Selenium results in decreased expression of IFT74 mRNA [Selenium co-treated with Vitamin E] results in decreased expression of IFT74 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 5:109,460,372...109,563,839
Ensembl chr 5:109,474,255...109,563,833
|
|
G |
Ift81 |
intraflagellar transport 81 |
decreases expression |
ISO |
Selenium results in decreased expression of IFT81 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr12:33,957,744...34,037,164
Ensembl chr12:33,957,806...34,037,057
|
|
G |
Igf2r |
insulin-like growth factor 2 receptor |
decreases expression |
ISO |
Selenium results in decreased expression of IGF2R mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 1:47,979,109...48,067,501
Ensembl chr 1:47,979,109...48,067,501
|
|
G |
Igfbp2 |
insulin-like growth factor binding protein 2 |
increases expression |
ISO |
Selenium results in increased expression of IGFBP2 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 9:74,415,574...74,442,945
Ensembl chr 9:74,415,546...74,442,937
|
|
G |
Igfbp3 |
insulin-like growth factor binding protein 3 |
increases expression |
ISO |
Selenium results in increased expression of IGFBP3 mRNA; Selenium results in increased expression of IGFBP3 protein |
CTD |
PMID:15318950 PMID:18997278 |
|
NCBI chr14:82,056,347...82,064,083
Ensembl chr14:82,056,347...82,064,083
|
|
G |
Igfbp4 |
insulin-like growth factor binding protein 4 |
increases expression |
ISO |
Selenium results in increased expression of IGFBP4 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr10:83,995,253...84,007,272
Ensembl chr10:83,989,591...84,007,225
|
|
G |
Igfbp6 |
insulin-like growth factor binding protein 6 |
increases expression |
ISO |
Selenium results in increased expression of IGFBP6 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 7:133,276,309...133,280,944
Ensembl chr 7:133,276,234...133,280,966
|
|
G |
Ik |
IK cytokine |
increases expression |
ISO |
Selenium results in increased expression of IK mRNA |
CTD |
PMID:19244175 |
|
NCBI chr18:28,358,004...28,372,809
Ensembl chr18:28,357,977...28,378,832
|
|
G |
Ikbkb |
inhibitor of nuclear factor kappa B kinase subunit beta |
multiple interactions |
ISO |
Selenium inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased activity of IKBKB protein] [Cadmium analog co-treated with Selenium analog co-treated with zinc sulfide analog] results in increased expression of IKBKB mRNA |
CTD |
PMID:17439952 PMID:21481475 |
|
NCBI chr16:69,319,487...69,373,251
Ensembl chr16:69,319,554...69,373,250
|
|
G |
Il10 |
interleukin 10 |
multiple interactions |
EXP ISO |
[Vanadium co-treated with Selenium co-treated with Vitamin E co-treated with Chromium] inhibits the reaction [Streptozocin results in decreased expression of IL10 protein]; Selenium affects the reaction [Mercuric Chloride results in decreased expression of IL10 protein] [Drugs, Chinese Herbal co-treated with Selenium] results in increased expression of IL10 mRNA [Cadmium analog co-treated with Selenium analog co-treated with zinc sulfide analog] results in decreased expression of IL10 mRNA; [Cadmium analog co-treated with Selenium analog co-treated with zinc sulfide analog] results in increased expression of IL10 mRNA |
CTD |
PMID:15862027 PMID:21481475 PMID:24626144 PMID:26089086 |
|
NCBI chr13:42,472,625...42,477,308
Ensembl chr13:42,472,839...42,477,313
|
|
G |
Il16 |
interleukin 16 |
increases expression |
ISO |
Selenium deficiency results in increased expression of IL16 mRNA |
CTD |
PMID:37422542 |
|
NCBI chr 1:137,617,702...137,718,022
Ensembl chr 1:137,617,944...137,718,130
|
|
G |
Il17rc |
interleukin 17 receptor C |
increases expression |
ISO |
Selenium results in increased expression of IL17RC mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 4:146,618,321...146,631,444
Ensembl chr 4:146,619,004...146,631,442
|
|
G |
Il1b |
interleukin 1 beta |
multiple interactions increases expression |
ISO EXP |
[Cadmium analog co-treated with Selenium analog co-treated with zinc sulfide analog] results in increased expression of IL1B mRNA; Acetylcysteine inhibits the reaction [bisphenol A promotes the reaction [Selenium deficiency results in increased expression of IL1B mRNA]]; Acetylcysteine inhibits the reaction [bisphenol A promotes the reaction [Selenium deficiency results in increased expression of IL1B protein]]; bisphenol A promotes the reaction [Selenium deficiency results in increased expression of IL1B mRNA]; bisphenol A promotes the reaction [Selenium deficiency results in increased expression of IL1B protein]; necrostatin-1 inhibits the reaction [bisphenol A promotes the reaction [Selenium deficiency results in increased expression of IL1B mRNA]]; necrostatin-1 inhibits the reaction [bisphenol A promotes the reaction [Selenium deficiency results in increased expression of IL1B protein]]; Selenium affects the reaction [IL1B protein results in increased abundance of Hydrogen Peroxide]; Selenium inhibits the reaction [IL1B protein results in increased abundance of Hydrogen Peroxide]; Selenium promotes the reaction [T-2 Toxin results in increased expression of IL1B protein] Selenium inhibits the reaction [Acrylamide results in increased expression of IL1B protein] [Selenium co-treated with Lipopolysaccharides co-treated with IL4 protein] results in decreased expression of IL1B mRNA; Selenium inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of IL1B mRNA] Selenium deficiency results in increased expression of IL1B mRNA; Selenium deficiency results in increased expression of IL1B protein; Selenium results in increased expression of IL1B mRNA |
CTD |
PMID:10802230 PMID:17293063 PMID:17630198 PMID:18196609 PMID:21481475 PMID:21775527 PMID:25187657 PMID:37422542 PMID:37987225 More...
|
|
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
|
|
G |
Il1r2 |
interleukin 1 receptor type 2 |
multiple interactions |
ISO |
[Cadmium analog co-treated with Selenium analog co-treated with zinc sulfide analog] results in decreased expression of IL1R2 mRNA |
CTD |
PMID:21481475 |
|
NCBI chr 9:42,384,280...42,424,726
Ensembl chr 9:42,384,433...42,424,725
|
|
G |
Il1rapl2 |
interleukin 1 receptor accessory protein-like 2 |
multiple interactions |
ISO |
[Cadmium analog co-treated with Selenium analog co-treated with zinc sulfide analog] results in decreased expression of IL1RAPL2 mRNA |
CTD |
PMID:21481475 |
|
NCBI chr X:100,961,509...102,271,753
Ensembl chr X:100,961,812...102,271,753
|
|
G |
Il1rl2 |
interleukin 1 receptor-like 2 |
multiple interactions |
ISO |
[Cadmium analog co-treated with Selenium analog co-treated with zinc sulfide analog] results in decreased expression of IL1RL2 mRNA |
CTD |
PMID:21481475 |
|
NCBI chr 9:42,591,658...42,639,351
Ensembl chr 9:42,591,934...42,636,667
|
|
G |
Il1rn |
interleukin 1 receptor antagonist |
multiple interactions |
ISO |
[Cadmium analog co-treated with Selenium analog co-treated with zinc sulfide analog] results in decreased expression of IL1RN mRNA |
CTD |
PMID:21481475 |
|
NCBI chr 3:7,111,567...7,127,451
Ensembl chr 3:7,111,550...7,127,445
|
|
G |
Il2 |
interleukin 2 |
affects expression |
EXP |
Selenium affects the expression of IL2 protein |
CTD |
PMID:19035182 |
|
NCBI chr 2:120,004,862...120,009,566
Ensembl chr 2:120,004,862...120,009,566
|
|
G |
Il4 |
interleukin 4 |
decreases expression multiple interactions |
ISO EXP |
Selenium results in decreased expression of IL4 protein 2-chloro-5-nitrobenzanilide inhibits the reaction [[Selenium co-treated with IL4 protein] results in increased activity of ARG1 protein]; 2-chloro-5-nitrobenzanilide inhibits the reaction [[Selenium co-treated with IL4 protein] results in increased expression of MRC1 mRNA]; 4-benzhydryloxy-1-(3-(1H-tetrazol-5-yl-)-propyl)piperidine inhibits the reaction [[Selenium co-treated with IL4 protein] results in increased activity of ARG1 protein]; [Selenium co-treated with IL4 protein] results in increased activity of ARG1 protein; [Selenium co-treated with IL4 protein] results in increased expression of ARG1 mRNA; [Selenium co-treated with IL4 protein] results in increased expression of MRC1 mRNA; [Selenium co-treated with Lipopolysaccharides co-treated with IL4 protein] results in decreased expression of IL1B mRNA; [Selenium co-treated with Lipopolysaccharides co-treated with IL4 protein] results in decreased expression of TNF mRNA; leflunomide inhibits the reaction [[Selenium co-treated with IL4 protein] results in increased activity of ARG1 protein]; rosiglitazone promotes the reaction [[Selenium co-treated with IL4 protein] results in increased activity of ARG1 protein]; Selenium deficiency inhibits the reaction [IL4 protein results in increased expression of GPX1 protein] [Vanadium co-treated with Selenium co-treated with Vitamin E co-treated with Chromium] results in increased expression of IL4 protein |
CTD |
PMID:14624943 PMID:15862027 PMID:21775527 |
|
NCBI chr10:37,771,203...37,776,750
Ensembl chr10:37,771,203...37,776,750
|
|
G |
Il4r |
interleukin 4 receptor |
multiple interactions increases expression |
ISO |
[Selenium co-treated with Vitamin E] results in decreased expression of IL4R mRNA Selenium results in increased expression of IL4R mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 1:180,115,061...180,139,981
Ensembl chr 1:180,115,120...180,139,980
|
|
G |
Il6 |
interleukin 6 |
multiple interactions increases expression |
ISO EXP |
[Cadmium analog co-treated with Selenium analog co-treated with zinc sulfide analog] results in increased expression of IL6 mRNA; Acetylcysteine inhibits the reaction [bisphenol A promotes the reaction [Selenium deficiency results in increased expression of IL6 mRNA]]; Acetylcysteine inhibits the reaction [bisphenol A promotes the reaction [Selenium deficiency results in increased expression of IL6 protein]]; bisphenol A promotes the reaction [Selenium deficiency results in increased expression of IL6 mRNA]; bisphenol A promotes the reaction [Selenium deficiency results in increased expression of IL6 protein]; necrostatin-1 inhibits the reaction [bisphenol A promotes the reaction [Selenium deficiency results in increased expression of IL6 mRNA]]; necrostatin-1 inhibits the reaction [bisphenol A promotes the reaction [Selenium deficiency results in increased expression of IL6 protein]] [Selenium co-treated with Zinc] inhibits the reaction [[Lead co-treated with Cadmium co-treated with Mercury co-treated with Arsenic] results in increased expression of IL6 protein]; Selenium affects the reaction [Mercuric Chloride results in decreased expression of IL6 protein]; Selenium inhibits the reaction [[Lead co-treated with Cadmium co-treated with Mercury co-treated with Arsenic] results in increased expression of IL6 protein]; Selenium inhibits the reaction [Acrylamide results in increased expression of IL6 protein] |
CTD |
PMID:21481475 PMID:26089086 PMID:37422542 PMID:37676925 PMID:37987225 |
|
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
|
|
G |
Il6st |
interleukin 6 cytokine family signal transducer |
decreases expression |
ISO |
Selenium results in decreased expression of IL6ST mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 2:44,065,979...44,106,255
Ensembl chr 2:44,066,130...44,109,936
|
|
G |
Ilf3 |
interleukin enhancer binding factor 3 |
multiple interactions |
ISO |
[Selenium co-treated with Vitamin E] results in increased expression of ILF3 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 8:19,922,409...19,960,495
Ensembl chr 8:19,922,460...19,960,350
|
|
G |
Ilk |
integrin-linked kinase |
increases expression |
ISO |
Selenium results in increased expression of ILK mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 1:160,088,839...160,095,140
Ensembl chr 1:160,088,897...160,095,140
|
|
G |
Ilrun |
inflammation and lipid regulator with UBA-like and NBR1-like domains |
increases expression |
ISO |
Selenium results in increased expression of ILRUN mRNA |
CTD |
PMID:19244175 |
|
NCBI chr20:5,809,931...5,876,197
Ensembl chr20:5,809,936...5,876,012
|
|
G |
Inpp5k |
inositol polyphosphate-5-phosphatase K |
increases expression |
ISO |
Selenium results in increased expression of INPP5K mRNA |
CTD |
PMID:19244175 |
|
NCBI chr10:60,474,262...60,495,813
Ensembl chr10:60,475,897...60,496,773
|
|
G |
Ins1 |
insulin 1 |
multiple interactions |
ISO |
[Selenium co-treated with Vitamin E co-treated with Vanadium co-treated with Chromium] results in increased expression of INS1 mRNA; [Selenium co-treated with Vitamin E co-treated with Vanadium co-treated with Chromium] results in increased expression of INS1 protein |
CTD |
PMID:20108212 |
|
NCBI chr 1:251,244,973...251,245,540
Ensembl chr 1:251,244,973...251,245,536
|
|
G |
Ins2 |
insulin 2 |
multiple interactions |
ISO |
[Selenium analog co-treated with Magnesium Oxide analog] inhibits the reaction [Diazinon results in decreased secretion of INS protein alternative form]; [Selenium analog co-treated with Magnesium Oxide analog] inhibits the reaction [Diazinon results in decreased secretion of INS protein]; Selenium analog inhibits the reaction [Diazinon results in decreased secretion of INS protein alternative form]; Selenium analog inhibits the reaction [Diazinon results in decreased secretion of INS protein] |
CTD |
PMID:27920530 |
|
NCBI chr 1:197,843,277...197,992,522
Ensembl chr 1:197,843,281...197,864,775
|
|
G |
Ints1 |
integrator complex subunit 1 |
increases expression |
ISO |
Selenium results in increased expression of INTS1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr12:14,861,312...14,886,048
Ensembl chr12:14,861,318...14,886,037
|
|
G |
Ints15 |
integrator complex subunit 15 |
increases expression |
ISO |
Selenium results in increased expression of INTS15 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr12:11,245,045...11,260,170
Ensembl chr12:11,245,842...11,260,166
|
|
G |
Ints3 |
integrator complex subunit 3 |
increases expression |
ISO |
Selenium results in increased expression of INTS3 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 2:175,859,421...175,911,683
Ensembl chr 2:175,859,440...175,911,709
|
|
G |
Ints6 |
integrator complex subunit 6 |
multiple interactions decreases expression |
ISO |
[Selenium co-treated with Vitamin E] results in decreased expression of INTS6 mRNA Selenium results in decreased expression of INTS6 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr15:36,908,966...37,048,043
Ensembl chr15:36,933,724...37,021,527
|
|
G |
Iqcb1 |
IQ motif containing B1 |
multiple interactions decreases expression |
ISO |
[Selenium co-treated with Vitamin E] results in decreased expression of IQCB1 mRNA Selenium results in decreased expression of IQCB1 mRNA |
| |